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Abstract
Enzymes are versatile catalysts for chemical reactions, mostly proteins, with various applica-
tions in white biotechnology due to their characteristic properties, such as reaction specificity,
substrate specificity, regiospecificity or stereospecificity. Proteins are macromolecules composed
of one or multiple chains of amino acids, with the amino acids serving as functional building
blocks. In addition, cofactors, usually organic compounds or ions, can be required for an en-
zyme to catalyze chemical reactions. Thus, the function of an enzyme is determined by its
molecular structure and composition, which is in turn encoded in the sequence of amino acids,
the protein sequence.
The vast amount of data on protein sequences that is nowadays available in publicly acces-
sible databases is a promising starting point for the exploration of new enzymatic functions or
enzymes with improved catalytic characteristics. On the other hand, sophisticated techniques
are required to organize these large data on protein sequences, to identify individual enzyme
candidates in such large data and to relate protein sequences of such a candidate enzyme with
homologous protein sequences of relevant function. Additionally, it is desirable to identify
structurally equivalent amino acid positions across a family of homologous protein sequences,
e. g. in order to prepare mutations for the design of enzymes with desired properties.
The first part of this thesis describes properties of protein sequence networks, which are gen-
erated by pairwise protein sequence alignments and are thereby a model for sequence-sequence
relationships. Individual protein sequences are represented as nodes connected by weighted
edges in a protein sequence network, with edges being defined by a threshold of pairwise se-
quence identity or sequence similarity. The concept of relating protein sequences in connected
networks, rather than in strictly separated homologous protein families, allows the identifica-
tion of individual protein sequences with interesting properties: The densely connected hubs
of a protein sequence network hint at evolvable proteins, as a starting point for mutations in
enzyme design. Protein sequences that are found as connectors between two different network
communities, i. e. between two densely connected regions in a protein sequence network (equiv-
alent of two homologous protein families), point at enzyme candidates with properties similar
to both groups of enzymes. Furthermore, the concept of protein sequence networks allows to
derive principles of enzyme evolution, such as the approximation of a fractal network dimension
representing evolvability and likelihoods of amino acid mutations.
At the end of the first part, an exemplary protein sequence network of ω-transaminases from
fold type IV is used to highlight sequences that match characteristic amino acid positions or
sequence motifs. The identification of these structurally equivalent positions is enabled by a
newly implemented standard numbering scheme for fold type IV ω-transaminases, showing
sequence-structure relationships.
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Besides bioinformatic analyses of protein sequence and structure, the biochemical charac-
terization of enzyme candidates results in additional, heterogeneous data from various sources,
which have to be linked with metadata on the conditions of the reaction or process under inves-
tigation. These biocatalytic data can be ratios, such as enantiomeric excess, yield or conversion
of a biocatalytic reaction, or data on substrate or product concentrations over time, which
are useful for investigating reaction kinetics. Hence, both bioinformatics and biocatalysis use
various types of inhomogeneous data, including protein sequences, taxonomic information on
source organisms, structural information on proteins, metadata on the reaction under investiga-
tion and experimental observations. It is desirable to unambiguously link these heterogeneous
data with each other, which requires a strategy for data integration to facilitate both the search
for new enzyme candidates and their experimental characterization.
The second part of this thesis describes implementations and applications of the BioCatNet
database system, as a consistent approach to integrate the different data types mentioned
above. The data model of the BioCatNet database system has been revised with regards to
experimental data. The BioCatNet concept distinguishes between original data, such as protein
sequences, structures and experimental data from collaborative research projects, and model-
derived information, such as annotations of structurally equivalent positions within protein
sequences or kinetic parameters that are derived from fitting kinetic models against measured
time-course data.
The symmetric carboligation catalyzed by benzaldehyde lyase from Pseudomonas fluorescens
is investigated as a test case for the the BioCatNet database system. Data sets of time-courses
for the two substrates benzaldehyde or 3,5-dimethoxybenzaldehyde are analyzed with different
kinetic models, highlighting the influence of different models and their respective assumptions
on the resulting kinetic parameter estimates. A kinetic model with substrate-dependent enzyme
inactivation is found as the best fit for the data on both substrates.
The lessons learned from the effects of different kinetic model equations on the outcome of
the parameter estimation allow in turn to refurbish the data management strategy of BioCat-
Net for future research projects on the exploration of enzymatic sequence-structure-function
relationships. The concepts of protein sequence networks, standard numbering schemes and the
estimation of kinetic parameters demand comparable requirements: The interpretation of the
results from data mining approaches depend on both data and models, with the term model
referring to concepts and assumptions that are applied on the original data, such as alignments
that are applied on protein sequences, or kinetic models that are applied on time-course mea-
surements. Therefore, both data and models should be combined in future data integration, to
ensure reproducibility of data mining results, ideally in one common data- and modelbase.
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Zusammenfassung
Enzyme sind vielseitige Katalysatoren fu¨r chemische Reaktionen, meistens Proteine, mit ver-
schiedenen Anwendungen in der weißen Biotechnologie aufgrund ihrer charakteristischen Ei-
genschaften, wie Reaktionsspezifita¨t, Substratspezifita¨t, Regiospezifita¨t oder Stereospezifita¨t.
Proteine sind Makromoleku¨le, welche aus einer oder mehreren Ketten von Aminosa¨uren
aufgebaut sind, wobei die Aminosa¨uren als funktionelle Bausteine dienen. Zusa¨tzlich ko¨nnen
Kofaktoren, fu¨r gewo¨hnlich organische Verbindungen oder Ionen, erforderlich sein, damit ein
Enzym chemische Reaktionen katalysieren kann. Folglich ist die Funktion eines Enzyms durch
seine molekulare Struktur und Zusammensetzung bestimmt, welche wiederum in der Sequenz
von Aminosa¨uren codiert ist, der Proteinsequenz.
Die gewaltige Datenmenge u¨ber Proteinsequenzen, die heutzutage in o¨ffentlich zuga¨nglichen
Datenbanken verfu¨gbar ist, ist ein vielversprechender Ausgangspunkt fu¨r die Erforschung neu-
er enzymatischer Funktionen oder von Enzymen mit verbesserten katalytischen Eigenschaften.
Andererseits sind anspruchsvolle Techniken erforderlich, um diese umfangreichen Daten u¨ber
Proteinsequenzen zu organisieren, einzelne Enzymkandidaten in solch umfangreichen Daten
ausfindig zu machen und die Proteinsequenzen eines solchen Enzymkandidaten mit homologen
Proteinsequenzen von relevanter Funktion in Beziehung zu setzen. Daru¨ber hinaus ist es erstre-
benswert, sich strukturell entsprechende Aminosa¨urepositionen u¨ber eine Familie homologer
Proteinsequenzen hinweg zu identifizieren, z. B. um Mutationen fu¨r das Design von Enzymen
mit gewu¨nschten Eigenschaften vorzubereiten.
Der erste Teil dieser Arbeit beschreibt Eigenschaften von Proteinsequenznetzwerken, wel-
che durch paarweise Sequenzalignments erzeugt werden und dadurch ein Model fu¨r Sequenz-
Sequenz-Beziehungen darstellen. Einzelne Proteinsequenzen werden als mit gewichteten Kan-
ten verbundene Knoten dargestellt, wobei die Kanten u¨ber einen Schwellenwert paarweiser
Sequenzidentita¨t oder Sequenza¨hnlichkeit festgelegt werden. Die Auffassung, Proteinsequenzen
in verknu¨pften Netzwerken miteinander in Beziehung zu setzen, anstatt in streng getrennten
homologen Proteinfamilien, erlaubt das Auffinden einzelner Proteinsequenzen mit interessan-
ten Eigenschaften: Die dicht verbundenen Knoten eines Proteinsequenznetzwerks deuten auf
evolvierbare Proteine hin, als Ausgangpunkt fu¨r Mutationen zum Design von Enzymen. Protein-
sequenzen, die als Verbinder zwischen zwei verschiedenen Netzwerkgruppen gefunden werden,
d. h. zwischen zwei eng verbundenen Bereichen in einem Proteinsequenznetzwerk (entspre-
chend zwei homologer Proteinfamilien), deuten auf Enzymkandidaten mit Eigenschaften, die
beiden Gruppen von Enzymen a¨hnlich sind. Daru¨ber hinaus erlaubt das Konzept von Pro-
teinsequenznetzwerken, Prinzipien der Enzymevolution herzuleiten, wie etwa die Anna¨herung
einer fraktalen Netzwerkdimension, welche die Evolvierbarkeit und die Wahrscheinlichkeit fu¨r
Aminosa¨ureaustausche darstellt.
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Am Ende des ersten Teiles wird ein beispielhaftes Proteinsequenznetzwerk fu¨rω-Transaminasen
aus Faltungstyp IV verwendet, um Sequenzen hervorzuheben, die zu charakteristischen Ami-
nosa¨urepositionen oder Sequenzmotiven passen. Das Auffinden dieser sich strukturell entspre-
chender Positionen wird durch ein neu implementiertes Standardnummerierungsschema fu¨r
Faltungstyp-IV-ω-Transaminasen ermo¨glicht, welches Sequenz-Struktur-Beziehungen aufzeigt.
Abgesehen von bioinformatischen Untersuchungen der Proteinsequenz und Struktur, fu¨hrt
die biochemische Charakterisierung von Enzymkandidaten zu weiteren, heterogenen Daten aus
verschiedenen Quellen, welche mit Metadaten u¨ber die Bedingungen der untersuchten Reaktion
oder des untersuchten Prozesses zusammengebracht werden mu¨ssen. Diese biokatalytischen
Daten ko¨nnen Verha¨ltnisse sein, wie Enantiomerenu¨berschuss, Ausbeute oder Umsatz einer
biokatalytischen Reaktion, oder Daten u¨ber Substrat- oder Produktkonzentrationen u¨ber der
Zeit, welche nu¨tzlich sind, um die Reaktionskinetik zu untersuchen. Dadurch verwenden sowohl
die Bioinformatik als auch die Biokatalyse verschiedene Typen heterogener Daten, darunter
Proteinsequenzen, taxonomische Information u¨ber Ursprungsorganismen, Strukturinformation
u¨ber Proteine, Metadaten u¨ber die untersuchte Reaktion und experimentelle Beobachtungen.
Es ist wu¨nschenswert, diese heterogenen Daten eindeutig miteinander zu verknu¨pfen, was eine
Strategie zur Datenintegration erfordert, um sowohl die Suche nach neuen Enzymkandidaten
als auch ihre experimentelle Beschreibung zu erleichtern.
Der zweite Teil dieser Arbeit beschreibt Implementierungen und Anwendungen des Bio-
CatNet-Datenbanksystems, als ein konsistenter Ansatz, um die verschiedenen oben erwa¨hnten
Datentypen zu integrieren. Das Datenmodell des BioCatNet-Datenbanksystems ist im Hinblick
auf experimentelle Daten u¨berarbeitet worden. Das BioCatNet-Konzept unterscheidet zwischen
Originaldaten, wie etwa Proteinsequenzen, Strukturen und experimentelle Daten aus gemein-
schaftlichen Forschungsprojekten, und Information, die mit Modellen abgeleitet wird, wie etwa
Annotationen sich strukturell entsprechender Aminosa¨urepositionen innerhalb von Proteinse-
quenzen, oder kinetische Parameter, welche von Fits kinetischer Modelle an gemessene Zeitver-
laufsdaten hergeleitet werden.
Die symmetrische Carboligation, welche von Benzaldehydlyase aus Pseudomonas fluorescens
katalysiert wird, wird als Fallbeispiel fu¨r das BioCatNet Datenbanksystem untersucht. Da-
tensa¨tze von Zeitverlaufsdaten fu¨r die zwei Substrate Benzaldehyd oder 3,5-Dimethoxybenz-
aldehyd werden mit verschiedenen kinetischen Modellen untersucht, wobei der Einfluss ver-
schiedener Modelle und ihrer entsprechenden Annahmen auf die daraus erfolgenden Parame-
terscha¨tzwerte hervorgehoben wird. Ein kinetisches Modell mit Substrat-abha¨ngiger Enzymin-
aktivierung wird als bester Fit fu¨r die Daten von beiden Substraten gefunden.
Die Lektionen, die aus den Einflu¨ssen verschiedener kinetischer Modellgleichungen auf das
Ergebnis der Parameterscha¨tzung gelernt wurden, erlauben wiederum die Strategie zur Da-
tenverwaltung von BioCatNet fu¨r zuku¨nftige Forschungsprojekte u¨ber enzymatische Sequenz-
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Struktur-Funktionsbeziehungen zu u¨berarbeiten. Die Konzepte von Proteinsequenznetzwer-
ken, Standardnummerierungsschemata und die Scha¨tzung kinetischer Parameter verlangen ver-
gleichbare Voraussetzungen: Die Interpretation der Ergebnisse aus den Data-Mining-Ansa¨tzen
ha¨ngt sowohl von den Daten als auch von den Modellen ab, wobei der Begriff Modell sich
auf Konzepte und Annahmen bezieht, welche auf die Originaldaten angewandt werden, wie
etwa Alignments, die auf Proteinsequenzen angewandt werden, oder kinetische Modelle, die auf
Zeitverlaufsmessungen angewandt werden.
Daher sollten sowohl Daten als auch Modelle in einer zuku¨nftigen Datenintegration kombi-
niert werden, um die Reproduzierbarkeit der Data-Mining-Ergebnisse zu gewa¨hrleisten, idea-
lerweise in einer gemeinsamen Daten- und Modelbank.
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1 Introduction
1 Introduction
According to the IUPAC Compendium of Chemical Terminology1 enzymes are mostly proteins
which catalyze chemical reactions, specific for a certain type of chemical reaction (reaction
specificity), with only certain types of chemical compounds being converted (substrate speci-
ficity) at specific sites (regiospecificity). Furthermore, in case of chiral substrates, one of the
enantiomers is converted preferably (stereospecificity).
Proteins are macromolecules, large polypeptides, composed of one or multiple chains of
amino acids. Sometimes additional helper molecules named cofactors, which are usually or-
ganic compounds or ions, are necessary for an enzyme to catalyze a chemical reaction. Amino
acids are functional building blocks encoding the molecular structure of an enzyme (or a protein
in general) in the amino acid or protein sequence. The protein structure in turn determines
the function of an enzyme. Related amino acid sequences are termed homologous sequences,
conceptualized in protein families, and are expected to result in proteins of comparable struc-
ture and function. Accordingly, it is assumed that there exists a relationship between protein
sequence, structure and function of enzymes. Mutations of amino acids are in turn expected to
result in different structural or functional features of an enzyme. The dynamics of an enzyme-
catalyzed reaction are described by kinetic model equations, representing the reaction velocity,
i. e. the changes of substrate or product concentrations over time (Xie, 2013).
The biological and biochemical diversity observed in nature is expressed in the diversity of
different data types, as descriptors of specific features and observations. Although this diversity
may be found overwhelming, it is a promising and tempting thought to consistently integrate
these different data and their aspects for subsequent routines of computational analyses (data
mining).
This chapter describes available data sources for sequence, structure and function of en-
zymes, as well as concepts of sequence-sequence and sequence-structure relationships. Finally,
enzyme function is described with a focus on enzyme kinetics, as outlined for the specific
exemplary kinetic model equations at the end of this chapter.
1.1 Data on sequence, structure and function of enzymes
Protein sequences are usually stored in large, publicly accessible databases, such as the non-
redundant protein database from the National Center for Biotechnology Information (NCBI)
(Benson et al., 2018), the UniProt database (Bateman et al., 2017) or the DNA Data Bank
of Japan (DDBJ) (Kaminuma et al., 2011). Due to advances in sequencing technologies, the
number of known protein sequences in these public databases is steadily increasing, raising the
1 https://goldbook.iupac.org/html/E/E02159.html, accessed on April 30, 2018.
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need for data management to facilitate the navigation in these large sequence data sets, as it
was outlined by the UniProt Consortium for its protein sequence databases (Bateman et al.,
2017). One of the central databases in the UniProt environment, the UniProt Knowledge Base
(KB), removed approximately 47,000,000 redundant entries in March 2015, still resulting in
tens of millions of non-redundant sequence entries, which exemplifies challenges in managing
these high amounts of data (Bateman et al., 2017). In addition to databases focused on protein
sequences, the Pfam database (Finn et al., 2015) organizes data on protein families by profile
hidden Markov models (HMMs), stochastic representations of sequence profiles derived from
multiple sequence alignments (reviewed by Eddy, 1998).
Information on individual protein structures is available in the Protein Data Bank (PDB),
with approximately 90 % of all protein structures being resolved by crystallography (Burley
et al., 2017). As an illustration, the UniProt database system currently contains tens of millions
of sequence entries (Bateman et al., 2017), whereas the number of individual protein structures
in the PDB is approximately 106 (Burley et al., 2017). Data on protein sequences and structures
have been proven as useful for the identification of enzymes with new functions (reviewed by
Lobb and Doxey, 2016).
For the investigations of relationships between protein sequence, structure and function of
enzymes, the different data sources mentioned above have to be considered in combination,
which demands technical means of data integration. Such a starting point for later data anal-
yses was provided by the previously developed data warehouse system for analyzing protein
families (DWARF ) that combined data on both protein sequence and protein structure in a
common data model (Fischer et al., 2006). This concept was later extended to link data from
biocatalytic experiments unambiguously to protein sequences of the respective enzymes, as
outlined in the first concepts of the BioCatNet database system by Reusch (2014) and Vogel
(2015), extending the data model of DWARF (Fischer et al., 2006) for time-course data from
biocatalytic measurements. Besides that, the BioCatNet data model from Reusch (2014) and
Vogel (2015) was also designed to contain more details on taxonomic data of source organisms
or source names that are linked to individual sequence entries.
Furthermore, there exist comprehensive and publicly available repositories on enzyme func-
tion, such as the Braunschweig Enzyme Database (BRENDA) (Schomburg et al., 2012), Ex-
plorEnz (McDonald et al., 2007), the Kyoto Encyclopedia of Genes and Genomes (KEGG)
REACTION (Kanehisa et al., 2006), and SABIO-RK (Wittig et al., 2012), which use literature
to collect biochemical data and information. In addition to these repositories, there have been
detailed suggestions for the description of experimental data on enzymes, such as the ones
provided by the Standards for Reporting Enzymology Data (STRENDA) Consortium (Tip-
ton et al., 2014) 2, as well as additional recommendations for data on biocatalytic reactions
2 http://www.beilstein-institut.de/en/projects/strenda/guidelines, accessed on April 30, 2018.
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(Gardossi et al., 2010). The concepts of STRENDA have recently been implemented for direct
data submission from experimenters, as a validation of data consistency prior to publication
(Swainston et al., 2018).
One type of investigations on enzyme function focuses on the kinetics of an enzyme-catalyzed
reaction, i. e. the identification of model equations and corresponding parameter values that
describe the changes in substrate or product concentration over time (Xie, 2013). These kinetic
models can be helpful in the identification of optimized process conditions for an enzyme-
catalyzed reaction (Vasic´-Racˇki et al., 2003; Almquist et al., 2014). Often, enzyme kinetic
studies focus on the initial rate of an reaction, missing information on the complete time-course
(also termed progress curve data) of substrate depletion or product formation, whereas time-
course data can provide deeper insights into the dynamics of a reaction system (Duggleby and
Morrison, 1978; Duggleby, 2001).
It would be desirable to combine the different resources on protein sequences and structures
mentioned above with experimental data. Furthermore, one could think of computational tools
to
1. identify enzyme candidates in large sequence data sets
2. describe evolutionary constraints for enzyme sequences
3. identify structurally equivalent positions within an enzyme family
4. analyze multiple sets of annotated time-course data by various models
1.2 Sequence-sequence relationships: networks
Atkinson et al. (2009) were among the first to apply the concept of networks (also named graphs)
on comprehensive data sets of protein sequences in an approach named Sequence Similarity
Network (SSN), based on the heuristics of BLAST (Basic Local Alignment Search Tool) for
pairwise combinations within a sequence set and the choice of an E-value threshold to define
edges in a network. The E-value describes the expectation value of finding random matches
during the local alignments of a BLAST search against a sequence database (Altschul et al.,
1990).
In such a network representation, protein sequences are regarded as nodes connected by
weighted edges, which in turn indicate a metric of sequence homology. Sequence similarity
networks constructed by the approach from Atkinson et al. (2009) were proven helpful in the
investigations of various sets of sequences, such as in recent studies on tautomerases (Davidson
et al., 2018) or proteins from Geminiviridae (Vaghi Medina et al., 2017). In this work, networks
between homologous sequences were constructed differently, as outlined in chapters A.1 and
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A.2, and were thus named more generally protein sequence networks, instead of the term
sequence similarity networks that was coined for the approach from Atkinson et al. (2009). Here,
the alignment techniques from the heuristics of USEARCH (Edgar, 2010) or pairwise alignments
according to Needleman and Wunsch (1970) were used to construct networks, instead of the
BLAST-based SSN approach from Atkinson et al. (2009).
Atkinson et al. (2009) also stated that a network representation of pairwise distances be-
tween protein sequences is generally advantageous in comparison to phylogenetic trees, since
the latter projects relationships from multiple sequence alignments onto a single dimension,
whereas networks are able to reveal multiple neighborhood relationships between protein se-
quences, thereby possibly showing links between divergent subfamilies of sequences that would
be omitted in a phylogenetic tree (Atkinson et al., 2009). Since phylogenetic trees are derived
from multiple sequence alignments, in contrast to protein sequence networks which are derived
from pairwise alignments of sequences against each other, they are not able to capture relation-
ships of protein sequences that are dissimilar to most of the other sequences in an alignment
(compare with Rost, 1999).
For the protein family of TEM β-lactamases, protein sequence networks could be con-
structed with edges defined as mutations of single amino acids, due to the high microdiversity
for this protein family, thereby following an alternative approach for the construction of protein
sequence networks (Zeil et al., 2016)
1.2.1 Exemplary properties of networks
TEM β-lactamases were shown to form a scale-free network (Zeil et al., 2016). A scale-free
network results in a typical degree distribution, with the term degree referring to the number
of adjacent nodes of a given node from the network3.
The typical degree distribution of a scale-free network is described by a power law
N(n) ∼ n−γ, (1.1)
with N as the number of degrees n and a scaling exponent γ, describing a ”small world”
network with few highly connected nodes (reviewed by Baraba´si and Albert, 1999). Such
power law distributions have been observed in various environments, e. g. metabolic rates
(West and Brown, 2004), population genetics (Manhart et al., 2012) or sequence networks of
proteins (Enright et al., 2003), interpreting the power law distribution as a consequence of
evolution (Deeds et al., 2003; Koonin et al., 2002) or protein structure (Deeds et al., 2003;
Wuchty, 2001). Furthermore, it was proposed that scale-free networks possess a rather robust
network topology, due to the connectivity of few network hubs (Albert et al., 2000). Power
3 The number of neighboring nodes is also named the degree centrality of a node.
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law distributions of scale-free networks have been mentioned frequently, but sampling of the
data can result in misleading conclusions on the actual network properties (Fox Keller, 2005;
Lima-Mendez and van Helden, 2009). Even if selected subsets of a network result in a degree
distribution following a power law, their scaling exponent might differ from the larger network
(Stumpf et al., 2005). Thus, alternative distributions besides a power law have to be tested on
various data and subsets of these data, to underline the hints for a scale-free network.
As a further network property, the fractal network dimension Df has been described as a
parameter of the network geometry (reviewed by Saberi, 2015). The concept of a fractal network
dimension can be linked to percolation theory which models transitions between communities4,
i. e. transitions between clusters of a lattice model representing a network (Saberi, 2015; Fisher,
1967). In chapters 2.1.2 and A.2, the concept of percolation theory is applied to protein
sequence networks by investigating the number N(s) of communities with given community
size s (the number of sequences belonging to a homologous group of sequences).
Percolation theory describes the cluster distribution on a randomly populated lattice, with
a parameter p describing the occupancy of the lattice sites (Christensen and Moloney, 2005).
For increasing values of p, the characteristic cluster size sξ and the fraction P of sites belonging
to the largest cluster increases. As p approaches the percolation threshold pc, an infinite cluster
appears for the first time on an infinite lattice, while on a finite-sized lattice the largest cluster
percolates between the lattice boundaries. The core of percolation theory is a set of scaling
relations that depend on |pc − p|, such as
sξ ∼ |pc − p|−1/σ (1.2)
P ∼ (p− pc)β (1.3)
with critical exponents σ and β that depend on the geometry of the lattice. Most importantly,
percolation theory predicts that the cluster size distribution N(s) (the number N of clusters
with size s) decreases for s  sξ as N(s) ∼ s−τ and decays exponentially for s  sξ. Near
to percolation (p → pc), sξ becomes infinite. Thus, for s spanning many orders of magnitude,
logN(s) depends linearly on log s, with Fisher’s exponent τ describing the ratio of small to
large clusters in the log-log plot of a histogram (Fisher, 1967).
1.3 Sequence-structure relationships: standard numbering schemes
Standard numbering schemes allow the identification of equivalent sequence positions across
members of a protein family by assigning unambiguous reference position numbers, as it was
previously shown for protein families such as the class B β-lactamases (Garau et al., 2004)
4 Communities of a network are also named subgraphs or clusters.
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or thiamine diphosphate-dependent decarboxylases (Vogel et al., 2012). Standard numbering
schemes require a consistent multiple sequence alignment that is supposed to represent the
protein family under investigation. In order to identify structurally equivalent positions within
a protein family, a structural superimposition of representative structures is used to derive a
structure-based multiple sequence alignment, i. e. an alignment in which the respective columns
represent the structural superimposition (compare with Vogel et al., 2012; Russell and Barton,
1992). The commercially available 3DM databases follow a similar approach by using multiple
structure alignments of reference enzymes to describe an enzyme family (Kuipers et al., 2010b).
The reference alignment can be refined manually to consistently align secondary structure
elements, especially in loop-rich regions (compare with Vogel et al., 2012). One protein sequence
from the reference alignment is selected to assign position numbers to all remaining protein
sequences from the respective protein family. To facilitate the alignment process, a profile
HMM is derived as stochastic representation of the multiple sequence alignment (reviewed by
Eddy, 1998). All sequences from a protein family are aligned against the reference profile HMM
and the position numbers from the selected reference sequence are assigned accordingly.
1.4 Exemplary enzymes and enzyme families
1.4.1 ω-transaminases
Transaminases (TAs) catalyze the transfer of an amino group from an amine donor to a carbonyl
acceptor, using pyridoxal 5’-phosphate (PLP) as cofactor (Jansonius, 1998). Besides transami-
nases, there are also further enzymes using PLP as cofactor such as lyases, oxidoreductases and
hydrolases (Percudani and Peracchi, 2009). There are two subgroubs of TAs: α-transaminases
transfer an amino group exclusively to a carbonyl group in α-position to a carboxyl group, in
contrast to ω-transaminases (oTAs or ω-TAs) that show a wider spectrum of possible acceptor
or donor substrates (Braunstein, 1973).
The case of transaminases shows the difficulties in distinguishing subfamilies of enzymes,
since there are different principles and assumptions for the annotation of groups within the
transaminase enzyme family, namely protein sequence, structure and function:
1. Sequence classification assigns TAs to five different aminotransferase classes based on
sequence similarity (Jensen and Gu, 1996; Ouzounis and Sander, 1993; Mehta et al.,
1993;  Lyskowski et al., 2014; Grishin et al., 1995). Alternatively, TAs were sorted into
six Pfam groups (Rausch et al., 2013; Finn et al., 2015), with phylogenetic trees sorting
α-TAs and ω-TAs in different Pfam groups (Rudat et al., 2012; Arvidsson et al., 2001).
2. Structure-based classification sorts α- and ω-TAs into two different types of protein folds
(fold type I and IV) (Grishin et al., 1995; Schneider et al., 2000; Eliot and Kirsch, 2004;
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Pavkov-Keller et al., 2016).
3. Functional classification distinguishes between α-TAs and ω-TAs (Ouzounis and Sander,
1993).
In addition to existing classification schemes on the levels of sequence, structure and function,
Ho¨hne et al. (2010) applied characteristic positions and motifs of protein sequences to predict
subgroups with respective enzyme activity for fold type IV such as: 4-amino-4-deoxychorismate
lyase (ADCL), (R)-amine transaminase (ATA), l-branched chain amino acid aminotransferase
(BCAT) and d-amino acid aminotransferase (DATA). It would be desirable to combine the
information on protein sequence and structure of transaminases in order to identify structurally
equivalent sequence positions.
1.4.2 Benzaldehyde lyase: a ThDP-dependent decarboxylase
Thiamine diphosphate (ThDP)-dependent enzymes catalyze various chemical reactions, such as
ligation or cleavage of carbon-carbon, carbon-nitrogen, carbon-sulfur or carbon-oxygen bonds
by using the cofactor ThDP as a catalyst (reviewed by Hailes et al., 2013; Kluger and Tittmann,
2008). From all these different reactions, cleavage or formation of carbon-carbon bonds has
gained most attention (Mu¨ller et al., 2013). By differences in the arrangement of protein
domains, ThDP-dependent enzymes can be grouped into different superfamilies, such as the
ThDP-dependent decarboxylases (Duggleby, 2006; Vogel and Pleiss, 2014).
One of these ThDP-dependent decarboxylases is benzaldehyde lyase (BAL), which was
first discovered in Pseudomonas fluorescens Biovar I, allowing the strain to grow on benzoin
as carbon source (Gonza´lez and Vicun˜a, 1989). BAL from P. fluorescens (Pf BAL) cleaves
the chiral hydroxyketone (R)-benzoin forming benzaldehyde (BA), but it also catalyzes the
symmetric carboligation (also termed self-ligation) from benzaldehyde to benzoin (Figure 1.1),
among other asymmetric C-C bond formations (Janzen et al., 2006). The enantioselective
synthesis of hydroxyketones catalyzed by Pf BAL was investigated in more detail due to its
commercial relevance, as chiral hydroxyketones are building blocks for drugs (Demir et al.,
2001)
For kinetic modeling of the symmetric carboligation catalyzed by Pf BAL, the alternative
substrate 3,5-dimethoxy-benzaldehyde (DMBA) was monitored by a fluorimeter approach in the
work of Zavrel et al. (2008) (Figure 1.1). Similarly, the reversible reaction from benzaldehyde
to benzoin was recently investigated by various kinetic models in the work of Ohs et al. (2018).
Both Zavrel et al. (2008) and Ohs et al. (2018) tested different kinetic model equations for the
ordered bi-uni reaction mechanism of the symmetric carboligation catalyzed by Pf BAL.
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Figure 1.1: Symmetric carboligations of benzaldehyde to benzoin (upper panel) and 3,5-di-
methoxybenzaldehyde to 3,3’,5,5’-tetramethoxybenzoin (lower panel) catalyzed by benzaldehy-
de lyase from Pseudomonas fluorescens.
1.5 Kinetic model equations for symmetric carboligation
For the type of reaction catalyzed by benzaldehyde lyase from P. fluorescens, it was shown
earlier by Du¨nkelmann et al. (2002) that one molecule of substrate is a donor and the other
an acceptor substrate. Whereas previous work on the kinetics of Pf BAL-catalyzed reactions
assumed a single Michaelis-Menten parameter Km (Stillger et al., 2006; Hildebrand et al., 2007),
the work from Zavrel et al. (2008) applied models with two respective Km parameters to capture
the binding of both donor and acceptor substrate separately (Figure 1.2).
The symmetric carboligation catalyzed by Pf BAL serves as a test case for comparing the
effect of different kinetic model equations on the resulting parameter estimates (Manuscript
5). The reactions under investigation comprise the conversion of benzaldehyde (BA) (Ohs
et al., 2018) and 3,5-dimethoxy-benzaldehyde (DMBA) (Zavrel et al., 2008) to the respective
products benzoin and 3,3’,5,5’-tetramethoxy-benzoin (Figure 1.1).
In the following, the term kinetic model refers to the mathematical representation of a
reaction mechanism. Thus, one reaction mechanism can be described by more than one set of
mathematical equations, depending on the assumptions for the kinetic model. Following the
naming convention used in (Zavrel et al., 2008), macrokinetic models are distinguished from
microkinetic models. The term macrokinetic model refers to kinetic model equations which
summarize elementary rate parameters in macrokinetic parameters, such as the Michaelis-
Menten parameter Km that can be expressed by elementary rate parameters k1, k−1 and k3:
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Figure 1.2: Representations inspired by the systematic of Cleland (1963) for the Michaelis-
Menten model for symmetric carboligation (model 1) with substrate (A), product (P), free
enzyme (E) and enzyme-substrate/product-complexes (EA, EAA, EP). For the models of the
ordered bi-uni mechanism (models 2 to 4), it is assumed that for the first and second binding
substrate (donor A and acceptor B) k1 = k2 and k−1 = k−2 (Zavrel et al., 2008; Ohs et al.,
2018).
Km =
k−1 + k3
k1
, (1.4)
where k1 and k−1 refer to the reversible formation of the enzyme-substrate complex and k3
refers to the release of product and unbound enzyme. Similarly, the term microkinetic model
refers to a mathematical representation using only elementary rate parameters, which can be
summarized in a respective macrokinetic representation.
Model 1 is an irreversible macrokinetic Michaelis-Menten model, with adapted stoichiometry
taking into account two identical substrates,
dcP
dt
= −1
2
dcA
dt
=
kcatf cEt cA
KmA + cA
, (1.5)
with time t, substrate concentration cA, product concentration cP and total enzyme concen-
tration cEt. Equation 1.5 has two independent parameters, the rate constant of the forward
reaction kcatf and the macrokinetic Michaelis-Menten parameter KmA, summarizing the ele-
mentary rate parameters according to Equation 1.4.
Model 2 is a macrokinetic representation of the (reversible) ordered bi-uni reaction mecha-
nism, where two identical molecules of substrate are ligated to form one product (Figure 1.2).
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The ordered bi-uni mechanism comprises two events for substrate binding, the first biding of a
donor substrate molecule and the second binding of an acceptor substrate molecule. Model 2
is formulated as
dcP
dt
= −1
2
dcA
dt
(1.6)
dcP
dt
=
kcatf
KiAKmB
(
c2A − cPKeq
)
cEt
1 + cA
KiA
+ KmA cA
KiAKmB
+
c2A
KiAKmB
+ cP
KmP
+ cA cP
KmP KiB
(1.7)
with relations
KiA = KmB −KmA (1.8)
Keq =
cP
c2A
(1.9)
KmP =
KmB (KmB −KmA)2Keq
2KmA
(1.10)
KiB =
KmBKiA
KmA
(
1−
(
KmA
KiA
− 1
)
KmP
KeqKmBKiA
) (1.11)
and four model parameters: the rate constant of the forward reaction kcatf , the equilibrium
constant Keq (see Equation 1.9), and the Michaelis-Menten parameters of the respective
donor and acceptor binding (KmA and KmB, respectively). The dependent parameters are the
Michaelis-Menten parameter of the product in the reverse reaction (Equation 1.10) and the
inhibition constants of the donor and acceptor substrate (Equations 1.8 and 1.11, respec-
tively) which are derived from the model parameters as in Zavrel et al. (2008). The relations
in Equations 1.8 and 1.9 result from the simplifying assumption that the elementary rate
parameters are identical for both donor and acceptor substrate, i. e. k1 = k2 and k−1 = k−2.
Model 3 is the microkinetic equivalent of model 2 in Equations 1.6 to 1.11 and thus a
different mathematical representation for the ordered bi-uni mechanism:
dcP
dt
= −1
2
dcA
dt
(1.12)
dcP
dt
=
(
k21 k3 c
2
A − k2−1 k−3 cP
)
cEt
k2−1 + k−1 k3 + k
2
1 c
2
A + k1 k−3 cA cP + (2 k1 k3 + k1 k−1) cA + 2 k−1 k−3 cP
(1.13)
where the four independent parameters k1, k−1, k3 and k−3 represent the corresponding
elementary reaction steps of the ordered bi-uni mechanism (Figure 1.2), assuming k1 = k2
and k−1 = k−2, too. As a consequence, the microkinetic parameters from model 3 can be
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converted to their macrokinetic counterparts and vice versa. The microkinetic parameters can
be derived from the macrokinetic parameters of model 2 (Equation 1.7) by
k1 = k2 =
kcatf
KmA
(1.14)
k−1 = k−2 =
kcatf (KmB −KmA)
KmA
(1.15)
k3 = kcatf (1.16)
k−3 =
kcatf
Keq (KmB −KmA) (1.17)
and the macrokinetic parameters can be derived from the microkinetic parameters by
kcatf = k3 (1.18)
KmA =
k3
k1
(1.19)
KmB =
k−1 + k3
k1
(1.20)
Keq =
k21 k3
k2−1 k−3
(1.21)
Model 4 is an extension of model 3 by substrate-dependent enzyme inactivation, i. e. it adds
an additional term
dcE
dt
= −kinS cA cE, (1.22)
with the inactivation parameter kinS leading to five independent parameters in total: k1, k−1,
k3, k−3 and kinS.
1.6 Data integration and data mining
As Stitt and Gibon (2014) outlined for the example of systems biology, data on a single biological
level are usually not informative at all levels, which points at the necessity of data integration.
Investigations on protein sequence, structure and function of enzymes make use of various
data types, ranging from simple text files for sequence information to various file types for
experimental data. To investigate sequence-structure-function relationships of enzymes, these
different data have to be combined by techniques of data integration, especially in case of high
amounts of data. Advanced analyses of data are often named data mining, referring to the
combination of multiple steps for data processing and analysis, following the previous steps of
data integration, which is usually supported by databases. A database allows to write, read
38
1.6 Data integration and data mining
and delete data according to a data model, which is defined by the technical requirements of
the underlying database management system. Such a data model is in turn designed by the
requirements of a real-world application. One of the most frequently used data models is the
relational data model that organizes data in unambiguously connected tables (Codd, 1970).
Data integration requires common standards for annotation, as it was exemplified by Gomez-
Cabrero et al. (2014) for genomics data. Standards for data sharing are also required to ensure
reproducibility of both data mining and experiments in general (Lapatas et al., 2015). The sug-
gestions of the STRENDA consortium (Tipton et al., 2014) and the requirements for reporting
data on biocatalytic reactions by Gardossi et al. (2010) mentioned above are examples of such
standards for data sharing. In addition, there exist even more generally applicable rules for data
management, such as the FAIR data principles (Wilkinson et al., 2016). The FAIR data princi-
ples aim at making data f indable (e. g. by assignments of metadata), accessible, interoperable
(e. g. by usage of standardized vocabularies and data formats) and reusable (e. g. by com-
munity standards such as the STRENDA guidelines) (Tipton et al., 2014; Wilkinson et al.,
2016).
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2 Results
This thesis comprises analyses on different data types relevant to understanding the relation-
ships between protein sequences, structural information and function of enzymes, with the
latter focusing on enzyme kinetics. In previous projects and theses, an in-house database sys-
tem for protein families had been established in the Bioinformatics research group of Prof. Dr.
Ju¨rgen Pleiss (University of Stuttgart, Germany). This database system serves as starting point
for multiple routines of data mining by integrating data on protein sequences and structural
information.
Chapter 2.1 comprises bioinformatic and statistic assessments of large data sets on protein
sequences, as a starting point for the elucidation of sequence-structure-function relationships.
In chapter 2.1.1 protein sequence networks were investigated with respect to highly connected
nodes and approximations of network dimensions (Manuscript 1). The subsequent chap-
ter 2.1.2 describes investigations on the connectivity of homologous families in protein sequence
networks (Manuscript 2). The finding that newly discovered protein sequences often appear
connected to already known homologous families could be shown in an additional study for
different esterases (Manuscript 6).
A further type of database application is the setup of a family-specific protein database to
link protein sequences and structural information followed by sequence comparisons with stan-
dard numbering schemes, which was exemplified for the family of ω-transaminases (Manus-
cript 3). Furthermore, a standard numbering scheme was also implemented for the superfamily
of transketolases (Manuscript 7).
Whereas the original intention of the BioCatNet database system was to provide means of
data archival similar to an electronic laboratory journal, this thesis changes the scope of man-
aging experimental data towards the analysis of experimental data by different kinetic models.
The BioCatNet database system was implemented and tested for biocatalytic measurements
(Manuscript 4). In addition, the BioCatNet data model was refurbished to describe more
details on the reaction conditions and to allow for other types of enzymatic data besides time-
course measurements, such as yield, conversion and enantiomeric excess of an enzymatic pro-
cess. Test cases for the estimation of kinetic parameters from time-course data of an enzymatic
reaction are described in (Manuscript 5) suggesting a revised data management strategy for
both measured data and data derived from kinetic model equations.
2.1 Properties of protein sequence networks
As it is rare to find a protein family whose sequences differ mostly by single mutations, individ-
ual point mutations are not an applicable metric for pairwise distances between sequences from
most protein families. There are, however, exceptions such as the family of TEM β-lactamases
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which share a high microdiversity that in turn allows to construct protein sequence networks by
point mutations of amino acids (see also Zeil et al., 2016). Therefore, protein sequence networks
were formed by pairwise alignments of amino acid sequences from a respective protein family,
as outlined in chapters A.1.3 and A.2.3. In the following, protein sequence networks were
investigated with respect to the distributions of degree and community size, with the former
being used for an approximation of network dimensions, too.
2.1.1 Distributions of degrees and network dimensions
In previous work by Zeil et al. (2016), a network of point mutations from the TEM β-lactamase
core region, corresponding to TEM-1 positions 24 to 280, exhibited a degree distribution fol-
lowing a power law: The N number of degrees (neighboring nodes) n followed a power law
distribution described by Equation 1.1 with a scaling exponent γ ≈ 1.2 (Zeil et al., 2016).
The family of TEM β-lactamases (TEMs) served as a test case for the comparison of a network
of point mutations and a network based on pairwise sequence identity (Manuscript 1). A
sufficiently high threshold of sequence identity was expected to result in a network topology
equivalent to the point-mutation network. By applying a threshold of 99.5 % pairwise sequence
identity, a network of 267 nodes and 401 edges was formed in analogy to the point mutation
network showing a degree distribution with a scaling exponent γ of 1.2, too (Figure 2.1). The
scaling exponent γ was determined by linear regression in log-log space. Alternative distribu-
tions such as a Gaussian and a Poisson distribution were not able to describe the observed
degree distribution (Figure A.7).
Figure 2.1: Distribution of the number of sequences N in a distance-based network of TEM β-
lactamases having n first neighbors. The degree distribution follows a power law with exponent
γ = 1.2. Compare with Figures A.6 and A.7 (see also Figures A.1 and A.2).
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It was a tempting hypothesis, whether protein sequence networks for other enzyme families
of low microdiversity, with homologous sequences differing by several mutations, would result
in qualitatively similar degree distributions of Equation 1.1 as it was verified for the TEM
β-lactamase family. Furthermore, it would be recommendable to investigate protein families
of different sample sizes and folds. As test cases, protein sequence networks were formed for
the enzyme families of β-hydroxyacid dehydrogenases/ imine reductases (bHADs), thiamine
diphosphate-dependent decarboxylases (DCs), ω-transaminases (oTAs) and short-chain dehy-
drogenases/reductases (SDRs), which showed qualitatively different distributions of pairwise
sequence identities (Figure A.3). Due to low micodiversity, the threshold of pairwise sequence
identity was set to 95 % for the four enzyme families bHADs, DCs, oTAs and SDRs, in contrast
to the higher threshold of 99.5 % that had been used for TEMs above. The respective protein
sequence networks resulted in qualitatively similar degree distributions (Figure 2.2), with the
distribution N(n) differing remarkably from a power law distribution for higher degrees n, re-
flecting the poor statistical sampling of the known sequence space. Thus, the scaling exponents
γ were only approximated for less connected nodes (with n < 70 (for oTA, SDR) or n < 50 (for
bHAD, DC)) by linear regressions in log-log space (Table 2.1), resulting in scaling exponents
γ ranging from 1.2 to 1.3 (Table 2.1). For protein sequence networks of bHADs, DCs, oTAs
and SDRs, the power law distribution was also observed for decreasing global sequence identity
thresholds to ≥ 90 %, ≥ 85 %, or ≥ 80 % (compare with Figures A.8 to A.10), with the
scaling exponents γ decreasing to 0.9 to 1.1 with decreasing sequence identity thresholds. The
power law distributions of degrees point at highly connected hubs, i. e. sequences with many
homologous sequences (Table A.3).
Table 2.1: Overview of the analyzed protein family networks by number of nodes, edges and
maximal degree (number of neighbors) for a 95 % sequence identity threshold, with average
sequence length. The small family of TEM β-lactamases is shown as reference, due to its high
microdiversity, with a threshold of 99.5 % sequence identity (a). The enzyme families comprise
TEM β-lactamases (TEMs), β-hydroxyacid dehydrogenases/ imine reductases (bHADs), thi-
amine diphosphate-dependent decarboxylases (DCs), ω-transaminases (oTAs) and short-chain
dehydrogenases/ reductases (SDRs). Values for γ refer to the scaling exponents of the degree
distributions from Figures 2.1 and 2.2. Values for Df refer to the slope in Figure 2.3.
Compare with Table A.2.
Enzyme family Nodes Edges Maximal degree Average sequence length γ Df
TEMa 267 401 86 250 1.2 1.8
bHAD 17,020 148,188 259 320 1.2 1.0
DC 24,880 309,635 266 580 1.1 0.7
oTA 79,987 1,444,727 381 460 1.2 0.9
SDR 81,680 838,743 312 300 1.3 1.0
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Figure 2.2: Degree distributions for the protein families with low microdiversity from Table 2.1
with neighbors defined by ≥ 95 % global sequence identity. The corresponding scale-free expo-
nents γ were derived from linear regression for degrees ≤ 50 (bHAD, DC) or ≤ 70 (oTA, SDR)
and are summarized in Table 2.1. See also Figure A.4.
As a further property of protein sequence networks, the (fractal) network dimension Df was
approximated by counting the number of sequence pairs p(d) that differed by less than d %
(100 % - sequence identity in %) for d = 2, 4, 6, . . . (Figure 2.3). Thus, the dimension Df was
derived from linear regressions in log-log space from a cumulative distribution of sequence pairs
(representing degrees of network nodes) over pairwise sequence distances from the respective
networks. For low values of pairwise sequence distance d (d ≤ 10, i. e. > 90% identity), log p(d)
increased linearly with log d, resulting in a network dimension Df between 0.7 and 1.0 for the
four superfamilies with low microdiversity from Table 2.1. For increasing pairwise distances d,
the network dimensions Df increased to Df between 3.5 and 4.5 for 30 ≤ d ≤ 70 (Figure 2.4).
For the family of TEM β-lactamases, Df was estimated to 1.8 from the values at d = 2 and
d = 4. Due to the high sequence identities of the members from the TEM β-lactamase family,
only few sequence pairs were found with distances > 4 % identity. The estimation of Df for the
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point-mutation network of TEM β-lactamases by comparing the number of single and double
mutants resulted in a higher value of Df = 4.0 (Figure A.12). For higher distances beyond
double mutants, the limited network size for TEMs resulted in an apparent decrease of Df , and
the analysis of double, triple, and quadruple mutants resulted in Df = 1.8, as observed for the
TEM β-lactamase network based on pairwise sequence identities (Figure A.5).
Figure 2.3: Cumulative distributions of sequence pairs p(d) for pairwise distances of d % for
the protein families TEM (open squares), DC (filled squares), bHAD (open circles), SDR (dia-
monds) and oTA (filled circles) from Table 2.1 in subsequent distance intervals of 2 % distance
d (100 % - sequence identity in %). Linear fits are shown as red lines for distances up to 10 %
identity (up to 4 % for TEM). For further distances between 30 and 70 %, an approximately
linear area is depicted in red (compare with Figure 2.4). See also Figure A.5.
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Figure 2.4: Detail view from Figure 2.3 for the protein families DC (filled squares), bHAD
(open circles), SDR (diamonds) and oTA (filled circles) showing cumulative distributions of
sequence pairs p(d) for pairwise distances of d %. Regression lines are given for the sequence
pairs from the DC (blue line), bHAD (red line) , SDR (blue dashed line) and oTA family (red
dashed line).
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2.1.2 Distributions of community sizes
The topology of the known sequence space was further analyzed for the four large protein su-
perfamilies of low microdiversity from Table 2.1 by analysis of the community (or cluster) size
distribution (Manuscript 2). By applying increasing thresholds of pairwise sequence identity,
the number of edges in a protein sequence network decreases, leading to the occurrence of sev-
eral isolated subgraphs, i. e. internally connected communities (clusters) which emerge without
connections to other communities. For each of the four protein superfamilies SDR, oTA, DC
and bHAD, sequences were clustered by an exemplary threshold of 60 % global sequence iden-
tity. The number N of communities with size s was analyzed in a histogram with logarithmic
bins for s between 1 and 10, 11 and 100, 101 and 1,000, 1,001 and 10,000, and 10,001 and
100,000 to improve statistical sampling (Figure 2.5).
Figure 2.5: Distribution of community sizes, resulting from subgroups clustered by 60 % pair-
wise sequence identity determined by USEARCH (Edgar, 2010), for the protein families SDR,
oTA, DC and bHAD following a power law distribution according to Equation 2.1. Compare
with additional results in Figure A.14.
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The distribution of community sizes followed a power law
N(s) ∼ s−τ , (2.1)
which was observable by a linear dependency of log s and logN(s) for the four different protein
superfamilies (SDR, oTA, DC and bHAD). The Fisher exponent τh of a histogram describes
the ratio between small and large communities and is derived from linear regression in the
log-log plot of the histogram (Figure 2.5). From the Fisher exponent τh of the histogram, the
Fisher exponent τ of the underlying community size distribution was calculated by fitting the
observed τh of the histogram to a model distribution of community sizes following a power law
distribution5. Though the protein families differed in size, structure, and function, the values
for the extrapolated Fisher exponent τ100 varied only slightly (Table 2.2).
While the Fisher exponent τ was almost independent of the protein family and its size,
its absolute value depended on the threshold criterion used for clustering. Upon clustering of
the four families with four thresholds between 60 and 90 %, the community size distributions
followed a power law for all thresholds. Consequently, the Fisher exponent τ increased almost
linearly with increasing thresholds from τ60 between 1.6 and 2.0 at 60 % threshold, to τ90
between 2.2 and 2.9 at 90 % threshold (Figures 2.6 and A.17).
The Fisher exponent τ was extrapolated to a threshold of 100 %, simulating a network of
nodes separated by single mutations (τ100). For the four protein families, the extrapolated τ100
values varied between 2.3 and 2.8 (Table 2.2). The Fisher exponent τ was also observed to
increase with a decreasing number of nodes, as it was observed for protein sequence networks of
randomly selected α/β-hydrolases (abHs) (Figure A.18). Additionally, many of the protein
sequences used in Manuscript 6 were found to be homologous to sequence entries already
present in the lipase engineering database (LED)6, suggesting that newly discovered proteins
emerge rather within connected communities and less frequently at the periphery of a protein
sequence network.
5 https://doi.org/10.1371/journal.pone.0189646.s006, accessed on April 30, 2018.
6 http://www.led.uni-stuttgart.de/, accessed on April 30, 2018.
Table 2.2: Protein superfamily size and the Fisher exponent extrapolated to 100 % sequence
identity (τ100) of the four protein families. Compare with additional results in Table A.6.
Enzyme superfamily Superfamily size τ100
SDR 14,100 2.4
oTA 121,000 2.3
DC 39,000 2.8
bHAD 31,000 2.5
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Figure 2.6: Fisher exponent τ of the community size distributions of protein superfamilies
from Figure 2.5 for clustering thresholds between 60 and 90 % pairwise sequence identity with
extrapolated Fisher exponent τ100 determined by linear regression. Compare with additional
results in Figure A.15.
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2.1.3 Exemplary sequence networks of ω-transaminases
Within this work, a family-specific protein sequence database was implemented for ω-trans-
aminases, the ω-transaminase engineering database (oTAED) (Manuscript 3), by methods
outlined in more detail in chapter A.3. Protein sequences in the oTAED were sorted into two
superfamilies named fold types I and IV. If the majority of sequence entries within a homologous
family in the oTAED were longer than 350 amino acids, the respective homologous family was
assigned to the fold type I superfamily. Consequently, homologous families were assigned to
the fold type IV superfamily, if most of their sequences were shorter than 350 amino acids.
While protein sequences from fold type I showed an average length of 432 amino acids in 124
homologous families, protein sequences from fold type IV had an average length of 297 amino
acids in 45 homologous families (Figure A.25). Most of the sequence entries for both fold
type I and IV were sorted in one large homologous family, underlining the concept of highly
connected protein sequence networks that was shown in the distributions of community sizes
in chapter 2.1.2.
Standard numbering schemes were established for the two superfamilies fold type I and
fold type IV as described in chapter A.3.3 (in an equivalent approach as for the transketolase
standard numbering scheme from Manuscript 7). The respective standard numbering schemes
for fold type I and IV were used to identify conserved positions and positions for substrate-
specificity mentioned in literature within the oTAED, based on alignments of representative
sequences (Table A.12). Furthermore, the Fold type IV standard numbering scheme was
applied to search for protein sequences that matched sequence motifs or characteristic positions
from Ho¨hne et al. (2010) (Table A.13).
In addition, these sequence positions and motifs were used to identify matching sequences in
a protein sequence network for representative fold type IV sequences (Figure 2.7), which was
constructed as described in chapter A.3.3. The annotation of the protein sequence network
showed that sequences matching positions and sequence motifs for ATA, ADCL, BCAT and
DATA were in relation with (R)-selective ω-TAs from fold type IV (Figure A.24). Besides
that, several of the annotated sequences appeared to form separate communities within network.
Furthermore, protein sequence networks of fold types I and IV were also applied to identify
nodes for sequences from extremophilic source organisms (Figure A.26). The information
on the growth conditions of the respective source organism was retrieved from the BacDive
database7, in combination with entries on taxonomic names and their possible synonyms from
the oTAED. In contrast to the previous annotation of sequence motifs and characteristic posi-
tions for the fold type IV sequence network, the occurrence of extremophilic source organisms
did not form communities within the sequence networks of fold types I and IV (Figure A.26).
7 https://bacdive.dsmz.de/, accessed on April 30, 2018.
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Figure 2.7: Example of a protein sequence network for 447 representative sequences from
the superfamily of ω-transaminases from fold type IV, clustered by 30 % sequence identity in
USEARCH (Edgar, 2010) with 13,752 edges defined by a threshold of 50 % sequence similarity
(derived from pairwise alignments according to Needleman and Wunsch (1970). Sequences
are annotated as 4-amino-4-deoxychorismate lyase (blue), (R)-amine transaminase (green), l-
branched chain amino acid aminotransferase (red) or d-amino acid aminotransferases (black).
See also Figure A.24.
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2.2 Kinetic modeling in the BioCatNet database system
The BioCatNet database system was established as repository for the sequence-structure-
function relationships of enzyme families (Manuscript 4), as it is described in chapter A.4.
In case of protein sequences and structures, original data is parsed from publicly available data
repositories, in contrast to measured data from biocatalytic experiments that are uploaded
directly from experimenters within collaborative research projects, as in the case studies for
kinetic modeling in chapter A.5 (Manuscript 5). The minimal requirements for data submis-
sion of experimental measurements to BioCatNet constitute a compromise between complete-
ness and usability. Therefore, the BioCatNet data model distinguishes between mandatory
and optional attributes, with complete annotations of reaction conditions being highly rec-
ommended to enhance reproducibility of both experimental investigations and computational
analyses, since the latter cannot be interpreted without considering all possibly relevant factors
(Table A.14). To facilitate the submission of biocatalytic data to BioCatNet, a formatted
template of a Microsoft Excel spreadsheet is provided on the BioCatNet documentation web-
site8.
2.2.1 Extensions of the relational data model
The BioCatNet database system makes use of the database management system Firebird9,
allowing to manipulate the relational data model, i. e. the tables and relationships between
tables for storage and linkage of data. Since not all research projects on enzymes are related
to the field of kinetic modeling, additional types of experimental measurements should be
included within the BioCatNet database system, to broaden to scope of possible applications
beyond time-course data on substrate depletion or product formation. Therefore, the relational
data model of BioCatNet was extended to allow for experimentally determined ratios, such as
enantiomeric excess (ee), yield or conversion of an enzymatic reaction, as these data types often
occur in screening experiments of enzyme candidates, which might be investigated with respect
to kinetics in a further round of experiments (Figure A.27).
Whereas measurement data on time-courses are stored in a separate table of the BioCatNet
data model (Reusch, 2014), an additional table was provided for measured ratios (ee, yield
or conversion), named PARAMETER MEASUREMENTS (Figure 2.8 and A.32). Since these ratios
(measured parameters) could refer to a specific reference enzyme, such as a wild-type enzyme,
a link to the SEQUENCES table was added, to allow for a linkage with the complete protein
sequence of such a reference enzyme. Furthermore, the table for measured parameters (ee, yield
or conversion) is linked with tables listing the chemical compound (i. e. substrate or product
8 http://wiki.biocatnet.de/wiki/examples/BioCatNet template.xlsx, accessed on April 30, 2018.
9 http://firebirdsql.org/, accessed on April 30, 2018.
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Figure 2.8: Detail view of the BioCatNet relational data model focusing on tables for experi-
mentally determined ratios (like yield, conversion or enantiomeric excess (ee)).
.
under investigation) and the measurement method (to allow for additional specifications on the
measurement principle or the applied type of measurement device). An additional table named
PARAMETER LIST was added to make the data model adaptable to further parameters besides
ee, yield or conversion.
Noteworthy, this part of the data model is not intended to store information on kinetic pa-
rameters, since their values are derived from fits of kinetic models equations against time-course
data of concentrations over time (compare with Figure A.28). Thus, for investigations on en-
zyme kinetics, BioCatNet stores the original data from time-course experiments (chapter A.4),
as it was shown for the data from Zavrel et al. (2008) and Ohs et al. (2018) on Pf BAL-catalyzed
symmetric carboligation.
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2.2.2 Parameter estimations for PfBAL-catalyzed symmetric carboligation
The symmetric carboligation (also named self-ligation) catalyzed by benzaldehyde lyase from
Pseudomonas fluorescens (Pf BAL) was used as an exemplary reaction system to point out a
data management strategy for biocatalytic experiments, with a focus on kinetic modeling.
Data sets for two substrates converted by Pf BAL under comparatively similar condi-
tions served as test cases: The first dataset comprised nine progress curves of 3,5-dimethoxy-
benzaldehyde (DMBA) depletion which were analyzed previously in the work of Zavrel et al.
(2008). The second dataset comprised thirteen progress curves for the self-ligation of ben-
zaldehyde (BA) to benzoin which were provided by the work from Ohs et al. (2018). The
investigations of Zavrel et al. (2008) had identified a simplified microkinetic model for the self-
ligation of DMBA, representing the bi-uni reaction mechanism (Equations 1.12 to 1.13). The
term microkinetic model refers to the representation of elementary reaction steps, in contrast
to the formulation of macrokinetic models which lump elementary reaction steps together, as
used in Zavrel et al. (2008).
The microkinetic and macrokinetic parameter estimates from Zavrel et al. (2008) can be
compared with each other, as both micro- and macrokinetic model have the same number of
parameters, respectively. The proposed model simplification from Zavrel et al. (2008) assumes
equal rate constants for the reversible binding of the first and the second substrate molecule of
DMBA. In addition, the previous work from Ohs et al. (2018) identified an extended microki-
netic model with substrate-dependent enzyme inactivation for the symmetric carboligation of
BA.
It was tempting to see whether this model would also fit for the data of the DMBA-self-
ligation from Zavrel et al. (2008). Furthermore, the results from Zavrel et al. (2008) and Ohs
et al. (2018) were a motivation to compare the impact of different kinetic model equations
on the resulting parameter estimates, such as the macro- and microkinetic model equations
and the uncertainties of their respective parameter estimates. Besides that, these two datasets
for the symmetric carboligation of BA and DMBA were chosen as a proof of principle for
the concept of the BioCatNet data analysis workflow (Manuscript 5), since they provide
heterogeneous data of experiments, with different sample sizes, reaction conditions and varying
initial concentrations (Table A.15). While the data for DMBA were measured by a fluorimeter,
thus providing a rather high sample size of 2786 data points (Zavrel et al., 2008), the data for
the symmetric carboligation of BA were measured by high performance liquid chromatography
(HPLC), with a smaller sample size of 374 data points (Ohs et al., 2018).
In the following, four different sets of kinetic model equations were applied for fits against
both the DMBA and the BA data set, as described in the introductory chapter 1.5. The
computational methods from Ohs et al. (2018) was applied as described in more detail in
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chapters A.5 and A.5.6.
Application of the Michaelis-Menten model Since the reactions investigated here are
reversible (Figure 1.1 and 1.2), the irreversible two-substrate Michaelis-Menten model (model
1, Equation 1.5) cannot describe the complete time-course, leading to estimates for KmA and
kcatf with high uncertainty (Table A.18).
Therefore, the Michaelis-Menten model was applied to the first six minutes of the time-
courses only, similar to initial rate measurements under presumably low product concentra-
tions. For both the DMBA and BA dataset, the shortened time-courses could be fitted more
reliably by the Michaelis-Menten model (as seen in the lower values for RSS
n
), resulting in pa-
rameter estimates for both KmA and kcatf with remarkably reduced relative standard deviations
(Tables 2.3 and 2.4), in contrast to the fits for the complete time-courses.
The evaluation of the first six minutes of the reaction progress covers DMBA concentrations
between 1.5 and 3 mM and BA concentrations between 30 and 75 mM (Table A.15), which is
below and above the respective estimates for KmA of 2.6 mM and 55 mM from the fits with the
Michaelis-Menten model. While the estimates for KmA differed by an order of magnitude, the
estimated values for kcatf were found similar for both DMBA and BA.
Effects of model 1 compared to model 2 The resulting estimated kinetic parameters
of the Michaelis-Menten model (model 1) covering the shortened time-courses (the first six
minutes of the actual measurements) were compared to the estimates from the previously
published macrokinetic model for the bi-uni mechanism (model 2) from Zavrel et al. (2008)
applied to the complete time-courses (Figures A.38 to A.41). While the estimated values
for kcatf for both the BA and DMBA data set were in a comparable order of magnitude to
the results for the Michaelis-Menten model (the latter applied to the shortened progress curve
data only), the estimates for KmA were similar with model 1 for BA, but differed by up to four
orders of magnitude for DMBA. Furthermore, the values of both KmA and KmB from model 2
showed larger relative standard deviations (> 100 %) implying that both Km parameters were
unidentifiable for model 2, in contrast to the Km returned by the fit of model 1 for the initial
time-courses.
Effects of model 2 compared to model 3 As expected, the macrokinetic (model 2) and the
microkinetic model (model 3) for the (reversible) ordered bi-uni reaction mechanism resulted in
comparable values for RSS
n
for both DMBA and BA, which is also seen in the similar overall fit
quality (Figures A.40 to A.43). In case of DMBA, the estimates for kcatf (which is equivalent
to k3, Equation 1.16), and Keq were found identical, whereas estimates for both KmA and
KmB differed approximately by an order of magnitude (1.7 · 10−4 and 2.9 · 10−3 mM for KmA,
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4.2 · 10−3 and 2.0 · 10−2 mM for KmB, respectively). Besides that, the microkinetic parameters
k1 and k−3 differed for models 2 and 3, too. Noteworthy, most relative standard deviations
for the parameter estimates were remarkably smaller for the microkinetic model 3 than for
the macrokinetic model 2, although both models describe the same ordered bi-uni reaction
mechanism. In case of the BA data set, all estimated kinetic parameters differed by less than a
factor of two. The low Km values for DMBA and the high Keq for BA gave doubts that models
2 and 3 were sufficient to describe the observed data.
Effects of model 3 compared to model 4 For both substrates, the RSS
n
and the rela-
tive standard deviations of the kinetic parameters were lower for the microkinetic model with
substrate-dependent inactivation (model 4, as an extension of model 3), indicating a higher fit
quality and more reliably identified parameter estimates in comparison to the remaining ki-
netic models (models 1 to 3) (Figures 2.9 and 2.10). Unexpectedly, the equilibrium constant
differed by a factor of twenty between both DMBA and BA. The catalytic activity of Pf BAL
towards both DMBA and BA differed by less than a factor of two, whereas KmA towards DMBA
was more than two orders of magnitude lower than KmA towards BA (Tables 2.3 and 2.4).
The differences in KmA and KmB between the substrates DMBA and BA correlate to the two
orders of magnitude difference in k1 and k−3 between the substrates, whereas k−1 and k3 were
estimated similarly for both substrates. In addition, the inactivation parameter kinS for BA
was one order of magnitude smaller than the respective estimate of DMBA.
55
2.2 Kinetic modeling in the BioCatNet database system
Table 2.3: Estimated kinetic parameters and the residual sum of squares (RSS)
over sample size n for the benzaldehyde lyase-catalyzed self-ligation of 3,5-dimethoxy-
benzaldehyde and four kinetic models1,2. Estimated parameter values are given in bold,
whereas parameter values obtained from Equations 1.14 to 1.21 are set in regular
font. The relative standard deviations (in %) are given in parentheses. Relative stan-
dard deviation values < 100 % are marked with ∗ to indicate the higher reliability of
the respective kinetic parameter values.
Unit Model 1 3 Model 2 4 Model 3 5 Model 4 5
k1
mM−1 min−1
-
1.6 · 107 9.3 · 105 4.5 · 104
(501) (108) (14)∗
k−1
min−1 - 6.4 · 104 1.6 · 104 4.3 · 103
(590) (53)∗ (6)∗
k3
min−1 - 2.7 · 103 2.7 · 103 2.8 · 103
(1)∗ (1)∗ (1)∗
k−3
mM−1 min−1
-
4.2 · 107 2.4 · 106 7.7 · 104
(547) (110) (16)∗
kinS
mM−1 min−1
- - -
8.0 · 10−3
(4)∗
kcatf
min−1 4.4 · 103 2.7 · 103 2.7 · 103 2.8 · 103
(5)∗ (1)∗ (1)∗ (1)∗
KmA
mM 2.6 1.7 · 10−4 2.9 · 10−3 6.2 · 10−2
(9)∗ (501) (108) (14)∗
KmB
mM
-
4.2 · 10−3 2.0 · 10−2 0.2
(262) (117) (15)∗
Keq
mM−1
-
3.9 3.9 4.1
(1)∗ (364) (35)∗
RSS
n
mM2 6.7 · 10−3 1.4 · 10−3 1.4 · 10−3 1.1 · 10−3
1 Estimated parameters, their relative standard deviation (%), and the residual sum
of squares (RSS) over sample size n were applied to nine experiments containing
n = 2786 samples. Relative standard deviations of independent parameters were
determined using the covariance matrix. Error propagation was used to determine
relative standard deviations of derived parameter values. Compare supplementary
material for details.
2 Model 1: Michaelis-Menten, model 2: macrokinetic model without inactivation,
model 3: microkinetic model without inactivation, model 4: microkinetic model
including substrate-dependent inactivation
3 Model 1 was applied for a maximum reaction time of 6 min, resulting in 549 samples.
Parameters of model 1 for the full progress curves are listed in Table A.18.
4 Values for k1, k−1, k3 and k−3 were calculated from the macrokinetic parameters
according to Equations 1.14 to 1.17 including propagation of uncertainty.
5 Values for kcatf , KmA, KmB andKeq were calculated from the microkinetic parameters
according to Equations 1.18 to 1.21 including propagation of uncertainty.
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Table 2.4: Estimated kinetic parameters and the residual sum of squares (RSS) over
sample size n for the benzaldehyde lyase-catalyzed self-ligation of benzaldehyde and four
kinetic models6. Footnotes and descriptions are equivalent to Table 2.3.
Unit Model 1 7 Model 2 4 Model 3 5 Model 4 5
k1
mM−1 min−1
-
135 134 245
(142) (77)∗ (22)∗
k−1
min−1 - 3.6 2.2 3.1 · 103
(1.4 · 105) (3 · 104) (37)∗
k3
min−1 - 3.0 · 103 3.1 · 103 4.9 · 103
(55)∗ (54)∗ (12)∗
k−3
mM−1 min−1
-
1.4 · 103 1.4 · 103 158
(2.9 · 105) (39)∗ (36)∗
kinS
mM−1 min−1
- - -
7.4 · 10−4
(4)∗
kcatf
min−1 5.0 · 103 3.0 · 103 3.1 · 103 4.9 · 103
(15)∗ (55)∗ (54)∗ (12)∗
KmA
mM 55 22 23 20
(28)∗ (131) (94)∗ (25)∗
KmB
mM
-
22 23 32
(113) (97)∗ (27)∗
Keq
mM−1
-
3.0 · 103 8.6 · 103 0.2
(3.6 · 104) (6.0 · 104) (94)∗
RSS
n
mM2 1.4 15 15 2.7
6 Estimated parameters, their relative standard deviation (%), and the residual sum
of squares (RSS) over sample size n were applied to thirteen experiments containing
n = 374 samples.
7 Model 1 was applied for a maximum reaction time of 6 min, resulting in 110 samples.
Parameters of model 1 for the full progress curves are listed in Table A.18.
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Figure 2.9: Fits for the dimethoxy-benzaldehyde self-ligation and the microkinetic model
with substrate-dependent enzyme inactivation (model 4, lines). Symbols as described in Fig-
ure A.36. The respective parameter estimates are given in Table 2.3 with reaction conditions
according to Figure A.36 and Table A.15 (Equivalent with Figure A.44).
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Figure 2.10: Fits for the benzaldehyde self-ligation and the microkinetic model with substrate-
dependent inactivation (model 4, lines). Symbols as described in Figure A.37. The re-
spective parameter estimates are given in Table A.17 with reaction conditions according to
Figure A.37 and Table A.15 (Equivalent with Figure A.45).
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The results from this thesis consist of two main parts: analyses of protein sequence networks
and kinetic parameter estimation. Protein sequence networks facilitate the identification of
enzyme candidates in large sequence data sets, such as potentially evolvable ”hub” sequences
and an approximation of a fractal network dimension as a measure of evolvability (Manuscript
1). Furthermore, communities within protein sequence networks hint at percolation in protein
sequence space and an overall connectedness of homologous protein sequences (Manuscript
2). Structurally equivalent positions can be identified by standard numbering schemes, as
outlined for the family of ω-transaminases, and used to annotate protein sequence networks
(Manuscript 3). Data on protein sequence, structure and function can be integrated in the
BioCatNet database system (Manuscript 4) (Reusch, 2014; Vogel, 2015), paving the way
for more reproducible data mining of enzyme kinetics (Manuscript 5). The lessons learned
from kinetic parameter estimation can be used to derive an overall data management strategy
for upcoming research projects on the investigation of enzymatic sequence-structure-function
relationships.
3.1 From protein families to protein networks
Homologies between individual sequences can be represented as nodes in a weighted graph, i. e.
a network connecting sequences with a predefined threshold of pairwise sequence identity (com-
pare with Atkinson et al., 2009). Usually, these weighted networks are generated for sequences
from a common protein family sharing fold or cofactor specificity. Mutations of proteins imply
changes in nucleic acid sequences. Here, amino acid sequences were used instead, since they
encode biochemical properties, thus representing a phenotype under selection pressure. The
topological or statistical properties of protein sequence networks can be useful in identifying
highly connected bridges between communities of a network (Manuscript 2) and in identifying
connected hubs in sequence space (Manuscript 1). In contrast to the fixed branches inside
a phylogenetic tree, sequence networks allow for multiple connections between two protein se-
quences, and seem thus more suitable to capture possible routes of protein evolution (compare
with Atkinson et al., 2009).
Several concepts for evolution have been proposed, among them the principle of gradualism,
which implies that natural systems evolve rather continuously, in contrast to strictly step-
wise developments. Gradualism has also been coined by the quote ”nature does not make
jumps” that was attributed to Carl von Linne´. Gradual evolution has been proposed for protein
structure and function, with evolution of protein sequences following small stepwise changes
by events such as mutation, recombination or duplication (Conrad, 1977). The imagination
of a globally connected sequence space by Smith (1970) suggests also that protein evolution
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occurs via small steps, which underlines that protein families can be represented or visualized
as connected sequence networks. The topological properties found in protein sequence networks
underline an evolutionary concept similar to gradualism, where protein families and subfamilies
emerge as connected communities within a network, rather than distinct phylogenetic branches.
3.1.1 Connectedness of protein sequence space
For the six protein superfamilies of α/β-hydrolases (abH), β-hydroxyacid dehydrogenases/
imine reductases (bHAD), cytochrome P450 monooxygenases (CYP), ω-transaminases (oTA),
short-chain dehydrogenases/ reductases (SDR) and thiamine diphosphate-dependent decar-
boxylases (DC), the respective community size distributions of known sequence space have
been investigated and found to follow a power law, with the extrapolated Fisher exponent τ100
being an upper limit to the Fisher exponent of the extant sequence space (Manuscript 2).
Since the Fisher exponent measures the ratio of small to large communities, it can be inter-
preted as an indicator of the global connectedness within the known sequence space of a given
protein family. The general observation of few communities containing many sequences might
relate with the assumption that more stable protein folds are more evolvable, thus forming
larger and higher connected communities of mutations (Deeds et al., 2003).
The protein superfamilies oTA, SDR, bHAD and abH had a smaller τ100 (2.3, 2.4, 2.5
and 2.6, respectively) and thus a higher ratio of large to small communities than the protein
superfamilies DC, or CYP (with τ100 of 2.8 and 3.3, respectively). A high ratio of large to small
communities indicates a high connectedness within a protein sequence network. There are at
least three possible reasons for a high connectedness of a protein family:
1. A high fraction of a protein superfamily’s extant sequence space has already been explored.
2. The protein superfamily shows high microdiversity, i. e. many sequences are known to be
connected by point mutations.
3. The protein family covers only a small region of the total sequence space with a low
overall variability in sequence homology.
The observation that the connectedness gradually increased as more sequences become known
is supported by the concept of gradual saturation of sequence space. This concept describes
the observation that the number of newly sequenced genes that form separate communities
plotted over time decreases to zero (compare with Nelson, 2011). Rather than expanding,
the sequence space of protein families seems to gradually become denser and more connected.
As τ100 measures the connectedness of a protein family, it also measures the current level of
saturation, with the investigated protein families SDR and CYP having the highest and lowest
saturation of their sequence space.
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The six protein superfamilies abH, bHAD, CYP, DC, oTA and SDR showed a similar linear
dependency of τ on the clustering threshold. Thus, many small communities were observed for
high threshold values, which gradually combined into larger communities with decreasing se-
quence identity threshold, as bridges between communities appeared. These bridging sequences
were formed at decreasing sequence identity thresholds by sequences that had been part of one
community and then became part of another community, or by previously isolated sequences.
These bridging sequences might be interesting enzyme candidates, as they possibly share bio-
chemical properties of both communities. If global sequence identity relates to biochemical
function, a community is characterized by a similar function that differs from other communi-
ties. Bridging sequences with similarities to at least two communities are therefore promising
candidates for substrate ambiguity (Jensen, 1976) or even catalytic promiscuity (Khersonsky
et al., 2006).
3.1.2 Hub regions in protein sequence space
The evolution of protein sequences occurs in iterative steps of random mutagenesis of the geno-
type and subsequent selection of the phenotype. Therefore, the sequence space that has been
iteratively explored during four billion years of evolution is expected to be connected (Smith,
1970). Since the number of explored protein sequences (estimated 1040) is much smaller than
the number of theoretical sequences (estimated > 10300), the dimension of the sub-space of
extant protein sequences is expected to be much smaller than the multi-thousand dimensional
space of theoretical sequences. An estimation of the dimension of the known sequence space
was achieved by counting numbers of neighbors at increasing distances. The fractal network
dimension Df of a protein family was similar among the investigated protein families. Df var-
ied between 0.7 and 1.0 for sequence identities between 98 and 90 %, whereas Df increased to
values between 3.5 and 4.5 at lower sequence identities between 70 and 30 %. The observation
of a distance-dependent fractal dimension of sequence space gives an interesting insight into the
sequence-function relationships of proteins. For uncorrelated random mutations, it has been
estimated that the probability of protein inactivation is 34 % for each mutation (Guo et al.,
2004). Therefore, for a small number of mutations, the chance of finding active mutants is
high (0.662 = 44 % and 0.664 = 19 % for two and four mutations, respectively). Thus, many
combinations of random mutations result in active proteins and Df ≈ 4.0 as evaluated for the
point-mutation network of TEM β-lactamases is a lower limit of the dimension of the extant
sequence space for a small number of mutations, because Df is expected to further increase
as more TEM β-lactamase sequences are discovered in the future. In contrast, if 10 % of all
positions are randomly exchanged, the chance of finding an active variant of a 300 amino acid
protein reduces to 0.6630 = 4 · 10−6. Therefore, the mutations that result in an active protein
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must be highly correlated, and evolution is dominated by the non-additive effects of epistasis
(Wu et al., 2016). The high correlation of mutations is compatible with the much lower fractal
network dimension Df between 0.7 and 1.0 that seems to be a generic property of all investi-
gated protein families. For lower sequence identities between 70 and 30 % the mutations become
more uncoupled, which results in a considerable increase of the fractal network dimension Df .
At a first glance, scale-dependent network dimensions are counter-intuitive. However, scale-
dependent spatial dimensions have also been observed for physical systems such as turbulent
interfaces (Catrakis and Dimotakis, 1996) and for the distribution of luminous matter in the
universe (Bak and Chen, 2001). Although the analysis of the distance dependence of protein
sequence space is based on a relatively small number of known sequences, it provides quantita-
tive estimates which are in agreement with known sequence-function relationships (Guo et al.,
2004). It will be interesting to see how Df develops in the future when many more protein
sequences become known.
Two complementary neighborhood definitions were applied to construct sequence networks.
A network construction based on point mutations allowed for an interpretation of alternative
evolutionary paths along the network (Zeil et al., 2016). However, mutation-based networks
are restricted to the rare families with high microdiversity such as TEM β-lactamases. In
contrast, the metric of global sequence identity can be applied to all protein families. For TEM
β-lactamases, the mutation-based and the identity-based degree distributions were identical
and approximated by a power law distribution with a scaling exponent γ = 1.2. A power law
degree distribution was also observed for four protein families with low microdiversity (bHAD,
DC, oTA, SDR) when using the distance metrics of pairwise sequence identity. Although the
four families had different structural folds, domain arrangements, and sequence lengths, and
differed in their level of sequence diversity (Figure A.3) and their size (Table 2.1), they
resulted in similar scaling exponents of γ between 1.1 and 1.3. The observation that different
protein families show similar scaling exponents indicates that the constraints governing protein
evolution are similar for all proteins (Keller, 2005). Scale-free distributions of protein families
have been described previously for networks of co-occurring protein domains and networks
of sequence motifs, with scaling exponents γ in the range from 1.7 to 2.0 (Wuchty, 2001;
Aziz et al., 2016). By clustering sequences into homologous families, scale-free cluster size
distributions have been observed with scaling exponents between 1.6 and 2.5 (Koonin et al.,
2002; Enright et al., 2003; Orengo and Thornton, 2005). It has been suggested that cluster
size distribution is a direct consequence of the necessity for a functional protein to fold into a
stable structure (Deeds et al., 2003). As a consequence, sequence space is highly connected,
as seen for families with high microdiversity (Zeil et al., 2016). Connectivity is also related to
findability of genotypes (McCandlish, 2013). Stability against random errors, another feature
attributed to scale-free networks, is also favorable during evolution (compare with Albert and
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Baraba´si, 2002).
Scale-free distributions have been found in all domains of life sciences, and far-reaching
conclusions have been drawn which were not supported by the data (Lima-Mendez and van
Helden, 2009). Therefore, the goodness of the power law fit was compared to alternative fits
by Poisson and Gaussian distributions. While their parameters could be adjusted to follow the
data in the tail, they failed to describe the monotonous increase of the number of nodes at
decreasing degrees, and thus confirmed the power law fit (see also Keller, 2005; Lima-Mendez
and van Helden, 2009). However, the limited number of sequences per protein family and
the small fraction (estimated 10−20) of known protein sequences (Dryden et al., 2008) are two
factors that favor the tendency to form a power law distribution, because it had been observed
that binning of the data has the tendency to form a power law distribution (Jeong et al., 2000)
and that sub-networks tend to exhibit a power law distribution, irrespective of the topological
property of the larger network they were sampled from (Han et al., 2004). Even if the sub-
networks retain the power law shape, their scaling exponent might differ from the larger network
(Stumpf et al., 2005). Thus, there is a risk that the apparent power law distribution might result
from a sampling artifact. As the number of newly sequenced genomes is rapidly expanding in
the near future, it will be interesting to see whether the degree distribution is robust upon
better sampling of the sequence space.
3.1.3 Evolutionary constraints for protein sequences
By analyzing the known sequence space, it was predicted that extant proteins form a perco-
lating, highly connected network where each sequence has multiple neighbors, and each pair
of sequences is connected by many different paths, as expected from evolution (Smith, 1970).
However, the density in sequence space is not uniform, but follows a power law distribution
which indicates that certain folds were more evolvable than others. Percolation allows for the
concept of evolution as adaptive walks on a fitness landscape (Kauffman and Levin, 1987),
where sequences at the ends of the walks may substantially differ from one another (Frenkel
and Trifonov, 2007). A high degree of connectedness also overcomes the possible blockage by
sign epistasis and reciprocal sign epistasis (Wu et al., 2016) and thus is a necessary condition of
efficient evolution, despite the fact that only an infinitesimally small portion of the theoretical
sequence space had been explored during the course of life on earth (Dryden et al., 2008). In a
highly connected sequence network as a model of evolution (Manrubia and Cuesta, 2015), se-
quences were found that form bridges between two communities. Since the number of bridges is
much smaller than the number of community members, they only gradually appear as the num-
ber of sequenced genes increases. Consequently, the observed separation of families is merely a
consequence of our limited knowledge of extant sequence space. With increasing sequence data
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from genomics and metagenomics projects, one can expect more and more sequences to occur
which form bridges between yet separated families and thus contribute to the connectedness
of known sequence space. These bridging sequences are equivalent to reconstructed ances-
tral sequences in binary trees (Merkl and Sterner, 2016). Since they form a link between two
branches, ancestral proteins are assumed to be generalists with a broader substrate spectrum
or even multiple activities (Khersonsky et al., 2006). While the binary tree model of evolution
assumes that the ancestor sequences have disappeared from the biosphere, the network model
of evolution assumes that bridging sequences still exist. For any two neighboring, biochemically
distinct communities, one expects bridging sequences to exist that contribute to the formation
of a continuous network. It will be challenging to analyze how the biochemical properties
change as one walks across the bridges. Most probably, bridging sequences are multi-functional
or promiscuous enzymes with known or latent activities of both sub-families. In contrast to
ancestors, these generalists already exist in the biosphere and are waiting to be found.
Protein networks with a highly inhomogeneous, exponential degree distribution with a long tail
have another interesting consequence: the existence of a few highly connected nodes. These
hubs are sequences or groups of sequences (hub regions) with a very large number of poten-
tially functional neighbors. The role of hub regions in evolution is still under discussion. It has
been suggested that highly connected nodes originated early in evolution (Fell and Wagner,
2000), while less connected nodes are recent results from divergent evolution (Dokholyan et al.,
2002). This interpretation of ”the old get richer” is based on preferential attachment network
models (see Baraba´si and Albert, 1999). However, preferential attachment is only one way to
generate networks, and there are different network topologies that all result in a power law
degree distribution (Lima-Mendez and van Helden, 2009). As a consequence, the most highly
connected protein sequences are not necessarily the phylogenetically oldest. By assuming that
evolution has reached an equilibrium in protein sequence space, the more evolvable folds might
have become densely populated as a consequence of convergent evolution (Dokholyan et al.,
2002), thus connecting the concept of hubs to the concept of evolvability. Evolvability of a
protein sequence has two aspects: robustness toward possible deleterious effects of mutations
and innovability, where additional mutations readily induce new functions (Dellus-Gur et al.,
2015). Since the hub sequences have many supposedly functional neighbors, they have proven
to be highly evolvable. Interestingly, some hub proteins have a pivotal role in metabolism.
The E1 subunit of the pyruvate dehydrogenase complex, a hub of the DC network, is also a
hub in the metabolism linking glycolysis and citric acid cycle (Gray et al., 2014; Zhang et al.,
2014). The aspartate aminotransferase, a hub of the oTA network, links the amino acid and
the carbohydrate metabolisms (Korla et al., 2015). These coincidences of hubs in sequence
networks and metabolic networks could point at a higher robustness against mutations to pre-
serve cellular function. The concept of hubs can also be applied to improve the efficiency of
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directed evolution experiments. Directed evolution is a powerful and widely applied strategy
for improving biochemical and biophysical properties of proteins by applying iterative rounds
of random mutations and screening. However, multiple random mutations tend to result in
inactive proteins with a probability of 92 % for only six random mutations (Guo et al., 2004).
Therefore, it has been suggested to start a directed evolution experiment either from a popula-
tion of neutral mutants (Gupta and Tawfik, 2008) or by constructing ancestor sequences (Merkl
and Sterner, 2016), which are believed to have a higher robustness and thus higher evolvability
than contemporary sequences (Gaucher et al., 2008). As a promising alternative, one could
suggest to use the hub sequences as starting points in directed evolution experiments and to
select highly evolvable homologues directly from the pool of contemporary sequences.
3.2 From data management to model management
The lessons learned from the effect of different kinetic model equations on the outcome of
the parameter estimation can be generalized for the application of models on original data in
general (compare with Figure A.28). The data on enzyme sequence, structure and function
used in white biotechnology can be analyzed by various models (exemplified in Figure 3.1).
Models refer to concepts and assumptions that are applied on original data on the level of
sequence, structure or function. The application of models results in model-dependent infor-
mation that cannot be understood correctly without annotations on the original data and the
models themselves. The influence of different models on the outcome of the parameter estima-
tions in Manuscript 5 emphasizes the necessity to store information on both data and models.
Furthermore, other models used in data mining should be integrated in databases as well, lead-
ing to the concept of modelbases instead of plain databases. Such a strategy for data and model
management for white biotechnology should be implemented in subsequent steps, based on the
demands of collaborative research projects combining computational routines (modeling) from
fields like bioinformatics with original data from public databases or experiments.
3.2.1 Models for bioinformatic sequence analyses
Original data on sequences can be analyzed by various models, such as standard numbering
schemes based on profile hidden Markov models (reviewed by Eddy, 1998). The concept of pro-
tein sequence networks from Atkinson et al. (2009) can be regarded as an exemplary application
of a model: an assumption on the relationships between homologous sequences, visualized in
the topology of a network. Similarly, protein families can be represented by profile HMMs, as
a further model-application on the level of protein sequences (Eddy, 1998; Finn et al., 2015).
As examples for models working on sequence data, protein sequence networks and standard
numbering schemes have been applied in chapters 2.1.1 to 2.1.3. The combination of a stan-
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Figure 3.1: Concept for data and model integration in a common data- and modelbase on the
levels of protein sequence (1), structure (2) and experimental time-course data (3). Models refer
to concepts and assumptions that are applied on the original data, such as: alignments that
are applied on protein sequences to construct protein sequence networks, standard numbering
schemes (based on profile HMMs of structure-guided sequence alignments) or equations of
kinetic models. The application of models results in model-dependent information (compare
with Figure A.28) that cannot be reproduced and interpreted without annotations on the
original data and the models themselves. Thus, routines of data mining rely on both data and
model quality. Exemplary results of data mining could be the identification of hubs or bridges
in protein sequence networks, conservation analyses based on standard numbering schemes or
kinetic parameter estimations.
dard numbering scheme (annotating structurally equivalent positions) with protein sequence
networks (representing distances between sequences) helps to identify protein sequences within
large data sets that match sequence motifs and are related to different subgroups of homologous
sequences, as exemplified for ω-transaminases from fold type IV (Figure 2.7) (Manuscript
3).
Since models like profile hidden Markov models or assumptions on sequence homology are
often used for the annotation of sequences, the biological relevance of the analyzed data in
sequence databases depends on both data and models. Thus, it becomes necessary to annotate
both sequence data and models. As an example for the annotation of a model, the underlying
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alignments for a profile hidden Markov model of a standard numbering scheme have to be
known in order the interpret the applicability of such a model. For protein sequence networks,
the programs and parameters used to construct such a network have to be reported as well to
avoid misinterpretation of results. A management strategy for bioinformatic models will help
to reproduce data mining results, similar to the data management strategies supported by the
FAIR data principles (Wilkinson et al., 2016).
3.2.2 Managing time-course data and kinetic models
The kinetic parameter estimations for Pf BAL-catalyzed symmetric carboligations suggested
the microkinetic model for substrate-dependent enzyme inactivation (model 4, Equations 1.13
and 1.22) as the best fit (Figures 2.9 and Figures 2.10). These observations would not
have been possible with parameter estimations based on initial reaction rates, since the initial
phase of the reaction could also be fitted by a two-substrate Michaelis-Menten model (model
1, Equation 1.5, Figures A.38 and A.39). The model fit and the parameter quality of the
microkinetic model 4 with substrate-dependent inactivation support the mechanism of inacti-
vation for both substrates as observed previously (Leksawasdi et al., 2004). Michaelis-Menten
model 1, which had a similar fit quality and similar kcatf values, cannot capture inactivation
since it neglects the later phases of the time-courses. These findings underline the importance
of full time-course data for proper investigations on enzyme kinetics (Duggleby and Morrison,
1978; Duggleby, 2001). Furthermore, it confirms the warning from Hill et al. (1977) that data
from literature does not often support the Michaelis-Menten model. The better model fit of
the Michaelis-Menten model 1 to the initial phases in comparison to the full time-courses does
not guarantee that this model sufficiently describes the underlying mechanism (Stroberg and
Schnell, 2016). When using time-courses for estimating kinetic parameters, the biochemist
avoids the information loss of the rate regression from concentration over time and is rewarded
by more precise information about the full enzymatic reaction, in contrast to investigations of
the initial reaction phase or steady-state kinetics (Schnell and Maini, 2003).
In addition, the applications of the macro- and microkinetic model (models 2 and 3, Equa-
tions 1.7 and 1.13) result in similar fits but in parameter estimates with different uncertainties
(Table 2.3 and 2.4), showing that different mathematical formulations for the same reaction
mechanism (Figure 1.2) do not necessarily result in parameter estimates of the same quality.
In summary, one can propose that the selection of a suitable kinetic model should start with
knowledge on the stoichiometry, which in turn determines the choice of possible reaction mech-
anisms. Finally, different equations describing the same reaction mechanism can be necessary
to estimate parameters with lower uncertainties.
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3.2.3 Data integration for bioinformatics and white biotechnology
As Lapatas et al. (2015) pointed out, experimenters and users have to be included in a data
management strategy. Accordingly, a Microsoft Excel spreadsheet was provided on the BioCat-
Net documentation website for facilitated sharing of data from experimenters (Manuscript 4).
To further enhance the usability of BioCatNet, standardized vocabularies could be integrated
as naming conventions for terms describing enzyme function, since consistent names and an-
notations are required for an applicable data integration (Goble and Stevens, 2008; Wilkinson
et al., 2016). Thus, ongoing projects on data integration and data mining should make use
of predefined names, such as the suggestions of the Gene Ontology (GO) for various biologi-
cally relevant terms and the relations between these names (Ashburner et al., 2000). Existing
guidelines, such as the descriptions of the STRENDA consortium (Tipton et al., 2014) and the
proposal for reporting data on biocatalytic reactions by Gardossi et al. (2010) mentioned earlier
are comparable examples of standards for data integration, which also inspired the concept of
BioCatNet (Reusch, 2014; Vogel, 2015). Hence, the need for standardization on data annotation
is comparable in bioinformatics and white biotechnology in general, since various data sources
have to be combined for investigations on protein sequence, structure and function. The usage
of common vocabularies will help to integrate different modeling routines with different data
on various levels, paving the way for more reproducible data mining in data-driven modeling
routines (Figure 3.1).
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The following publications comprise additional results and details on data and computational
methods for chapter 2.
• chapter A.1 (Manuscript 1) refers to chapter 2.1.1.
• chapter A.2 (Manuscript 2) refers to chapter 2.1.2.
• chapter A.3 (Manuscript 3) refers to chapter 2.1.3.
• chapter A.4 (Manuscript 4) refers to chapter 2.2.1.
• chapter A.5 (Manuscript 5) refers to chapter 2.2.2.
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one, 13(8):1–14, 2018b
Own contributions
I established the computational methods for the generation and analysis of protein sequence
networks and applied them for different superfamilies (see chapter 2.1.1). I contributed to the
writing of the original manuscript.
A.1.1 Abstract
The sequence space of five protein superfamilies was investigated by constructing sequence net-
works. The nodes represent individual sequences, and two nodes are connected by an edge if the
global sequence identity of two sequences exceeds a threshold. The networks were characterized
by their degree distribution (number of nodes with a given number of neighbors) and by their
fractal network dimension. Although the five protein families differed in sequence length, fold,
and domain arrangement, their network properties were similar. The fractal network dimension
Df was distance-dependent: a high dimension for single and double mutants (Df = 4.0), which
dropped to Df = 0.7 - 1.0 at 90 % sequence identity, and increased to Df= 3.5 - 4.5 below 70 %
sequence identity. The distance dependency of the network dimension is consistent with evo-
lutionary constraints for functional proteins. While random single and double mutations often
result in a functional protein, the accumulation of more than ten mutations is dominated by
epistasis. The networks of the five protein families were highly inhomogeneous with few highly
connected communities (”hub sequences”) and a large number of smaller and less connected
communities. The degree distributions followed a power-law distribution with similar scaling
exponents close to 1. Because the hub sequences have a large number of functional neighbors,
they are expected to be robust toward possible deleterious effects of mutations. Because of their
robustness, hub sequences have the potential of high innovability, with additional mutations
readily inducing new functions. Therefore, they form hotspots of evolution and are promising
candidates as starting points for directed evolution experiments in biotechnology.
A.1.2 Introduction
Power laws of the form f(x) ∼ xγ are ubiquitous in many physical systems and describe
scale free phenomena, for which changing the scale of the independent variable x preserves
the functional form f of the solution (f(λx) = λγf(x)) (Newman, 2005). Because scaling is a
manifestation of the dynamics and geometry of a physical system, scaling laws reflect underlying
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generic features and provide insight into important universal principles, characterized by the
scaling exponent γ.
Power laws also play an important role in life sciences. Spanning many orders of magnitude,
fundamental variables such as metabolic rate, growth rate, or tree height follow a power law
with an exponent γ which is an integer multiple of 1
4
(West and Brown, 2004). The observation
of scaling relationships throughout the living world has inspired the search for basic principles
that explain complex biological phenomena from unicellular organisms to trees. Power laws also
describe population genetics for unlinked loci in the monomorphic limit and are a consequence
of Darwin’s theory of evolution (Manhart et al., 2012). For proteins, scaling relations were
observed for the solvent-accessible surface area (Moret et al., 2009), the packing (Reuveni
et al., 2008), and the equilibrium dynamics (Tang et al., 2017), and it has been suggested that
near-criticality might be a characteristic of biological systems (Mora and Bialek, 2011).
Power law distributions have also been detected in sequence similarity networks of proteins
(Enright et al., 2003) and have been interpreted as a consequence of evolution (Deeds et al., 2003;
Koonin et al., 2002) or the constraints of protein structure (Deeds et al., 2003; Wuchty, 2001).
Detailed modelling of protein evolution is challenging due to the high complexity of combining
random genotypic variation with selection of phenotypic traits such as folding pathway, protein
stability, and biological function of the protein. Usually, the effects of mutations are non-
additive and dominated by epistasis (Wu et al., 2016). Moreover, only an infinitesimally small
fraction of the sequence space of proteins has been inspected yet, despite the rapidly growing
amount of DNA data due to advances in DNA sequencing techniques. While we currently know
the sequences of 108 proteins (Bateman et al., 2015), the number of different protein sequences
existing in the biosphere was estimated to be 1034, and up to 1043 different protein sequences
might have been explored during 4 Gyr of evolution (Dryden et al., 2008). Though this number
seems to be large, it is extremely small as compared to the number of possible protein sequences
(10300 theoretical sequences for a medium-sized protein). Thus, we only know a tiny fraction
of the total sequence space of viable proteins, and the theoretical sequence space is sparsely
populated by the extant proteins.
In the absence of knowledge about the extant sequence space, relationships between known
sequences can be measured by a metric based on global sequence identity or by neighborhood
relationships in a protein sequence network where sequences form nodes that are connected by
edges (Widmann and Pleiss, 2014; Zeil et al., 2016). While pairwise sequence identity can be
determined for all protein families, extended protein sequence networks only exist for families
with high microdiversity such as TEM β-lactamases, which form a single connected network of
more than 260 single point variants. In this network, the number of neighbors of each sequence
is not equally distributed, but follows a power law with a scaling exponent of 1.2 (Zeil et al.,
2016). The protein sequence network of TEM β-lactamases contains a few ”hubs” such as
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TEM-1 and TEM-116 (Jacoby and Bush, 2016) and a large number of less connected nodes,
with about 10 times less sequences having 10 times more neighbors each. It is tempting to relate
the property of being a highly connected node to the property of being an ancestral sequence
by intuitively assuming a preferential attachment model of network generation (Baraba´si and
Albert, 1999). However, the observed scale-free degree distribution can result from a variety of
different mechanisms (Lima-Mendez and van Helden, 2009) and might be determined by the
actual constraints of the system rather than a unique mechanism (Fox Keller, 2005).
A central constraint in protein evolution is the evolvability of a protein sequence, which
includes two elements, robustness to faults and innovability (Dellus-Gur et al., 2013). Innov-
ability seems to be a consequence of active site location (Dellus-Gur et al., 2013). Robustness
can be measured by the tolerance of a protein for deleterious effects of mutations and is related
to stability and conformational dynamics of a protein (Tokuriki and Tawfik, 2009; Dellus-Gur
et al., 2015). Thus, robustness is expected to vary between and inside a protein family, and
it is desirable to identify or construct highly evolvable protein family members as promising
starting points for directed evolution experiments.
A.1.3 Methods
Datasets of protein sequences The datasets of the individual protein families were updated
by performing BLAST searches against the non-redundant protein database from the NCBI
(GenBank) (Benson et al., 2018). The sequence datasets were updated for the families of TEM
β-lactamases (TEM, 422 sequences), β-hydroxyacid dehydrogenases/ imine reductases (bHAD,
30781 sequences), thiamine diphosphate-dependent decarboxylases (DC, 39290 sequences), ω-
transaminases (oTA, 120921 sequences), and short-chain dehydrogenases/ reductases (SDR,
141496 sequences). In case of TEM β-lactamases, the core region from positions 24 to 280 was
used only (referring to TEM-1 position numbering).
Sequence alignments and sequence networks The distances between pairs of protein
sequences can be measured either by counting point mutations or by pairwise sequence align-
ments. The former metric was applied for the densely connected family of TEM β-lactamases,
for which a single point mutation forms the minimal distance between two sequences. TEM β-
lactamase protein sequences were connected by an edge, if they differed by one point mutation,
which was feasible due to the high microdiversity of this protein family.
Pairwise distances between sequences of the remaining protein superfamilies were calculated
by combining the heuristic alignment approach of USEARCH, which reduced the number of
sequence pairs, with global Needleman-Wunsch sequence alignment (Edgar, 2010; Needleman
and Wunsch, 1970). USEARCH alignments were performed to identify highly similar neighbor
sequences with an identity threshold of 0.5, corresponding to 50 % sequence identity without
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terminal gaps. In the second step, more accurate global sequence identities were derived from
pairwise Needleman-Wunsch alignments (implemented in the EMBOSS bioinformatics software
suite (Rice et al., 2000)) with gap opening penalty of 10 and gap extension penalty of 0.5.
USEARCH and EMBOSS were run on multiple threads by applying GNU Parallel (Tange,
2011).
The point-mutation network of TEM β-lactamases and the identity-based networks of the
remaining protein superfamilies, i.e. the sequence networks calculated by global sequence align-
ments as described above, were constructed and visualized by Cytoscape (version 3.4.0) using
prefuse force directed layout. For the identity-based networks, prefuse force directed layout was
applied with respect to the edge weights (i. e. the higher the sequence identity, the closer the
sequences are placed).
Degree distribution and fractal network dimension For identity-based sequence net-
works, the number of neighboring sequences for a given sequence, i. e. the degree of a network
node, was determined by counting the number of sequence pairs having a minimum sequence
identity to the respective sequence, such as ≥ 95 % sequence identity and thus less than 5 %
pairwise distance. For the point mutation network of TEM β-lactamases, the degree of a net-
work node was determined by counting neighboring sequences within the distance of one point
mutation to the respective sequence. The degrees were calculated for all sequences of a given
sequence network and the number of sequences N having n neighbors was plotted over the
degree n.
To derive the fractal network dimension Df of identity-based sequence networks, the number
of sequence pairs p(d) that differed by less than d %, with d % = (100 - sequence identity) %,
was computed for pairwise sequence identities determined by USEARCH (Edgar, 2010). The
respective fractal network dimension Df was calculated assuming p(d) ∼ dDf and plotting
log(p(d)) over log(d) for d = 2, 4, 6, ..., 100. In addition, p(d) was determined for the point-
mutation network of TEM β-lactamases with d = 1, 2, 3, 4 point mutations.
A.1.4 Results
All members of a protein family are related to each other by their global sequence identity
obtained from pairwise sequence alignments. This relationship was analyzed by constructing
networks where the nodes represent individual sequences and the edges represent a neighbor-
hood relationship. Two types of neighborhood relationships were applied for network construc-
tion. In identity-based networks, an edge is formed between a pair of sequences if their global
sequence identity exceeds a threshold. By adjusting the sequence identity threshold, the con-
struction of identity-based sequence networks was feasible for all homologous protein families
and resulted in connected networks for each family. In the rare case of protein families with high
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microdiversity, such as the TEM β-lactamase family, a second network type was constructed,
where an edge between two nodes was formed if the two sequences differed by a point mutation.
If such a point mutation network is feasible, it is expected to be highly similar to the respective
identity-based with high sequence identity threshold.
Network models for TEM β-lactamases, a family of high microdiversity The TEM
β-lactamase family is a large protein family of high microdiversity (Zeil et al., 2016). A point
mutation network was constructed for variants of the TEM β-lactamase core region, resulting in
267 nodes and 401 edges (Figure A.1). The number of neighbors varied widely for each node.
While there were two highly connected hubs (TEM-1 with 86 and TEM-116 with 55 neighbor
sequences), most nodes had only few neighbors. The network properties were characterized by
calculating the degree distribution, and the number N of nodes with n neighbors followed a
power law distribution N(n) ∼ n−γ with a scaling exponent γ = 1.2 (Figure A.2).
For comparison, an identity-based network was constructed using a global sequence identity
threshold of 99.5 % pairwise sequence identity, corresponding to a distance of one point mutation
(Figure A.6). The global sequence identity measures the number of mutations between two
sequences, but is independent of the number of known sequences between the two sequences.
The network consisted of 267 nodes and 401 edges, too, and its degree distribution followed
a power law with a scaling exponent γ which was identical to the point mutation network
(Figure A.7).
Alternatively, the degree distributions of the sequence networks were fitted by a Poisson
distribution P (λ) and a Gaussian distribution G(µ, σ). In contrast to the power-law distribu-
tion, the Poisson and the Gaussian distribution resulted in noticeably qualitative deviations
from the experimental data (Figure A.7).
Degree distributions for protein superfamilies with low microdiversity Except for
the TEM β-lactamases, the microdiversities of the protein families were too low to result
in connected point mutation networks. Therefore, four protein superfamilies (β-hydroxyacid
dehydrogenases/ imine reductases, bHAD; thiamine diphosphate-dependent decarboxylases,
DC; ω-transaminases, oTA; short-chain dehydrogenases/ reductases, SDR) were analyzed by
constructing networks based on pairwise sequence identity (Table A.1). The protein families
differed in their distributions of pairwise sequence identities, which is expected for superfamilies
of different sequence length, fold, and domain arrangement (Figure A.3).
Sequence pairs with a global sequence identity ≥ 95 % were defined as neighbors. For
the four identity-based networks, the degree distribution was approximated by a power law
distribution N(n) ∼ n−γ, whereas the distributions deviated from a scale-free behavior for the
most highly connected nodes (Figure A.4). Thus, data for degrees ≥ 50 or 70 were excluded
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from linear regression, resulting in scaling exponents of γ = 1.2 - 1.3 (Table A.2). The power
law distribution was maintained upon decreasing the global sequence identity thresholds for
the construction of identity-based networks to ≥ 90 %, ≥ 85 %, or ≥ 80 % (Figures A.8 to
A.10), and the scaling exponents γ decreased slightly with decreasing threshold to γ = 0.9 -
1.1. Furthermore, subsets between 10 % and 90 % randomly selected sequences from the DC
superfamily resulted in similar scaling exponents γ between 1.1 and 1.4 (Table A.4).
The inhomogeneous power law degree distributions of identity-based sequence networks
point to the existence of highly connected hubs in the sequence space of the four protein super-
families (Table A.3). Instead of individual hub sequences, communities of highly connected
nodes with similar degrees were identified in the identity-based networks. For the DC super-
family, the 100 most highly connected protein sequences had between 250 and 266 neighboring
sequences. Upon random selection of a subset of protein sequences from the DC superfamily,
the respective sequences with the highest number of neighboring sequences were found to be
highly similar, unless very small subsets were analyzed (Table A.5).
Dimensions of protein sequence networks As a further network property, the fractal
network dimension Df was evaluated by counting the number of sequence pairs p(d) that
differed by less than d % (100 % - sequence identity) for d = 2, 4, 6, . . . (Figure A.5). For low
values of d (d ≤ 10 %, i. e. ≥ 90 % identity), log p(d) increased linearly with log d, resulting
in a network dimension Df = 0.7 - 1.0 for the four superfamilies with low microdiversity
(Table A.2). Random selection of a subset of protein sequences from the DC superfamily lead
to almost identical values of Df ≈ 0.7 for d ≤ 10 % (Figure A.11). For increasing distance d,
the network dimension Df increased to Df = 3.5 - 4.5 for 30 % ≤ d ≤ 70 %. For the familyof
TEM β-lactamases, Df was estimated to 1.8 from the values at d = 2 % and d = 4 %.
Because of the high sequence identities of the members of the TEM β-lactamase family, only
few sequence pairs showed distances higher than 4 %. Estimating the fractal network dimension
for the point-mutation network of TEM β-lactamases by comparing the number of single and
double mutants resulted in a higher value of Df = 4.0 (Figure A.12). Beyond double mutants,
the limited network size resulted in an apparent decrease of the network dimension, and the
analysis of double, triple, and quadruple mutants resulted in Df = 1.8, as observed for the
identity-based TEM β-lactamase network.
A.1.5 Discussion
The dimension of protein sequence space The evolution of protein sequences occurs in
iterative steps of random mutagenesis of the genotype and subsequent selection of the pheno-
type. Therefore, the sequence space that has been iteratively explored during 4 Gyr of evolution
is expected to be connected (Smith, 1970). Since the number of explored protein sequences
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(1040) is much smaller than the number of theoretical sequences (> 10300), the dimension of the
sub-space of extant protein sequences is expected to be much smaller than the multi-thousand
dimensional space of theoretical sequences. An estimation of the dimension of the known se-
quence space was achieved by counting the numbers of neighbors at increasing distances. The
fractal network dimension Df of a protein family was similar among the investigated protein
families. Df varied between 0.7 and 1.0 for sequence identities between 98 and 90 %, whereas Df
increased to values between 3.5 and 4.5 at lower sequence identities between 70 and 30 %. The
observation of a distance-dependent fractal dimension of sequence space gives an interesting in-
sight into the sequence-function relationships of proteins. For uncorrelated random mutations,
it has been estimated that the probability of protein inactivation is 34 % for each mutation (Guo
et al., 2004). Therefore, for a small number of mutations, the chance of finding active mutants
is high (0.662 = 44 % and 0.664 = 19 % for two and four mutations, respectively). Thus, many
combinations of random mutations result in active proteins, and Df ≈ 4.0 as evaluated for the
point-mutation network of TEM β-lactamases is a lower limit of the dimension of the extant
sequence space for a small number of mutations, because Df is expected to further increase
as more TEM β-lactamase sequences are discovered in the future. In contrast, if 10 % of all
positions are randomly exchanged, the chance of finding an active variant of a 300 amino acid
protein reduces to 0.6630 = 4 · 10−6. Therefore, the mutations that result in an active protein
must be highly correlated, and evolution is dominated by the non-additive effects of epistasis
(Wu et al., 2016). The high correlation of mutations is compatible with the much lower fractal
network dimension Df = 0.7 - 1.0, which seems to be a generic property of all investigated
protein families. For lower sequence identities between 70 and 30 %, the mutations become
more uncoupled, which results in a considerable increase of the fractal network dimension Df .
At a first glance, scale-dependent network dimensions are counter-intuitive. However, scale-
dependent spatial dimensions have also been observed for physical systems such as turbulent
interfaces (Catrakis and Dimotakis, 1996) and for the distribution of luminous matter in the
universe (Bak and Chen, 2001). Although the analysis of the distance dependence of protein
sequence space is based on a relatively small number of known sequences, it provides quantita-
tive estimates which are in agreement with known sequence-function relationships (Guo et al.,
2004). It will be interesting to see how Df develops in the future, when many more protein
sequences become known.
Evolutionary constraints for protein sequence space Two complementary neighbor-
hood definitions were applied to construct sequence networks. A network construction based
on point mutations allows for an interpretation of alternative evolutionary paths along the net-
work (Zeil et al., 2016). However, mutation-based networks are restricted to the rare families
with high microdiversity such as TEM β-lactamases. In contrast, the metric of global sequence
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identity can be applied to all protein families. For TEM β-lactamases, the mutation-based and
the identity-based degree distributions were identical and were approximated by a power law
distribution with a scaling exponent γ = 1.2. A power law degree distribution was also observed
for four protein families with low microdiversity (bHAD, DC, oTA, SDR) when using the dis-
tance metrics. Although the four families have different structural folds, domain arrangements,
and sequence lengths, and differ in their level of sequence diversity (Figure A.3) and their
size (Table A.1), they resulted in similar scaling exponents γ = 1.2 − 1.4. The observation
that different protein families show similar scaling exponents indicates that the constraints that
govern protein evolution are similar for all proteins (Fox Keller, 2005).
Scale-free distributions of protein families have been described previously for networks of
co-occurring protein domains and networks of sequence motifs, with scaling exponents γ in the
range from 1.7 to 2.0 (Wuchty, 2001; Aziz et al., 2016). By clustering sequences into homologous
families, scale-free cluster size distributions have been observed with scaling exponents between
1.6 and 2.5 (Enright et al., 2003; Koonin et al., 2002; Orengo and Thornton, 2005; Buchholz
et al., 2017). It has been suggested that cluster size distribution is a direct consequence of
the necessity for a functional protein to fold into a stable structure (Deeds et al., 2003). As
a consequence, sequence space is highly connected, as seen for families with high microdiver-
sity (Zeil et al., 2016). Connectivity is also related to findability of genotypes (McCandlish,
2013). Stability against random errors, another feature attributed to scale-free networks, is
also favorable during evolution (Albert and Baraba´si, 2002).
Pitfalls and limitations for protein sequence networks While scale-free distributions
seem to be ubiquitous in many domains of life sciences, care should be taken when drawing
far-reaching conclusions which are not supported by the data (Lima-Mendez and van Helden,
2009). Therefore, the goodness of the power law fit was compared to alternative fits by Poisson
and Gaussian distributions. While the parameters of the Poisson and Gaussian distributions
could be adjusted to follow the data in the tail, they fail to describe the monotonous increase of
the number of nodes at decreasing degrees, and thus confirm the power law fit (Lima-Mendez
and van Helden, 2009; Fox Keller, 2005). However, the limited number of sequences per protein
family and the small fraction (10−20) of known protein sequences (Dryden et al., 2008) are
two factors that favor the tendency to form a power law distribution, because it has been
observed that binning of the data has the tendency to form a power law distribution (Jeong
et al., 2000) and that sub-networks tend to exhibit a power law distribution, irrespective of
the topological property of the larger network they were sampled from (Han et al., 2004). By
analyzing randomly selected sub-networks, we demonstrated that the scaling exponent was
robust upon resampling, thus excluding the possibility that the scaling exponent might differ
between network and sub-networks (Stumpf et al., 2005). However, there is still a risk that
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the apparent power law distribution might result from a sampling artifact. As the number of
newly sequenced genomes is rapidly expanding in the near future, it will be interesting to see
whether the degree distribution is robust upon better sampling of the sequence space.
Implications for protein evolution and protein engineering Protein networks with a
highly inhomogeneous, exponential degree distribution with a long tail have another interesting
consequence: the existence of a few highly connected nodes. These hubs are sequences or groups
of sequences with a very large number of potentially functional neighbors.
The role of hubs in evolution is still under discussion. It has been suggested that highly con-
nected nodes originated early in evolution (Fell and Wagner, 2000), while less connected nodes
are recent results from divergent evolution (Dokholyan et al., 2002). This interpretation of
”the old get richer” is based on preferential attachment network models (Baraba´si and Albert,
1999). However, preferential attachment is only one way to generate networks, and there are
different network topologies which all result in a power law degree distribution (Lima-Mendez
and van Helden, 2009). As a consequence, the most highly connected protein sequences are
not necessarily the phylogenetically oldest, thus hub sequences should not be interpreted as
ancestors. By assuming that evolution has reached an equilibrium in protein sequence space,
the more evolvable folds might have become densely populated as a consequence of conver-
gent evolution (Dokholyan et al., 2002), thus connecting the concept of hubs to the concept
of evolvability. The observation of a uniform distribution of sequences from thermophilic and
hyperthermophilic sources in the oTA network demonstrated that hub sequences are not char-
acterized by increased thermostability (Figure A.26, (Buß et al., 2018))
Evolvability of a protein sequence has two aspects: robustness toward possible deleterious
effects of mutations and innovability, where additional mutations readily induce new functions
(Dellus-Gur et al., 2013). Since the hub sequences have many supposedly functional neighbors,
they have proven to be highly evolvable. Interestingly, some hub proteins have a pivotal role
in metabolism. The E1 subunit of the pyruvate dehydrogenase complex, a hub of the DC
network, is also a hub in the metabolism linking glycolysis and citric acid cycle (Gray et al.,
2014; Zhang et al., 2014). The aspartate aminotransferase, a hub of the oTA network, links
the amino acid and the carbohydrate metabolisms (Korla et al., 2015). These coincidences of
hubs in sequence networks and metabolic networks could point at a higher robustness against
mutations to preserve cellular function.
The concept of hubs can also be applied to improve the efficiency of directed evolution exper-
iments. Directed evolution is a powerful and widely applied strategy for improving biochemical
and biophysical properties of proteins by applying iterative rounds of random mutations and
screening. However, multiple random mutations tend to result in inactive proteins with a
probability of 92 % for only six random mutations (Guo et al., 2004). Therefore, it has been
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suggested to start a directed evolution experiment either from a population of neutral mutants
(Gupta and Tawfik, 2008) or by constructing ancestor sequences (Merkl and Sterner, 2016)
which are believed to have a higher robustness and thus higher evolvability than contempo-
rary sequences (Gaucher et al., 2008). As a promising alternative, we suggest to use the hub
sequences as promising starting points in directed evolution experiments and to select highly
evolvable homologues directly from the pool of contemporary sequences.
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Figure A.1: Sequence network for 267 TEM β-lactamases formed by 401 point mutations
(edges) with 259 sequences forming a densely connected network with two hub sequences (TEM-
1 depicted as black rectangle, TEM-116 as black oval). First neighbors of hub sequences are
depicted in dark gray, other sequences in white.
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Figure A.2: Distribution of the number of sequences N in a network of TEM β-lactamase point
mutations having n first neighbors (Figure A.1). The degree distribution follows a power law
with exponent γ = 1.2.
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Figure A.3: Distributions of pairwise global sequence identity for the protein families from
Table A.1 as determined by high-scoring sequence pairs in USEARCH (Edgar, 2010).
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Figure A.4: Neighbor distribution for the protein families with low microdiversity from Ta-
ble A.1 with neighbors defined by ≥ 95 % global sequence identity. The corresponding scale-
free exponents γ were derived from linear regression for degrees ≤ 50 (bHAD, DC) or ≤ 70
(oTA, SDR) and are summarized in Table A.2.
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Figure A.5: Cumulated distributions of sequence pairs p(d) for pairwise distances of d % of
the protein families TEM (open squares), DC (filled squares), bHAD (open circles), SDR (dia-
monds) and oTA (filled circles) from Table A.1 in subsequent distance intervals of 2 % distance
d (100 % - sequence identity). Linear fits are shown as red lines for distances up to 10 % identity
(up to 5 % for TEM). For further distances between 70 and 30 %, an approximately linear area
is depicted in red.
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Table A.1: Overview of the analyzed protein family networks by number of nodes (sequences)
and maximal degree (number of neighbors) for a 95 % sequence identity threshold, with average
sequence length. The small family of TEM β-lactamases is shown as reference due to its high
microdiversity with a threshold of 99.5 % sequence identity (a).
Enzyme family (abbreviation) Nodes Maximal degree Length
TEM β-lactamases (TEM) 267 a 86 a 250
β-hydroxyacid dehydrogenases/ imine reductases
(bHAD)
17020 259 320
thiamine diphosphate-dependent decarboxylases (DC) 24880 266 580
ω-transaminases (oTA) 79987 381 460
short-chain dehydrogenases/ reductases (SDR) 81680 312 300
Table A.2: Overview of the analyzed protein families from Table A.1 and their derived pa-
rameters. The scale-free exponent γ refers to sequence identity networks constructed with
pairwise identity thresholds of 95 % (compare with Table A.4, 99.5 % threshold for TEM β-
lactamasesa). Network dimension Df refers to the slope from Figure A.5 in different regions
of pairwise sequence identity (> 90 %).
Enzyme family γ Df
TEM 1.2 a 1.8
bHAD 1.2 1.0
DC 1.1 0.7
oTA 1.2 0.9
SDR 1.3 1.0
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Table A.3: Exemplary network hubs and their annotations from sequence networks with a
threshold of 95 % sequence identity (99.5 % for TEM β-lactamases)a for the protein families
from Table A.1.
Family Annotation Source NCBI accession Degree
TEMa β-lactamase TEM-1 Acinetobacter baumannii AAP20891 86
bHAD 2-hydroxy-3-
oxopropionate reduct-
ase
Proteobacteria WP 001303675 259
DC pyruvate dehydroge-
nase subunit
Gammaproteobacteria WP 044256366 266
oTA
putrescine amino-
transferase
Enterobacter cloacae WP 042715413 381
aspartate aminotrans-
ferase
Shigella WP 000069444 378
SDR GDP-mannose 4,6-de-
hydratase
Helicobacter pylori WP 058338748 312
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A.1.6 Supporting Information
P. C. F. Buchholz, C. Zeil, and J. Pleiss. The scale-free nature of protein sequence space. PloS
one, 13(8):1–14, 2018b
In this supplementary material, abbreviations for protein families are used for TEM β-
lactamases (TEM), as an exemplary family having high microdiversity, and β-hydroxyacid
dehydrogenases/ imine reductases (bHAD), thiamine diphosphate-dependent decarboxylases
(DC), ω-transaminases (oTA) and short-chain dehydrogenases/ reductases (SDR).
Figure A.6: Sequence network for 267 TEM β-lactamases connected by 401 edges above a
99.5 % pairwise sequence identity threshold, in comparison to the point mutation network
(Figure A.1). Hub sequences are depicted in black (TEM-1 as black rectangle, TEM-116 as
black oval) with their first neighbors depicted in dark gray, other sequences in white.
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Figure A.7: Distribution of the number of sequences N having n first neighbors for the distance-
based network of TEM β-lactamases (Figure A.6). The degree distribution hints at a power
law distribution with exponent γ = 1.2 (A). In addition, probability density functions were
fitted for a power-law distribution (line, γ = 1.2), a Gaussian distribution (dashed line, µ =
3.0, σ = 6.4) and a Poisson distribution (dotted line, λ = 3.0) with residual sum of squares
0.01, 0.2 and 0.1, respectively (B - D).
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Figure A.8: Degree distribution for the protein families with low microdiversity from Table A.1
with neighbors defined by ≥ 90 % global sequence identity. Linear regression was performed
for degrees ≤ 50 (bHAD, DC) or ≤ 70 (oTA, SDR).
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Figure A.9: Degree distribution for the protein families with low microdiversity from Table A.1
with neighbors defined by ≥ 85 % global sequence identity. Linear regression was performed
for degrees ≤ 50 (bHAD, DC) or ≤ 70 (oTA, SDR).
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Figure A.10: Degree distribution for the protein families with low microdiversity from Ta-
ble A.1 with neighbors defined by ≥ 80 % global sequence identity. Linear regression was
performed for degrees ≤ 50 (bHAD, DC) or ≤ 70 (oTA, SDR).
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Figure A.11: Cumulative distributions of sequence pairs p(d) for pairwise distances of d % of
the DC protein superfamily for the complete data set (open squares) and 10 %, 20 %, . . . , 90 %
randomly selected subsets of sequences (filled squares). The areas marked in red correspond to
the linear approximations from Figure A.5.
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Figure A.12: Cumulative distribution of sequence pairs p(d) with distance in d point mutations
of TEM β-lactamases (open squares). Linear fits are shown for d = 1, 2 (red line) and for d =
2, 3, 4 point mutations (blue line).
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Table A.4: Scaling exponents γ for randomly selected subnetworks of the DC superfamily,
with edges formed by a threshold of 95 % pairwise sequence identity. Linear regressions were
performed up to a limited number of neighbors only, due to low sampling quality for higher
degrees. Thus, values for γ were determined up to a maximum degree.
Selection [%] γ Maximal degree
100 1.1 50
90 1.2 50
80 1.2 50
70 1.2 30
60 1.1 30
50 1.2 30
40 1.1 20
30 1.2 10
20 1.2 10
10 1.4 10
Table A.5: Exemplary protein sequences found in hub regions of the DC networks for varying
subsets of randomly selected sequences. The Annotations are listed as ”pyruvate dihydro-
genase subunit” (PDH), ”glyoxylate carboligase” (GLX) or ”acetolactase synthase 2 catalytic
subunit” (ALS). Pairwise sequence identities towards the hub sequence of the complete network
(WP 044256366) are given in the column on the right.
Selection [%] Annotation Source NCBI accession Degree Identity [%]
100 PDH Gammaproteobacteria WP 044256366 266 100.0
90 PDH Citrobacter sp. MGH 55 WP 043001220 229 99.8
80 PDH Gammaproteobacteria WP 044256366 212 100.0
70 PDH Citrobacter sp. MGH 55 WP 043001220 180 99.8
60 PDH Enterobacteriaceae WP 000815384 146 96.2
50 PDH Gammaproteobacteria WP 044256366 133 100.0
40 PDH Escherichia coli WP 021550521 103 95.8
30 GLX Salmonella enterica WP 038390089 68 24.0
20 PDH Citrobacter sp. MGH 55 WP 043001220 51 99.8
10 ALS Escherichia albertii WP 025238020 24 28.1
125
A.2 Percolation in protein sequence space
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P. C. F. Buchholz, S. Fademrecht, and J. Pleiss. Percolation in protein sequence space. PLoS
one, 12(12), 2017
Own contributions
I applied the computational methods to calculate distributions of pairwise sequence identity and
community (cluster) sizes for different protein superfamilies (see chapter 2.1.2). I contributed
to the writing of the original manuscript.
A.2.1 Abstract
The currently known protein sequences are not distributed equally in sequence space, but cluster
into families. Analyzing the cluster size distribution gives a glimpse of the large and unknown
extant protein sequence space, which has been explored during evolution. For six protein
superfamilies with different fold and function, the cluster size distributions followed a power
law with slopes between 2.4 and 3.3, which represent upper limits to the cluster distribution of
extant sequences. The power law distribution of cluster sizes is in accordance with percolation
theory and strongly supports connectedness of extant sequence space.
Percolation of extant sequence space has three major consequences:
1. It transforms our view of sequence space as a highly connected network where each se-
quence has multiple neighbors, and each pair of sequences is connected by many different
paths. A high degree of connectedness is a necessary condition of efficient evolution,
because it overcomes the possible blockage by sign epistasis and reciprocal sign epistasis.
2. The Fisher exponent is an indicator of connectedness and saturation of sequence space of
each protein superfamily.
3. All clusters are expected to be connected by extant sequences that become apparent as
a higher portion of extant sequence space becomes known. Being linked to biochemically
distinct homologous families, bridging sequences are promising enzyme candidates for
applications in biotechnology because they are expected to have substrate ambiguity or
catalytic promiscuity.
A.2.2 Introduction
Despite the rapidly growing amount of DNA data due to advances in DNA sequencing tech-
niques, only a tiny fraction of all protein sequences existing in the biosphere has been sequenced,
yet. While we currently know the sequences of almost 108proteins (Bateman et al., 2015), the
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number of extant sequences was estimated to be 1034, and up to 1043 different protein sequences
might have been explored during 4 Gyr of evolution (Dryden et al., 2008). Though this num-
ber seems to be large, it is infinitesimally small as compared to the theoretical sequence space
(10400 possible sequences for a medium-sized protein), and it would be highly improbable to
find functional proteins by random search (Salisbury, 1969). Therefore, the Darwinian model
of protein evolution based on mutation of the genotype and subsequent natural selection of
the phenotype excludes the possibility of extant sequences being scattered in the theoretical
sequence space, but they are expected to form a connected network, where functional sequences
and mutations form the nodes and edges, respectively (Smith, 1970). In his fundamental article
about the structure of sequence space, J. Maynard Smith asked the questions whether indeed
all existing proteins are part of a single network with a single starting point, what fraction of
the functional sequence space has been explored yet, and how large is the space of functional,
but never-born proteins (Chiarabelli et al., 2006). Although the sequence space of functional
proteins is unknown, we can reliably measure distances between sequences by global or local
alignment methods (Henikoff and Henikoff, 1992). The currently known protein sequences are
not equally distributed, but cluster into homologous families (Rappoport et al., 2012). How-
ever, due to the sparsity of the known sequence space, in most clusters even neighboring nodes
differ by multiple mutations. As an exception, the TEM β-lactamase family has a very high
microdiversity, and the variants form a dense single network with nodes connected by single
mutations (Zeil et al., 2016).
The apparent sparsity of the known sequence space is a consequence of our limited knowledge
of the extant sequences in the biosphere. Therefore, we expect that as we know more sequences,
all nodes will gradually form a connected network. As an alternative explanation of sparsity, the
observed separation between clusters is the consequence of ancestor sequences having become
extinct during evolution (Thornton, 2004).
In this work, the known sequence space was explored by applying percolation theory to
learn about the extant sequence space. Percolation theory describes the cluster distribution
on a randomly populated lattice, with a parameter p describing the occupancy of the lattice
sites (Christensen and Moloney, 2005). For increasing values of p, the characteristic cluster
size sξ and the fraction P of sites belonging to the largest cluster increases. As p approaches
the percolation threshold pc, an infinite cluster appears for the first time on an infinite lattice,
while on a finite-sized lattice the largest cluster percolates between the lattice boundaries.
The core of percolation theory is a set of scaling relations that depend on |pc − p|, such as
sξ ∼ |pc − p|−1/σ and P ∼ (p− pc)β with critical exponents σ and β which depend on the
geometry of the lattice. Most importantly, percolation theory predicts that the cluster size
distribution N(s) (the number N of clusters with size s) decreases for s  sξ as N(s) ∼ s−τ
and decays exponentially for s sξ. Near to percolation (p→ pc), sξ becomes infinite. Thus,
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for s spanning many orders of magnitude logN(s) depends linearly on log s, with the Fisher
exponent τ describing the ratio of small to large clusters.
Thus, investigating the cluster size distribution N(s) of homologous protein families provides
insights into the structure of the known sequence space and gives a glimpse of the extant
sequence space, despite our limited knowledge.
A.2.3 Materials and methods
Clustering The in-house databases on α/β hydrolases (abH, 395000 sequences) (Pleiss et al.,
2000), cytochrome P450 monooxygenases (CYP, 53000 sequences) (Gricman et al., 2015), thi-
amine diphosphate-dependent decarboxylases (DC, 39000 sequences) (Vogel and Pleiss, 2014),
and β-hydroxyacid dehydrogenases/ imine reductases (bHAD, 31000 sequences) (Fademrecht
et al., 2016) were updated by searching the NCBI non-redundant protein database (GenBank
(Benson et al., 2011)) by BLAST (Camacho et al., 2009). For each homologous family, repre-
sentative sequences were selected as seed sequences. Family databases for short-chain dehydro-
genases/ reductases (SDR, 141000 sequences) and ω-transaminases (oTA, 121000 sequences)
were established based on seed sequences derived from literature (Persson and Kallberg, 2013;
Rudat et al., 2012). For each protein database, sequence identities of high-scoring sequence
pairs were calculated by the USEARCH software suite (version 9.2) (Edgar, 2010). Sequence
pairs with a distinct sequence identity cutoff were clustered by the Python module graph-tool
(version 2.17)12.
Cluster size distribution For the six protein superfamilies, the cluster size distribution
N(s) was analyzed for cluster sizes s=1, 2, 3, . . . , 1000. Because for large cluster sizes data
becomes increasingly sparse, a histogram distribution was generated by counting the number
of clusters Ni,j =
∑j
s=iN(s) with cluster sizes between i and j.
The observed cluster size distributions were compared to three model distributions: a Gaus-
sian distribution N(s) ∼ exp (1
2
· (s− µ)2 /σ2), an exponential distribution N(s) ∼ exp (−b · s)
and a power law distribution N(s) ∼ s−τ with the Fisher exponent τ characterizing the model
distribution (Figure A.16). Excel sheets for the calculation of the distributions are provided
as supporting information13. The log-log plots of the three model distributions differ consider-
ably: logN(s) of the Gaussian distribution increases gradually with log s and decays rapidly
for s > µ, while for the exponential distribution is decays rapidly for all s > 0. In contrast, for
the power law distribution logN(s) depends linearly on log s with a slope of −τ .
For each model distribution, the respective histogram distribution was calculated. Qual-
itatively, the histogram distributions were similar to the model distributions. For power law
12 https://graph-tool.skewed.de/, accessed on December 8, 2017.
13 https://doi.org/10.1371/journal.pone.0189646.s006, accessed on April 30, 2018.
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distributions with τ > 1, the corresponding histogram distribution could also be approximated
by a straight line with a slope of −τh. However, the two slopes −τ and −τh deviated.
For each histogram distribution of the six protein families, the slope −τh was determined
by fitting the initial linear decay (N1,10, N11,100 , and N101,1000) by linear regression, and the
Fisher exponent of the respective cluster size distribution was derived from τh by varying τ of
the model distribution to fit the observed τh.
A.2.4 Results
Sequence space The known protein sequence space is rapidly increasing, but it represents
only a tiny fraction of the extant sequence space, that has been explored during evolution.
In turn, the extant sequence space represents a fraction p of the much bigger sequence space
coding for functional proteins. Although both the extant and the functional sequence space
and therefore also p are unknown, the scaling properties of the cluster size distribution can be
used as an indicator of p: if the cluster size distribution in the extant sequence space follows a
power law over many orders of magnitude, p is close to a critical percolation threshold pc.
The scaling properties of the extant sequence space are investigated by analyzing the scaling
properties of the much smaller space of known sequences. Because a typical protein superfamily
consists of 104 − 105 protein sequences, the cluster size range is limited to 2 - 3 orders of
magnitude. The sparsity of the known sequence space has three major consequences:
1. Because of the poor statistics of the cluster size distribution N(s) between s = 1 and
1000, the number of clusters with a size between 1 and 10 (N1,10), 11 and 100 (N11,100),
and 101 and 1000 (N101,1000) are analyzed, and the corresponding cluster size distribution
is derived from this histogram distribution.
2. Except for very few families, e.g. TEM β-lactamases, it is rare that two members of a
protein superfamily differ by only one amino acid. Therefore, neighbor relationships are
established by global sequence identity as a cutoff criterion. Using a 90 % cutoff criterion,
two proteins of 400 amino acids are considered to be neighbors if they differ in less than
40 positions. As a consequence, the structure of the resulting network and the Fisher
exponent τ depend on the cutoff criterion for the neighborhood relationship.
3. The Fisher exponent τ depends on the number of known sequences. As the number of
known sequences increases, the protein families become more densely populated, and the
number of large clusters is expected to increase. As a consequence, the Fisher exponent
τ decreases. Therefore, the observed Fisher exponent τ as evaluated from the known
protein superfamilies represents an upper limit to the Fisher exponent of the extant
sequence space.
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The structure of the known sequence space was analyzed for six large protein superfam-
ilies with high diversity in sequence and function: α/β hydrolases (abH, 395,000 sequences)
(Pleiss et al., 2000), short-chain dehydrogenases/ reductases (SDR, 141,000 sequences), ω-
transaminases (oTA, 121,000 sequences), cytochrome P450 monooxygenases (CYP, 53,000 se-
quences) (Gricman et al., 2015), thiamine diphosphate-dependent decarboxylases (DC, 39,000
sequences) (Vogel and Pleiss, 2014), and β-hydroxyacid dehydrogenases/ imine reductases
(bHAD, 31,000 sequences) (Fademrecht et al., 2016) (Table A.6). The six protein super-
families differ in their fold and their number of family members, which is reflected in the
distributions of pairwise sequence identity (Figure A.13). In the abH superfamily, the ma-
jority of sequences had pairwise sequence identity of 40 - 60 %, while almost all CYPs had a
pairwise sequence identity of 15-25 %. SDRs, DCs and bHADs showed a bimodal distribution
with maxima at 20 - 30 and 40 - 50 %.
Cluster size distribution For each of the six protein superfamilies, the sequences were
clustered by a cutoff criterion of 60 % global sequence identity which is often applied for defining
homologous families. The number N of clusters with size s was analyzed in a histogram with
logarithmic bins for s between 1 and 10, 11 and 100, 101 and 1,000, 1,001 and 10,000, and 10,001
and 100,000 to improve statistical sampling (Figure A.14). Intuitively, we had expected
a Gaussian normal distribution, assuming a random distribution of cluster sizes. However,
in contrast to intuition, the distribution of cluster sizes followed a power law N(s) ∼ s−τh ,
indicated by a linear dependency of log s and logN(s) for the six protein superfamilies (abH,
SDR, oTA, CYP, DC, bHAD). The Fisher exponent τh of a histogram describes the ratio
between small and large clusters and is derived from linear regression in the log-log plot of the
histogram (Fisher, 1967). From the Fisher exponent τh of the histogram, the Fisher exponent
τ of the underlying cluster size distribution was calculated by fitting the observed τh of the
histogram to a model distribution of cluster sizes following a power law distribution. Though
the protein families differ in size, structure, and function, for four of the five (SDR, oTA, DC,
bHAD) the Fisher exponent τ varied only slightly (1.8 - 1.9). The smallest Fisher exponent
was derived for the CYP superfamily (τ = 1.6). For the largest superfamily (abH), the Fisher
exponent was 2.0. These values are in agreement with the Fisher exponent of τ ≈ 2 determined
for the protein family size distribution of the Gene3D database (Orengo and Thornton, 2005)
or the TRIBES resource (Enright et al., 2003), while the distribution of protein folds showed a
slightly larger exponent of 2.5 (Koonin et al., 2002).
Dependency of τ on the cluster criterion While the Fisher exponent τ was almost inde-
pendent of the protein family and its size, its absolute value depended on the cutoff criterion
used for clustering. Upon clustering of the six families with six cutoffs between 60 and 90 %,
130
A.2 Percolation in protein sequence space
the cluster size distributions followed a power law for all cutoffs (Figure A.17). With in-
creasing clustering cutoff, the relative number of small clusters increases, while the number of
large clusters decreases. Consequently, the Fisher exponent τ increased almost linearly with
increasing cutoff (Figure A.15) from τ60 = 1.6 - 2.0 at 60 % cutoff, to τ90 = 2.2 - 2.9 at 90 %
cutoff. The Fisher exponent τ was extrapolated to a cutoff of 100 %, representing a network
of nodes separated by only one mutation (τ100). For the six protein families, the extrapolated
τ100 values varied between 2.4 and 3.3 (2.6, 2.4, 2.3, 3.3, 2.8 and 2.5 for abH, SDR, oTA, CYP,
DC, and bHAD, respectively).
Dependency of τ on the number of sequences Of the 395,000 abH sequences, 50, 25, or
12.5 % were randomly selected and clustered, and the cluster size distribution was determined
for four distinct cutoff values (Figure A.18). With a decreasing number of sequences, the
relative number of small clusters increased, while the number of large clusters decreased. Con-
sequently, the Fisher exponent τ increased with decreasing number of sequences: at 60 % cutoff
from 2.0 for the complete database to 2.0, 2.2, and 2.3 at 50, 25, and 12.5 % randomly selected
abH sequences, respectively. A similar trend was observed for the other cutoff values: τ70 =
2.1 - 2.5, τ80 = 2.2 - 2.9, τ90 = 2.4 - 3.2. Therefore, it is expected that the Fisher exponent
τ of the cluster distribution of the known sequences decreases as more extant sequences will
be sequenced in the future, and the extrapolated τ100 values for the six families (between 2.4
and 3.3) represent upper limits to the cluster size distribution of the extant sequence network.
Because percolation theory predicts values of τ between 2.055 for percolation in a 2-dimensional
lattice and 2.5 in a lattice with more than 5 dimensions (Saberi, 2015), the upper limits of 2.4
- 3.3 are in agreement with percolation in the extant sequence space.
Thus, the observation of a power law cluster size distribution results from the connectedness
of extant sequence space which is as a consequence of Darwinian evolution. Interestingly, a
model that describes protein structural evolution on a three dimensional lattice also results
in a power law cluster size distribution with an exponent of 2.3 (Deeds et al., 2003). It is
a tempting observation that the two foundations of protein evolution, the connectedness of
extant sequence space and the formation of a stable fold, both result in a power law cluster
size distribution with a similar exponent. This observation relates to the fundamental property
of protein folds: the stability of a fold is closely related to its evolvability. The more stable
a fold is, the more sequences can adopt it, thus forming larger and better connected sequence
networks.
A.2.5 Discussion
Connectedness and saturation of sequence space The cluster size distribution of the
known sequence space of six protein superfamilies followed a power law, with the extrapolated
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Fisher exponent τ100 being an upper limit to the Fisher exponent of the extant sequence space.
The observation of few clusters containing many sequences might relate with the assumption
that more stable protein folds are more evolvable, thus forming larger and higher connected
clusters of mutations. The extrapolated Fisher exponent is independent of characteristic prop-
erties of the protein families such as family size (Table A.6). Because the Fisher exponent
measures the ratio of small to large clusters, it can be interpreted as an indicator of the global
connectedness of the known sequences of a protein family. The protein families oTA, SDR,
bHAD and abH (τ100 = 2.3, 2.4, 2.5 and 2.6, respectively) had a smaller τ100 and thus a higher
ratio of large to small clusters than the protein families DC, or CYP (τ100 = 2.8 and 3.3, re-
spectively). A high ratio of large to small clusters indicates a high connectedness. There are
at least three possible reasons for a high connectedness of a protein family:
1. The protein family is well explored; thus, a high fraction of its extant sequence space is
already known.
2. The protein family has a high microdiversity.
3. The protein family covers only a small region in sequence space, thus overall variability
is low.
Our observation that the connectedness gradually increased as more sequences become
known is supported by the concept of gradual saturation of sequence space. This concept
describes the observation that the number of newly sequenced genes that form separate clus-
ters plotted over time decreases to zero (Nelson, 2011). Rather than expanding, the sequence
space of protein families is gradually becoming denser and more connected. As τ100 measures
the connectedness of the protein family, it also measures the current level of saturation, with
the protein families SDR and CYP having the highest and lowest saturation, respectively.
Bridges between homologous families The six protein families showed a similar linear
dependency of τ on the clustering cutoff. Thus, for high cutoff values many small clusters
were observed, which gradually combine into larger clusters as the clustering cutoff was de-
creased, and bridges between clusters gradually appeared (Figures A.19 and A.20). These
bridges were formed by sequences that had been part of one cluster and then became part of
a second cluster, or were recruited from previously isolated sequences, as the clustering cutoff
was decreased. These bridging sequences are interesting, as they belong to both clusters. If
global sequence similarity relates to biochemical function, a cluster is characterized by a similar
biochemical function that differs between the clusters. The bridging sequences, having similar-
ities to two or even more clusters, are therefore promising candidates with substrate ambiguity
(Jensen, 1976) or even catalytic promiscuity (Khersonsky et al., 2006).
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Protein evolution By analyzing the known sequence space, we predict that extant proteins
form a percolating, highly connected network where each sequence has multiple neighbors,
and each pair of sequences is connected by many different paths, as expected from evolution
(Smith, 1970). However, the density in sequence space is not uniform, but follows a power law
distribution which indicates that certain folds were more evolvable than others. Percolation
allows for the concept of evolution as adaptive walks on a fitness landscape (Kauffman and
Levin, 1987), where sequences at the ends of the walks may substantially differ from one another
(Frenkel and Trifonov, 2007). A high degree of connectedness also overcomes the possible
blockage by sign epistasis and reciprocal sign epistasis (Wu et al., 2016) and thus is a necessary
condition of efficient evolution, despite the fact that only an infinitesimally small portion of the
theoretical sequence space been explored during the course of life on Earth (Dryden et al., 2008).
In a highly connected sequence network as a model of evolution (Manrubia and Cuesta, 2015),
sequences are found that form bridges between two clusters. Since the number of bridges is
much smaller than the number of cluster members, they only gradually appear as the number
of sequenced genes increases. Consequently, the observed separation of families is merely a
consequence of our limited knowledge of extant sequence space. With increasing sequence data
from genomics and metagenomics projects, we expect more and more sequences to occur which
form bridges between yet separated families and thus contribute to the connectedness of known
sequence space.
These bridging sequences are equivalent to reconstructed ancestral sequences in binary trees
(Merkl and Sterner, 2016). Since they form a link between two branches, ancestral proteins
are assumed to be generalists with a broader substrate spectrum or even multiple activities
(Khersonsky et al., 2006). While the binary tree model of evolution assumes that the ancestor
sequences have disappeared from the biosphere, the network model of evolution assumes that
bridging sequences still exist. For any two neighboring, biochemically distinct clusters, we
expect bridging sequences to exist that contribute to the formation of a continuous network.
It will be challenging to analyze how the biochemical properties change as we walk across
the bridges. Most probably, bridging sequences are multi-functional or promiscuous enzymes
with known or latent activities of both sub-families. In contrast to ancestors, these generalists
already exist in the biosphere and are waiting to be found.
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Figure A.13: Distributions of pairwise global sequence identity for the protein families of α/β-
hydrolases (abH), short-chain dehydrogenases/ reductases (SDR), ω-transaminases (oTA), cy-
tochrome P450 monooxygenases (CYP), thiamine diphosphate-dependent decarboxylases (DC)
and β-hydroxyacid dehydrogenases/ imine reductases (bHAD).
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Figure A.14: Cluster size distribution of α/β hydrolases (abH), short-chain dehydrogenases/ re-
ductases (SDR), ω-transaminases (oTA), cytochrome P450 monooxygenases (CYP), thiamine
diphosphate-dependent decarboxylases (DC), and β-hydroxyacid dehydrogenases/ imine reduc-
tases (bHAD) follow a power law distribution: N(s) ∼ s−τ (N(s), number of clusters of size s;
γ, Fisher exponent). Cluster criterion: 60 % global sequence identity.
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Figure A.15: Fisher exponent τ of the size distribution of homologous families for cluster-
ing cutoffs between 60 and 90 % with extrapolated Fisher exponent τ100 determined by linear
regression (abbreviations according to Figure A.14).
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Table A.6: Protein superfamily size and the Fisher exponent extrapolated to 100 % sequence
identity (τ100) of the six protein families.
Abbreviation Enzyme superfamily Superfamily size τ100
abH α/β hydrolases 395000 2.6
SDR short-chain dehydrogenases/reductases 141000 2.4
oTA ω-transaminases 121000 2.3
CYP cytochrome P450 monooxygenases 53000 3.3
DC thiamine diphosphate-dependent decarboxylases 39000 2.8
bHAD β-hydroxyacid dehydrogenases/ imine reductases 31000 2.5
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P. C. F. Buchholz, S. Fademrecht, and J. Pleiss. Percolation in protein sequence space. PLoS
one, 12(12), 2017
Figure A.16: Model distributions displayed as log-log plot: Gaussian distribution N(s) =
a·exp
(
−1
2
(s−µ)2
σ2
)
with a = 10000, µ = 200, σ = 50, exponential distributionN(s) = a·exp (−bs)
with a = 10000 and b = 0.2, power law distribution N(s) = a · s−τ with a = 10000, −τ = 2.5.
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Figure A.17: Cluster size distributions for 60, 70, 80, and 90 % global sequence identity of
the six protein superfamilies from Table A.6 (α/β-hydrolases in blue, shortchain dehydro-
genases/reductases in green, ω-transaminases in black, cytochrome P450 monooxygenases in
red, thiamine diphosphate-dependent decarboxylases in cyan and β-hydroxyacid dehydroge-
nases/imine reductases in orange).
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Figure A.18: Cluster size distributions for 60, 70, 80, and 90 % global sequence identity of all
abH sequences (filled squares) and randomly selected abH sequences: 50 % (open squares), 25 %
(filled circles) and 12.5 % (open circles) of the original dataset.
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Figure A.19: Details of sequence identity networks for two homologous families of short-chain
dehydrogenases/ reductases (SDR) with clustering cutoff at 39 % sequence identity. The net-
work shows bridges connecting the two homologous families (indicated in red hexagons). Visu-
alization in Cytoscape (version 3.2.1) using organic layout.
Figure A.20: Details of sequence identity networks for two homologous families of short-chain
dehydrogenases/ reductases (SDR) with clustering cutoff at 40 % sequence identity. The bridge
sequences from Figure A.19 are indicated in red hexagons. Visualization in Cytoscape (version
3.2.1) using organic layout.
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the writing of the original manuscript.
A.3.1 Abstract
The ω-Transaminase Engineering Database (oTAED) was established as a publicly accessible
resource on sequences and structures of the biotechnologically relevant ω-transaminases (ω-
TAs) from Fold types I and IV. The oTAED integrates sequence and structure data, provides
a classification based on fold type and sequence similarity, and applies a standard numbering
scheme to identify equivalent positions in homologous proteins. The oTAED includes 67,210
proteins (114,655 sequences) which are divided into 169 homologous families based on global
sequence similarity. The 44 and 39 highly conserved positions which were identified in Fold
type I and IV, respectively, include the known catalytic residues and a large fraction of glycines
and prolines in loop regions, which might have a role in protein folding and stability. However,
for most of the conserved positions the function is still unknown. Literature information on
positions that mediate substrate specificity and stereoselectivity was systematically examined.
The standard numbering schemes revealed that many positions which have been described in
different enzymes are structurally equivalent. For some positions, multiple functional roles have
been suggested based on experimental data in different enzymes. The proposed standard num-
bering schemes for Fold type I and IV ω-TAs assist with analysis of literature data, facilitate
annotation of ω-TAs, support prediction of promising mutation sites, and enable navigation
in ω-TA sequence space. Thus, it is a useful tool for enzyme engineering and the selection of
novel ω-TA candidates with desired biochemical properties.
A.3.2 Introduction
The ubiquity of amino groups in natural products leads to a great diversity of different transam-
inases (TAs, E.C. 2.6.1). TAs catalyze the transfer of an amino group from an amine donor
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to a carbonyl acceptor with pyridoxal-5-phosphate (PLP) as a cofactor, which is bound via
its aldehyde moiety to a lysine side-chain in the active site of the enzyme (Jansonius, 1998).
Because the structure of the donor and the acceptor might differ and because the reaction is
reversible, the enzymes accept 2 different amines as amino donors, which is known as dual
substrate recognition (Hirotsu et al., 2005). As a further consequence of the reversibility of the
transamination, subsequent reaction steps or product separation are required in biosynthetic
applications (Han and Shin, 2014). Other members of the family of PLP-dependent enzymes
include lyases, oxidoreductases, and hydrolases (Percudani and Peracchi, 2009). Because TAs
differ by their amine donor and acceptor scope, substrate specificity was used to assign TAs
to 2 major families. α-transaminases (α-TAs) catalyze transfer of the amino group exclusively
to a carbonyl group in α-position to a carboxyl group. The acceptor can be molecules like ox-
aloacetate or pyruvate, which are converted to the corresponding amino donor l-glutamate or
l-α-alanine. ω-transaminases (ω-TAs) lack the selectivity toward α-keto substrates and have
a wide spectrum of acceptor or donor molecules, for example, α-alanine, 1-phenylethylamine,
putrescine, and other amines. α-TAs are involved in amino acid biosynthesis, which makes
them interesting enzymes for the production of d- or l-amino acids. Their limitation to α-
carbonyl substrates is a disadvantage for broader application of these enzymes (Cristen and
Metzler, 1985; Rozzell, 1984; Breslow et al., 1988).
Applications of ω-transaminases In contrast, ω-TAs lack the dependence on a carboxyl
group in the acceptor substrate and are therefore promising enzymes for the synthesis of a broad
range of optically pure amines (Rudat et al., 2012; Koszelewski et al., 2010; Malik et al., 2012;
Ingram et al., 2007; Tauber et al., 2013; Mathew et al., 2016c, 2015; Crismaru et al., 2013)
such as the pharmaceuticals imagabalin and sitagliptin (Midelfort et al., 2013; Savile et al.,
2010) rivastigmine, a-aminosteroids, mexiletine, cathine, and 3-amino-8-aza-bicyclo[3.2.1]oct-
8-yl-phenylmethanone (Fuchs et al., 2012; Richter et al., 2014; Koszelewski et al., 2009; Sehl
et al., 2013; Weiß et al., 2016). However, considerable enzyme engineering efforts were needed
to adapt enzymes to the desired substrates. In amino acid synthesis, a special focus lies on the
synthesis of optically pure β-amino acids like β-phenylalanine which can be produced using
lipase-ω-TA cascade reactions or racemic resolution reactions using Fold type I-(S )- selective
ω-TAs (Mathew et al., 2015; Dold et al., 2016a). Non-standard amino acids might be applied
in synthetic peptides or for the synthesis of the antitumor drug paclitaxel (Dold et al., 2016a;
Arvidsson et al., 2001; Alvin et al., 2014). In asymmetric synthesis, the reaction equilibrium
is pushed toward the desired product by removing the co-product, by high concentrations of
the amine donor or by regenerating the co-substrate. For example, in the lactate dehydroge-
nase - glucose dehydrogenase system, the co-product pyruvate is enzymatically removed from
the reaction (Weiß et al., 2016; Pavlidis et al., 2016; Ho¨hne et al., 2010). By using isopropyl
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amine as the amine donor, the resulting acetone can be easily removed by lowering the pressure
(Park et al., 2013). If ortho-xylylenediamine is used as the amine donor, it polymerizes after
deamination thereby shifting the equilibrium (Green et al., 2014). Beside the reaction equilib-
rium, solvent stability of ω-TAs is an important factor. Many relevant substrates exhibit low
solubility in aqueous solvents. While the co-solvent DMSO is compatible with ω-TAs, only
few ω-TAs are known to be active in organic solvents such as tert-butyl ether (Savile et al.,
2010; Mutti and Kroutil, 2012). Further applications are presented in the reviews of Guo and
Berglund (2016), Slabu et al. (2017) and Dold et al. (2016b). More particularly, Slabu et al.
(2017) presented several approaches for synthesis of pharmaceuticals using ω-TAs.
The most widely used ω-TAs are from the microorganisms Vibrio fluvialis, Chromobac-
terium violaceum and Arthrobacter citreus Dold et al. (2016b). To overcome the limitations
of wild type ω-TAs, screening, data mining, and enzyme engineering are promising strategies
to develop enzymes with high stability, broad substrate specificity, and high selectivity. While
literature mining is an obvious starting point for most engineering projects, its success is limited
by the lack of naming conventions and position numbering of ω-TAs, which makes it difficult
to compare mutagenesis studies or conserved sequence motifs in different ω-TAs.
Enzyme engineering of ω-transaminases The substrate binding sites of ω-TAs consist
of the large O- and the small P-pocket, (Crismaru et al., 2013) also called A and B pocket,
respectively (Ho¨hne et al., 2010). Promising mutation sites of ω-TAs were reviewed recently
(Guo and Berglund, 2016). In recent years, the aim of engineering efforts is obtaining enzymes
with high activity toward bulky substrates lacking a carboxyl group (Pavlidis et al., 2016). In
the case of Vibrio fluvialis ω-TA, the activity of the enzyme toward β-keto-methylester was
substantially increased by only 8 point mutations (Midelfort et al., 2013). The most beneficial
single mutation was W57F (located in the P-pocket). Pavlidis et al. (2016) could increase
activity of an (S )-selective ω-transaminase from Ruegeria sp. TM1040 by 8900 fold. The best
variant was created by introducing only 4 mutations, Y59W, Y89F, Y152F, and T231A.
Classification of ω-transaminases Three classification schemes for TAs based on biochem-
ical function, sequence, or structure have been proposed. The functional classification divided
the protein sequences into α-TAs and ω-TAs (Braunstein, 1973). The sequence classification
assigned TAs to 5 different aminotransferase classes based on sequence similarity (Jensen and
Gu, 1996; Ouzounis and Sander, 1993; Mehta et al., 1993;  Lyskowski et al., 2014; Grishin et al.,
1995) or 6 Pfam groups based on profile hidden Markov models (Rausch et al., 2013; Finn
et al., 2014). Evolutionary analysis led to a phylogenetic tree with α-TAs in Pfam group I
and ω-TAs in Pfam group III (Rudat et al., 2012; Arvidsson et al., 2001). Based on structure,
PLP-dependent enzymes have been divided into 7 different fold types, (Percudani and Peracchi,
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2009; Grishin et al., 1995; Schneider et al., 2000) with α- and ω- TAs found in Fold types I and
IV (Grishin et al., 1995; Schneider et al., 2000; Eliot and Kirsch, 2004; Pavkov-Keller et al.,
2016). Fold type I (S )-selective ω-TAs have an α-β-α-structure. In contrast, Fold type IV
(R)-selective ω-TAs consist of 2 domains, a 2-layer β-sandwich and an α-β-barrel. TAs of both
fold types form at least homodimers, and the active sites are located at the homodimer inter-
face. Because both α- and ω-TAs are found in each of the 2-fold types, regioselectivity is not
strictly linked to global protein structure. The substrate binding sites of Fold types I and IV
are mirror images with the catalytic lysine located at the si - and re-face of PLP, respectively,
resulting in the observed enantiocomplementarity of the 2-folds with Fold type I (S )-selective
ω-TAs converting (S )-amines and (S )-amino acids, whereas Fold type IV (R)-selective ω-TAs
convert (R)-amines and (R)-amino acids as well as branched-chain l-amino acids ( Lyskowski
et al., 2014; Pavkov-Keller et al., 2016; Mugford et al., 2008). The 3 classification schemes are
used in parallel. TAs are named by their stereopreference ((R)/(S )-selective), their substrate
specificity, their regioselectivity (α/ω-TAs), or their Pfam group (aminotransferase class), re-
sulting in enzyme names such as: ω-aminotransferase, (S )-selective aminotransferase, aromatic
amino acid TA, γ-aminobutyrate TA, ω-amino acid:pyruvate TAs, and class III aminotrans-
ferase (Midelfort et al., 2013; Shin et al., 2003; Han et al., 2015; Hwang et al., 2008; Clark
et al., 2009; Steffen-Munsberg et al., 2013). A public online database on ω-TAs will be a help-
ful tool, connecting information about mutation sites, structure data and substrate scope, thus
allowing researchers the mining of uncharacterized ω-TAs for the desired enzyme functions
and predicting interesting mutation sites. The first public database for ω-TA screening was
the B6-database for the description and classification of vitamin B6 dependent enzymes (Per-
cudani and Peracchi, 2009). Ho¨hne et al. (2010) and Pavlidis et al. (2016) demonstrated data
mining as a successful strategy for in silico screening of (R)-selective TAs accepting bulky sub-
strates (Weiß et al., 2016; Pavlidis et al., 2016; Pavkov-Keller et al., 2016). To support enzyme
engineering and to facilitate navigation and annotation, we established a publicly available
database on ω-TAs which includes sequence information and structural data. Additionally,
standard numbering schemes were established for both fold types to identify equivalent posi-
tions in homologous proteins and to compare the effects of corresponding mutations in different
proteins.
A.3.3 Methods
Setup and clustering of the ω-transaminase engineering database (oTAED) The
sequences of 9 representative ω-transaminases (ω-TAs) were used as query sequences against
the NCBI non-redundant protein database with an E-value threshold of 10−10 (Table A.11)
(Benson et al., 2011). The setup of the oTAED and the clustering of the sequences was per-
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formed within the BioCatNet database system (Buchholz et al., 2016). A sequence identity
threshold of 98 % was applied to assign sequences to proteins and a threshold of 40 % sequence
similarity was used to form homologous families. If the majority of sequence entries from a ho-
mologous family showed sequence lengths longer than 350 amino acids, the homologous family
was assigned to the Fold type I superfamily. Consequently, homologous families were assigned
to the Fold type IV superfamily if most of their sequences were shorter than 350 amino acids.
All sequences within a superfamily that could not be assigned to a homologous family were
collected in a separate group. Sequences shorter than 200 and longer than 550 amino acids
were discarded. If available, crystal structures from the PDB repository were assigned to the
sequence entries. Multiple sequence alignments and phylogenetic trees were generated using
Clustal Omega (Sievers and Higgins, 2014) and can be downloaded from a WWW-accessible
user interface. The oTAED is available at 14.
Standard numbering schemes Standard numbering schemes were established for the 2
superfamilies Fold type I and Fold type IV as described previously (Vogel et al., 2012). For the
respective superfamily, reference structures containing the cofactor PLP and covering the most
abundant homologous families were selected (Table A.12). For Fold type IV, a structural
alignment of 6 reference structures was created using STAMP (Russell and Barton, 1992).
For Fold type I, 14 characterized ω-TAs were selected. The N-terminal region (positions 1
to 64 of PDB entry 2YKU), which was not resolved completely in all Fold type I reference
structures, was discarded to improve the robustness of the alignment. The multiple sequence
alignment of the Fold type I reference sequences from Clustal Omega was refined manually,
guided by structural superimposition (Sievers and Higgins, 2014). From the manually optimized
alignments of Fold type I and IV reference structures, profile hidden Markov models were
created by HMMER (version 3) (Eddy, 1998). By aligning all sequences to their respective
sequence profile, position numbers were transferred to Fold type I sequences from PDB entry
2YKU (ω-TA from Mesorhizobium sp. LUK) and to Fold type IV sequences from PDB entry
4CE5 (ω-TA from Aspergillus terreus).
Conservation analysis The 2 standard numbering schemes for Fold type I and Fold type IV
sequences were used separately to analyze the amino acid composition of both superfamilies.
A position was considered to be conserved in a superfamily, if a single amino acid was present
in > 70 % of all sequences.
Sequence networks Sequence networks were generated for distances between pairs of homol-
ogous sequences. To reduce the number of sequences for pairwise alignments, sequences were
14 https://otaed.biocatnet.de, accessed on April 30, 2018.
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clustered by 30 % identity using the algorithm of USEARCH (Edgar, 2010). Pairwise global
sequence alignments were calculated using the implementation of the Needleman-Wunsch al-
gorithm in the EMBOSS software suite (Rice et al., 2000). Sequence networks were created by
using a cutoff of 50 % pairwise sequence similarity, and the resulting networks were visualized
by Cytoscape version 3.4.0 using the prefuse force-directed layout algorithm with respect to
the edge weights.
A.3.4 Results
Theω-transaminase engineering database (oTAED) Theω-Transaminase Engineering
Database (oTAED) consists of 2 superfamilies, Fold types I and IV. The ω-TA sequences were
assigned to the 2 superfamilies by sequence length. Fold type I proteins have an average length
of 432 amino acids, whereas Fold type IV proteins have an average length of 297 amino acids
(Figure A.25). The oTAED includes 67,210 proteins (114,655 sequences) which were separated
into 169 homologous families (HFams) based on global sequence similarity.
Fold type I The Fold type I superfamily consists of 101,738 protein sequences (89 % of the
oTAED entries), which were assigned to 124 homologous families. Most of the putative Fold
type I (S )-selective ω-TAs belong to 1 large homologous family (HFam 239) comprising 99,559
sequences (98 % of all Fold type I sequences) and 164 structures. This homologous family
contains the previously characterized (S )-selective ω-TAs from Mesorhizobium sp. LUK and
Variovorax paradoxus (PDB entries 4AO4 and 4AOA), which are active toward aromatic β-
amino acids (Crismaru et al., 2013; Wybenga et al., 2012). Their host organisms are soil bacteria
living in symbiosis with plants for fixation of nitrogen (Kaneko et al., 2000; Satola et al., 2013).
A furthermember of HFam 239 is the ω-TA from Rugeria sp. TM1040 (PDB entry 3FCR),
which was characterized as an (S )-selective ω-TA with activity toward small amino acids,
α-methylbenzylamine, bicyclic acceptor molecules such as exo-3-amino-8-aza-bicyclo[3.2.1]oct-
8-yl-phenylmethanone and succinic semialdehyde (Weiß et al., 2016; Steffen-Munsberg et al.,
2013). Other members of HFam 239 are the ω-TA from Chromobacterium violaceum (PDB
entry 4AH3), which exhibited (S )-selectivity and a broad substrate range toward amines and
amino acids, as well as aldehydes and ketones as acceptor molecules (Kaulmann et al., 2007),
and an ω-TA from Pseudomonas aeruginosa (UniProt entry V6A7F6) with activity towards
mono- and diamines. This newly characterized enzyme converts cadaverine and spermidine and
catalyzes the transfer of the amino group to aromatic ketone acceptor molecules (Galman et al.,
2017). These examples demonstrate the large diversity of substrate specificities in the largest
homologous family of the Fold type I superfamily. The other homologous families consist of
< 400 sequences each (Hfam 35: 397 sequences, HFam 134: 339 sequences and 8 structures).
The respective proteins are often annotated as (S )-selective ω-TAs, mostly γ-aminobutyrate
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aminotransferases from eukaryotic organisms.
Fold type IV The Fold type IV superfamily consists of 12,917 protein sequences assigned to
45 homologous families (11 % of the oTAED entries). It contains sequences annotated as (R)-
selective ω-TAs as well as (R)-selective d-α-TAs (DATA). This class of enzymes is selective for
d-α-amino acids like d-alanine or d-glutamate (Tanizawa et al., 1989). Furthermore, it contains
l-branched-chain aminotransferases (l-BCAT) with activity toward aliphatic α-amino acids
like valine, leucine, and isoleucine (Yvon et al., 2000; Hutson, 2001). l-BCATs show a different
enantiopreference in comparison to DATA and (R)-selective ω-TAs, presumably caused by the
reverse arrangement of the substrate in the active site (Pavlidis et al., 2016). However, the
annotation in public databases such as NCBI or Uniprot is often restricted to DATA or l-
BCAT (Ho¨hne et al., 2010), lacking differentiation between DATA, (l-BCAT, and (R)-selective
ω-TAs. The largest homologous family (HFam 11) includes 11,689 sequences (90 % of all Fold
type IV sequences) and 23 annotated structures such as a branched-chain-amino-acid TA (PDB
entry 4WHX) and an amino lyase with activity toward 4-amino-4-deoxychorismate (PDB entry
2Y4R) (O’Rourke et al., 2011). The second largest homologous family (HFam 10) contains 511
sequences and 9 structures. This HFam contains mostlyω-TAs annotated as (R)-selective TAs,
such as the ω-TA from Arthrobacter sp. (PDB entries 5FR9 and 3WWH) which was adapted
by large site directed mutagenesis experiments for activity toward bulky substrates such as
aromatic β-fluoroamines or sitagliptin, and 2 (R)-selective ω-TAs from the fungi Aspergillus
fumigatus and A. terreus (PDB entries 4CHI and 4CE5) showing activity toward aromatic
amines (Savile et al., 2010; Ho¨hne et al., 2010;  Lyskowski et al., 2014; Cuetos et al., 2016;
Thomsen et al., 2014). The other homologous families of Fold type IV contain < 200 sequences
each.
Conserved positions Evolutionary conserved positions often point to structurally or func-
tionally relevant residues. Conserved positions for the 2 fold types were determined by applying
the numbering schemes, as equivalent residues have the same standard number. Though some
conserved positions have already been mentioned in literature, for most of the conserved po-
sitions their biochemical role is still unknown, thus being promising targets for mutational
studies in the future. By applying the standard numbering schemes for Fold types I, 44 con-
served positions (present in > 70 % of the sequences) were identified (Table A.7) with position
numbers according to the ω-TA from Mesorhizobium sp. LUK (PDB entry 2YKU). The highly
conserved positions D189 and K216 were found in all sequences of Fold type I. The side-chain
of D189 is fixed by interacting with H109 and is involved in binding the cofactor PLP by a
hydrogen bond between the carboxylic group and the pyridine nitrogen, and is thus essential
for all PLP-dependent enzymes. The conserved K216 forms a Schiff base with the intermediate
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or with the cofactor PLP. The role of the highly conserved D210 in (S )-selective ω-TAs is
still unknown, but it might participate in a conserved salt bridge between an α-helix and a
β-strand, since in most structures an arginine or asparagine residue is found in close distance
to D210 (Figure A.21). Besides the functionally relevant positions, it is remarkable that 13
of the 44 conserved residues are glycines and 4 are prolines, most of them localized in loops (12
glycines and 2 prolines, respectively) and might therefore be involved in protein folding. For
23 conserved positions, their function is still unknown. Thirty-nine conserved positions were
identified in Fold type IV (Table A.8) with position numbers according to the ω-TA from
Aspergillus terreus (PDB accession 4CE5). The highly conserved position R79 is present in all
sequences and is part of the conserved PLP-binding cup formed by E213, L235, I238, and T239
( Lyskowski et al., 2014). E213 forms a hydrogen bond to the cofactor PLP and might form a
salt bridge to R169 in some Fold type IV proteins ( Lyskowski et al., 2014). Surprisingly, the
catalytically active lysine is only conserved in 88 % of all sequences at Fold type IV standard
position 180. As in Fold type I, R79 might also form a salt bridge to the conserved E61. A
further salt bridge could be formed between D268 and the partly conserved K/R223. All of the
11 conserved glycines were located in loops. For 20 conserved positions, their function is still
unknown.
Selectivity- and specificity-determining positions Considering that (S )-selective and
(R)-selective ω-TAs have a different fold, different substrate specificities, and different con-
served amino acids in their substrate binding pockets, it is surprising that only 1 mutation can
switch enantiopreference. By engineering the ω-TA of Artherobacter citreus (Fold type I), it
was shown that a mutation at Fold type I standard position 328 from valine to alanine changes
the enantiopreference from (S ) to (R) for the substrate 4-fluoro-phenylacetone (Svedendahl
et al., 2010).
Other relevant positions in Fold type I are Y108 near the cofactor PLP, W26 inside the
small binding pocket, and F53.1. Position F53.1 is missing in some Fold type I proteins,
but was shown to have an influence in steric hindrance of bulky substrates for the ω-TA from
Chromobacterium violaceum (Denesyuk et al., 2003). With respect to the binding mechanism of
substrate and cofactor of (R)- and (S )-selectiveω-TAs, the mechanism of binding the phosphate
group of PLP via a hydrogen bond network in the phosphate-binding cup is common to both
Fold types (Figure A.22) ( Lyskowski et al., 2014; Denesyuk et al., 2003; Humble et al., 2012).
The planar cofactor PLP is sandwiched between Y108 and V191 in Fold type I (S )-selective
ω-TAs and between L235 and F217 in Fold type IV (R)-selective ω-TAs (Midelfort et al.,
2013; Sayer et al., 2014). To explore which positions are involved in substrate specificity and
stereoselectivity of Fold type I (S )-selective x-TAs, 2 sequence motifs at 17 sites and 36 Fold type
I standard positions were examined, which have been described in literature to be involved in
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substrate interactions for different ω-TAs (Table A.9). The standard numbering of Fold type
I revealed that many positions that have been described in different enzymes are structurally
equivalent. One example is Fold type I standard position 192, which was described in Vibrio
fluvialis and Pseudomonas putida as positions 259 and 262, respectively. This position is also
part of the P-pocket (small pocket) motif, and mutations at the mentioned positions to less
bulky residues can allow larger substrate molecules inside the small substrate binding pocket
(Midelfort et al., 2013; Park et al., 2012). It is noteworthy that multiple functional roles
have been suggested in literature for the same position. Fold type I standard position 53.1 is
mentioned 4 times in literature for 3 different ω-TAs. Mutation of this position resulted in
changing substrate specificity or inversion of enantiopreference. Fold type I standard position 26
was mentioned 7 times for 6 differentω-TAs. The mutation from a large residue at this position
to a smaller hydrophobic residue allows the conversion of larger aromatic and hydrophobic
substrates. The previously described flipping R346 was described as an important site for dual
substrate recognition (Hirotsu et al., 2005; Steffen-Munsberg et al., 2013). It was also mentioned
in a motif for the recognition of α-carboxyl binding of amino-acceptor substrate and described
for the ω-TA from Vibrio fluvialis, Pseudomonas sp. strain AAC and Silicibacter pomeroyi
(Steffen-Munsberg et al., 2013; Wilding et al., 2016). The flipping arginine is also known
for the β-phenylalanine converting ω-TAs from Variovorax paradoxus and Mesorhizobium sp.
LUK. For the ω-TA from Sphaerobacter thermophilus, which transfers an amino group to the
γ-position (Mathew et al., 2016c), this position is a leucine, but arginines are next to this
position at 346.8 and 346.13. In contrast Mathew et al. (2016c) determined the position 0.41
(R41) as flipping arginine in Sphaerobacter thermophilus, which is located at the substrate
binding pocket and not in the outer shell of the enzyme (Mathew et al., 2016c; Crismaru
et al., 2013). Furthermore, Fold type I standard position 108 seems to be an important site
for the coordination of PLP. This site was mentioned in literature 4 times (Table A.9). In
comparison to Fold type I, literature information about mutations in (R)-selectiveω-TAs in the
Fold type IV superfamily is sparse, and only 17 Fold type IV standard positions were described
(Table A.10). Most mutation data were generated by engineering of Arthrobacter ω-TA for
activity against prositagliptin. Fold type IV standard position 62 is part of the small pocket.
In ω-TA from Arthrobacter sp. 117, the mutation of V62G increased the small pocket (Savile
et al., 2010). In ω-TA from Nectria haematococca, V62 was described as part of a motif which
mediates specificity toward (R)-amines (Sayer et al., 2014). Besides that, a mutation at Fold
type IV standard position 62 is proposed to increase activity toward aromatic ketone substrates
(Savile et al., 2010).
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A.3.5 Discussion
The ω-Transaminase Engineering Database (oTAED) was implemented as a public database
for navigating the sequence space of the biotechnologically relevant ω-TAs from Fold types I
and IV. Besides the oTAED, databases have been published for Fold type IV (Ho¨hne et al.,
2010) and Fold type I proteins (Steffen-Munsberg et al., 2015). The conserved positions in Fold
type I and IV were analyzed by standard numbering schemes in the oTAED. For each Fold
type, a standard numbering scheme allowed for the unambiguous comparison of structurally
equivalent positions in different ω-TAs described in literature. The annotation of previously
identified sequence motifs and the comparison of functionally relevant positions are expected to
facilitate the annotation of yet uncharacterized ω-TAs (Rudat et al., 2012; Koszelewski et al.,
2010; Guo and Berglund, 2016). The inhomogeneous size distribution of homologous families,
with few large and many small families has been observed previously for several other protein
superfamilies, which can be interpreted as a general property of the evolved sequence space
(Buchholz et al., 2017).
Comparison of fold types I and IV The putative (S )- and (R)-selective ω-TAs of Fold
type I and IV, respectively, have different sequence lengths, different folds, and lack global
sequence similarity, and thus are evolutionarily separate. Despite their different folds, the
substrate binding sites of both fold types consist of a large O- and a small P-pocket (Crismaru
et al., 2013; Ho¨hne et al., 2010) and the catalytically important residues are located in the
same spatial arrangement with a highly conserved catalytic lysine (standard positions 216 or
180 in Fold types I or IV, respectively) pointing to the cofactor PLP from the si - or re-face
(Figure A.23). Thus, in respect to the cofactor and the catalytic lysine, both active sites
are mirror images to each other, which explains the observed enantiocomplementarity of Fold
type I (S )-selective and Fold type IV (R)-selective ω-TAs (Green et al., 2014; Grishin et al.,
1995). In contrast to Fold type I (S )-selective ω-TAs, Fold type IV (R)- selective ω-TAs have
no reported activity toward β- or γ-amino acids (Ho¨hne et al., 2010; Guo and Berglund, 2016;
Cuetos et al., 2016; Mutti et al., 2011; Wu et al., 2017). Enzymes from both superfamilies
show activity toward the small-sized α-alanine (Ho¨hne et al., 2010; Guo and Berglund, 2016;
 Lyskowski et al., 2014). However, isopropyl amine (IPA) is also a small amino donor, but it is
not accepted by a variety of ω-TAs (Park et al., 2013; Iwasaki et al., 2012). Furthermore, it
is striking that the PLP binding cup of Fold type IV is more strictly conserved than in Fold
type I, which may be explained by the smaller number of currently known sequences for this
superfamily. By integrating and annotating sequence data on ω-TAs, the oTAED could be
used as a training dataset for machine learning to characterize sequences without experimental
background, which was demonstrated to be a promising method for prediction of E.C. numbers
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(Li et al., 2016). Fold type I and Fold type IV enzymes are still a relatively uncharted territory
with only a small fraction of characterized enzymes. By using the conservation analysis as
a guideline, new functionally relevant positions might be identified and explored by protein
engineering.
Fold type I For putative Fold type I (S )-selective ω-TAs, the standard numbering allowed
the determination of functional amino acid residues within different target sequences. Residues
were predicted to mediate dual substrate recognition, such as the flipping arginine at Fold type
I standard positions 346 or 346.1 (Hirotsu et al., 2005) which is conserved in 11,243 sequences
within Fold type I and might serve as an indicator of ω-TA activity. α-TAs are absent in the
Fold type I superfamily, because sequence similarities between α-TAs and (S )-selective ω-TAs
are very low (Sugio et al., 1995). However, they are functionally related, since a single mu-
tation was sufficient to change an α-TA to an ω-TA (Deszcz et al., 2015). Moreover, many
enzyme families like GABA-transaminases or β-phenylalanine amine transaminases were de-
scribed previously within this group (Steffen-Munsberg et al., 2015). The known fingerprints
of sequence positions are helpful to predict activity toward naturally occurring or technically
applied amines (Steffen-Munsberg et al., 2015). According to this fingerprint-based annota-
tions, the largest group ofω-TAs could be classified as glutamate-1-semialdehyde-aminomutases
(12,667 sequences) and the second largest as β-phenylalanine transaminases (1,527 sequences).
In contrast, only 883 ω-TAs were predicted to have catalytic activity toward bulky or unusual
amines, which is expectable if those amines occur seldom in nature (Deszcz et al., 2015). Sur-
prisingly, the large group of glutamate-1-semialdehyde-aminomutases comprises aminomutases
and ω-TAs, which is a misleading annotation, but not unexpected when the sequence similarity
is analyzed (Steffen-Munsberg et al., 2015).
Fold type IV Correspondingly, Fold type IV comprises different enzyme families with high
global sequence similarity, but different substrate specificity: ω-TAs, 4-amino-4-deoxychorismate
lyases, d-amino acid TAs (DATA), and l-branched-chain amino acid TAs (l-BCAT), which have
been identified by specific sequence motifs (Table A.13), but could not be distinguished based
on global sequence similarity (Ho¨hne et al., 2010; Steffen-Munsberg et al., 2015). Interestingly,
l-BCAT, 4-amino-4-deoxychorismate lyases, and DATA enzymes are related to (R)-selective
ω-TAs within Fold type IV (Ho¨hne et al., 2010) and appear as a separate branch in the
oTAED (Figure A.24). The different substrate specificities are reflected by specific binding
sites. In (S )-selective l-BCATs, the α-carboxyl group is bound in the small P-pocket, while in
(R)-selective TAs it is bound in the larger O-pocket (Ho¨hne et al., 2010). As a consequence,
l-BCATs show an opposite enantiopreference in comparison to DATA and (R)- selective ω-
TAs, and were successfully engineered into ω-TAs accepting large aliphatic substrates (Ho¨hne
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et al., 2010; Skalden et al., 2015). Furthermore, it is surprising that the arginine residue rele-
vant for substrate recognition is not conserved within Fold type IV. This substrate recognition
site was assigned to Fold type IV standard position 128 (Skalden et al., 2015). Therefore, the
Fold type IV superfamily of the oTAED probably includes further enzyme classes other than
ω-TAs or several inactive enzymes. The sequence similarity network indicates that sequences
with matching positions for potential (R)-selectivity did not form distinct groups, whereas se-
quences matching motifs for ADCL, DATA, l-BCAT, or ATA activity were found in different
subgroups. It is, however, difficult to predict overlapping substrate scopes between different
enzyme classes. Thus, enzymes annotated as l-BCATs in public repositories might behave as
Fold-type IV (R)-selective ω-TAs when exposed to non-a-amino acid substrates (Boyko et al.,
2016).
Understanding the substrate specificity of ω-TAs Substrate specificity depends on
distinct amino acid residues in the substrate pockets (Steffen-Munsberg et al., 2013). Among
them, Fold type I standard position 26 seems to be pivotal in mediating the P-pocket size. This
position is relevant in ω-TAs from Chromobacterium violaceum, Ochrobactrum anthropi, Vibrio
fluvialis, Pseudomonas putida, Bacillus megaterium, and Caulobacter crescentus mentioned in
at least 6 publications (Table A.9). The mutation from tryptophan to a smaller hydrophobic
amino acid residue at Fold type I standard position 26 allowed for conversion of larger aromatic
and hydrophobic substrates. Additionally, Fold type I standard position 53.1 is crucial for
the conversion of large substrates, but this position is missing in some ω-TAs like in the V.
paradoxus ω-TA (Humble et al., 2012). An exchange from a large residue like W/F to F/V/A
opened the small binding pocket (P) toward larger residues and led to inverted enantioselectivity
and reduced activity toward 1-phenylethyl-amine, an amine donor which is accepted by all ω-
TAs (Guo and Berglund, 2016; Scha¨tzle et al., 2009). However, the sequence region between Fold
type I standard positions 44 and 81, which is probably involved in substrate recognition, showed
low sequence conservation and thus could not be reliably aligned. Fold type I standard position
108 is a promising hotspot which mediates substrate recognition. This site can be exchanged
with many different amino acids (M/S/N/F/A) with varying effects on substrate specificity.
It was expected that a smaller residue at position 108 would allow for higher flexibility of the
PLP cofactor at the active site and decrease steric hindrance for bulky substrates (Weiß et al.,
2016). It was even shown that this site has an influence on a- versusω-TA activity by structural
comparison of an α- with an ω-TA from C. violaceum (Deszcz et al., 2015).
Thermostability of ω-TAs Besides substrate specificity, enzyme stability is a target of
enzyme engineering, which can be examined using the oTAED. Robustness of an enzyme toward
harsh process conditions is often linked to its thermostability, which is therefore of major interest
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in enzyme design.
Furthermore, psychrophilic enzymes are interesting because of their high activity at low
temperatures (Struvay and Feller, 2012). Until now, no psychrophilic ω-TA and only a few
thermostable ω-TAs are known for Fold type I (Mathew et al., 2016a). Recently, 3 ther-
mostable ω-TA genes from hot spring sources were found and characterized (Uniprot entries
A0A1U9WZ51, A0A1U9WZ50, and A0A1U9WZ53). Further examples are ω-TAs from Ther-
momicrobium roseum and from Sphaerobacter thermophiles (Mathew et al., 2016c,a). The
taxonomic sources of sequence entries in the oTAED were searched for matching entries in
the BacDive database (release 27.02.2017) which comprises environmental conditions of the
2 domains Bacteria and Archaea (So¨hngen et al., 2016). For Fold type I, 2,923 sequences
from thermophilic, 1,171 sequences from hyperthermophilic, and 2,434 sequences from psy-
chrophilic source organisms were identified. For Fold type IV, 449 sequences from thermophilic
and 40 sequences from hyperthermophilic source organisms were identified. In contrast, the
motifs (V/I)xLDxR and PFG (K/H)YL from Stekhanova et al. (2017) for thermostable ω-TAs
matched with only 12 sequences. Sequences from extremophilic source organisms did not form
separate clusters, but were distributed across the respective sequence network (Figure A.26).
Noteworthy, the representative node matching the motifs from Stekhanova et al. (2017) is not
necessarily surrounded by matches from thermo- or hyperthermophilic sources
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Figure A.21: Salt bridge inω-TA Fold type I. Showed for 4AOA, 2YKU, 5GFH, and 3NUI. The
conserved D210 seems to be an important salt bridge starting point, but the corresponding salt
bridge partner residue is not conserved, the distance between arginine/ asparagine and aspartate
is < 3.5 A˚
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Figure A.22: The active sites of (R)- and (S )-selective ω-TAs (Fold type IV and I, respectively)
as viewed from the re- and si -face, respectively. The functional residues were defined according
to  Lyskowski et al. (2014) and to Humble et al. (2012). For (S )-selective-ω-TA, the amino acid
residues of the phosphate binding cup at position 82 are serine or threonine (Rice et al., 2000;
Denesyuk et al., 2003)
c©2018 Wiley Periodicals, Inc. 156
A.3 The ω-transaminase engineering database (oTAED): a navigation tool in protein
sequence and structure space
Figure A.23: Structure comparison of Fold type I and IV. The pattern of Fold type I consists of
an α/β/α pattern with the active site located at the interface of the homodimer (only monomer
is shown). Fold type IV consists of 2 clear separated domains. Domain 1 is a 2 layer sandwich.
Domain 2 consists of an α-β barrel. The active site is also located at the interface of the
homodimer.
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Figure A.24: Protein sequence networks of Fold type IV sequences with (A) annotated sequences
matching positions of likely (R)- selective transaminases depicted in black and with (B) motifs
for ADCL (blue), DATA (black), l-BCAT (red), and ATA (green) from 27 and Table A.13.
Nodes correspond to representative sequences of clusters formed by 30 % identity in USEARCH.
A cutoff of 50 % pairwise sequence similarity is used to select the edges. The network is shown
as force-directed layout, with pairs with higher similarity arranged in closer proximity
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Table A.7: Conserved positions in putative Fold type I (S )-selective ω-TA
sequences with standard numbering according to the ω-TA from Mesorhizo-
bium sp. LUK (PDB accession 2YKU) and their location inside the protein
structure or annotated function. Positions listed here are conserved to at
least 70 %.
Standard
position
Conserved amino acids Location/function
7 G (88 %), N (5 %) loop
12 D (81 %), L (6 %)
15 G (91 %) β-turn (Crismaru et al., 2013)
20 D (97 %)
31 G (98 %) loop
32 H (75 %), Y (18 %)
40 A (83 %)
44 Q (75 %), A (10 %)
81 G (98 %) backbone hydrogen bond to PLP
(Crismaru et al., 2013)
83 E (72 %), D (10 %), V (6 %)
84 A (83 %), S (10 %)
88 A (85 %)
90 K (70 %), R (26 %)
92 A (80 %), V (8 %)
109 H (98 %) interaction with D189 (Martin et al.,
2007)
110 G (99 %) loop
151 A (79 %), C (9 %)
152 A (78 %), C (10 %), G (9 %)
156 E (97 %) hydrogen bond to PLP (Markova et al.,
2005)
157 P (79 %), T (7 %), A (5 %) loop
160 G (82 %) loop
163 G (92 %) loop
185 L (75 %), V (13 %)
186 L (71 %), F (15 %), M (5 %)
187 I (75 %), V (20 %)
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Standard
position
Conserved amino acids Location/function
189 D (100 %) hydrogen bond to PLP (Crismaru
et al., 2013; Steffen-Munsberg et al.,
2015)
190 E (96 %)
194 G (93 %) loop
195 G (71 %), R (15 %), A (8 %) loop
196 R (82 %), V (8 %)
198 G (84 %), L (6 %) loop
201 A (70 %), G (15 %), S (6 %)
209 P (93 %), A (6 %) loop
210 D (99 %) salt bridge to arginine (Figure A.21)
216 K (100 %) catalytic lysine (Crismaru et al., 2013)
221 G (91 %) loop
223 P (88 %), T (5 %)
250 T (94 %), S (5 %) backbone hydrogen bond to PLP
(Crismaru et al., 2013)
253 G (83 %), A (11 %) loop
255 P (79 %), A (6 %)
259 A (77 %), V (5 %)
288 L (74 %), I (7 %), F (6 %)
302 R (77 %), N (6 %)
305 G (94 %) loop
Table A.8: Conserved positions in putative Fold IV ω-TA sequences with
standard numbering according to the ω-TA from Aspergillus terreus (PDB
accession 4CE5) annotated as in Table A.7.
Standard
position
Conserved amino acids Location/function
36 G (86 %) loop
44 A (83 %)
56 G (77 %), A (17 %), S (5 %) loop
61 E (89 %), D (9 %) salt bridge to standard position 79
68 G (82 %), T (5 %) loop
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Standard
position
Conserved amino acids Location/function
76 H (98 %)
79 R (100 %) PLP binding cup ( Lyskowski et al.,
2014)
80 L (84 %), F (11 %)
83 S (82 %), G (11 %)
109 N (73 %), S (9 %)
123 G (95 %) loop
158 G (86 %) loop
180 K (88 %) catalytic lysine ( Lyskowski et al., 2014)
194 A (83 %)
198 G (83 %) loop
201 E (72 %), D (18 %)
209 G (89 %) loop
213 E (94 %) hydrogen bond to
PLP and interaction
with position 169
(R: 50 %, W: 11 %))
( Lyskowski et al.,
2014)
218 N (92 %)
220 F (76 %), W (7 %), Y (6 %)
222 V (73 %), I (15 %)
225 G (77 %), N (7 %), D (5 %) loop
229 T (87 %)
230 P (78 %), R (7 %), H (5 %)
235 L (94 %) PLP binding cup ( Lyskowski et al.,
2014)
237 G (97 %) loop
238 I (81 %), V (10 %) PLP binding cup ( Lyskowski et al.,
2014)
239 T (89 %) PLP binding cup ( Lyskowski et al.,
2014)
240 R (90 %)
256 E (75 %), V (5 %)
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Standard
position
Conserved amino acids Location/function
267 A (84 %), F (7 %)
268 D (72 %), E (9 %) salt bridge to position
223 (K: 51 %, R: 24 %)
269 E (94 %)
271 F (83 %), W (7 %)
273 T (72 %), S (14 %), C (8 %)
281 P (84 %), A (8 %)
286 D (78 %), G (8 %)
293 G (76 %) loop
296 G (89 %) loop
Table A.9: Substrate specificity-determining positions and substrate-specific
sequence motifs in Fold type I (S )-selective ω-transaminases. Standard po-
sitions refer to position numbers of the ω-TA from Mesorhizobium sp. LUK
(PDB accession 2YKU).
Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
0.19 F19W higher activity to-
wards β-keto esters
V. fluvialis F2XBU9 (Midelfort
et al., 2013)
26 W57F
53.1 F85A
111 V153A
118.1 K163F
192 I259V
346 R415F
53.4 R88K
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
0.20 L20 hydrophobic L-
pocket
C. cres-
centus and
others
P28269 (Park et al.,
2012)
0.23 (Y/ W/
L)23
53.2 (Y/
F)88
108 Y152
0.36 R36 decrease of activity
towards aromatic
β-amino acid
S. ther-
mophilus
D1C218 (Mathew
et al., 2016c)
0.41 R41 coordination of
substrate carboxyl-
group
V.paradoxus H8WR05 (Crismaru
et al., 2013)
0.41 R41 coordination of
substrate carboxyl-
group
V.paradoxus H8WR05 (Crismaru
et al., 2013)
0.43 (A/ V/
I)43
0.50 P50
14 D65
15 G66
24 (E/
D/ N/
Q)75
25 (Y/ F/
W)76
14 G48R improved stability;
activity towards
aminotetralin
A. citreus
(alterna-
tive B.
mega-
terium)
A0A1C7D191 (Martin et al.,
2007)
26 Y60C
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
118.5 Y164F
126.5 R186S
161 A242V
165 A245T
172 I252V
175 F255I
188 N268S
346.9 T409R
346.24 K424E
346.36 V436A
24 E75 interaction with
R41
V. para-
doxus
H8WR05 (Crismaru
et al., 2013)
25 Y85I shift of activity:
from ornithine-TA
to γ-TA
Homo
sapiens
P04181 (Markova
et al., 2005)
25 L56V increase of activity
towards branched
chain substrates
V. fluvialis F2XBU9 (Genz et al.,
2016)
26 W57C
53.1 F85V
111 V153A
25 L57A allows for re-face
attack; increased
activity towards
butyrophenone
O.
antrhopi
A6WVC6 (Han et al.,
2017)
26 W58A
26 W57F opening of P-
pocket
V. fluvialis F2XBU9 (Midelfort
et al., 2013)
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
26 W60C increase of enan-
tioselectivity and
activity towards
aromatic substrate
C. vio-
laceum
Q7NWG4 (Humble
et al., 2012;
Deszcz et al.,
2015; Cas-
simjee et al.,
2012)
26 W58L opening of sub-
strate pocket;
activity towards
aromatic ketons
O. an-
thropi ; V.
fluvialis
A6WVC6 (Midelfort
et al., 2013;
Han et al.,
2015)
26 Y59 determines size of
the O-pocket
Ruegeria
sp.
TM1040
Q1GD43 (Pavlidis
et al., 2016;
Steffen-
Munsberg
et al., 2013)
26 W60 determines size of
the S-pocket
C.crescentus P28269 (reviewed by
Park et al.,
2012)
161 S231
192 I262
47 G98M increase of stability V. para-
doxus
4AOA (Buß et al.,
2017)
53.1 Y87 interacts with aro-
matic substrate in
P-pocket
Ruegeria
sp.
TM1040
Q1GD43 (Pavlidis
et al., 2016;
Steffen-
Munsberg
et al., 2013)
53.1 F85L activity towards
PEA and longer
side chains
V. fluvialis F2XBU9 (Midelfort
et al., 2013;
Nobili et al.,
2015a)
111 V153A
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
53.1 F85A increase of binding
pocket
V. fluvialis F2XBU9 (Midelfort
et al., 2013)
53.1 F88A inversion of enan-
tiopreference from
(S ) to (R)
C. vio-
laceum
Q7NWG4 (Humble
et al., 2012)
53.2 F92V inhibits activity
towards aromatic
PEA
Ruegeria
sp.
TM1040
Q5LMU1 (Steffen-
Munsberg
et al., 2013)
108 Y153M/
S/ N
switch from a α-TA
to a ω-TA
C.violaceum Q7NWG4 (Deszcz et al.,
2015)
108 Y150F higher activity to-
wards amino alco-
hols
V.fluvialis F2XBU9 (Nobili et al.,
2015b)
111 V153A
108 Y152 determines size of
the small pocket
and allows only
methyl residue of
PEA
P. putida P28269 (Park et al.,
2012)
192 I262
111 V153A increases size of
P-pocket of ω-TA;
activity towards
aliphatic α-keto
acids
P. denitri-
ficans
A1B956 (Park et al.,
2014)
118.1 N161I improved stability P. man-
delii PD30
A0A059KSX8 (Bo¨rner et al.,
2017)
118.5 Y164L
164 V228G increase of activity
towards aromatic
β-amino acid
C. crescen-
tus
Q7WWK8 (Hwang et al.,
2008)
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
220 N286A
192 I259V tolerance for alco-
hol ester substrate
V. fluvialis F2XBU9 (Midelfort
et al., 2013)
248 V328A Inversion of enan-
tiopreference from
(S ) to (R)
A.citreus A0A1C7D191 (Svedendahl
et al., 2010)
251 Y331C Increases ena-
tiopreference for
(S )
A.citreus A0A1C7D191 (Svedendahl
et al., 2010)
346 R415 flipping arginine
(dual substrate
recognition)
V. fluvialis F2XBU9 (Midelfort
et al., 2013)
346 R415F less polarity inside
P-pocket
V.fluvialis F2XBU9 (Midelfort
et al., 2013)
346.1 R414 flipping arginine
(α-carboxyl bind-
ing site)
C.crescentus P28269 (Park et al.,
2014)
346.1 R414K loss of activity Pseudo-
monas
sp. strain
AAC
A0A081YAY5 (Wilding
et al., 2016)
346.4 P423 entrance of sub-
strate pocket
Ruegeria
sp.
TM1040
Q1GD43 (Pavlidis
et al., 2016)
346.20 R416 flipping arginine
(dual substrate
recognition)
C.violaceum Q7NWG4 (Manta et al.,
2017)
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Table A.10: Substrate specificity-determining positions and substrate-
specific sequence motifs in Fold type IV (R)-selectiveω-transaminases. Stan-
dard positions refer to position numbers of theω-TA from Aspergillus terreus
(PDB accession 4CE5).
Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
55 H53 specificity towards
(R)-amines
Nectria
haemato-
cocca
C7YVL8 (Sayer et al.,
2014)
60 Y58
62 V60
55 H62A increase of activity
towards aromatic
ketone substrate
Arthero-
bacter
117
F7J696-1 (Savile et al.,
2010)
62 V69G increases size of
small pocket
Arthero-
bacter
117
F7J696-1 (Savile et al.,
2010)
115 F122I
276 A284G
125 E125 entrance tun-
nel limiting the
substrate size
C.pusillum A0A1S4NYF0 (Pavkov-
Keller et al.,
2016)
147 E140
126 G136Y increase of hy-
drophobic interac-
tion with substrate
Arthero-
bacter
117
F7J696-1 (Savile et al.,
2010)
127 E137I
191 V199I
201 A209L
128 R138 interacting with
keto group of the
substrate
Arthero-
bacter
117
F7J696-1 (Savile et al.,
2010)
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Standard
position
Position Function Source or-
ganism
Uniprot ID Ref.
130 T130M increase of ther-
mostability
Aspergillus
terreus
Q0C8G1 (Huang et al.,
2017)
133 E133F
215 S223P increases size of
large pocket
Arthero-
bacter
117
F7J696-1 (Savile et al.,
2010)
274 T273 enantiopreference
by limiting space
in small pocket
Nectria
haemato-
cocca
C7YVL8 (Sayer et al.,
2014)
275 T274
276 A275
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engineering database (oTAED): a navigation tool in protein sequence and structure space. Pro-
teins: Structure, Function, and Bioinformatics, 86(5):1–15, 2018
Figure A.25: Distribution of sequence lengths of Fold type IV (oTA IV) and Fold type I (oTA
I), ω-transaminases from the oTAED, represented as histograms and boxplots with maximum
whisker length 1.5 times the interquartile range and outliers marked as crosses.
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Figure A.26: ω-transaminases of Fold type I (A) and Fold type IV (B) from psychrophilic
(green), thermophilic (red), and hyperthermophilic (black) sources retrieved from the Bac-
Dive database (release 27.02.2017) (So¨hngen et al., 2014) and the representative node (orange)
containing the motif from Stekhanova et al. (2017) for thermostable Fold type IV sequences
(V/I)xLDxR and PFG(K/H)YL. The nodes correspond to representative sequences of clusters
formed by 30 % identity in USEARCH (Edgar, 2010). A cutoff of 50 % pairwise sequence sim-
ilarity was used to construct the edges. The network is shown as force-directed layout, thus
pairs with higher similarity are positioned in closer proximity.
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Table A.11: Query sequences for the initial BLAST search to set up the ω-Transaminase
Engineering Database (oTAED).
UniProt iden-
tifier
Annotation Source organism Reference
H8WR05 Beta-Phenyla-
lanine Amino-
transferase
Variovorax paradoxus (Crismaru et al., 2013)
Q0C8G1 AT-OmegaTA Aspergillus terreus ( Lyskowski et al., 2014)
A1TDP1 Multispecies:
Aminotransfer-
ase IV
Mycobacterium vanbaalenii (Mathew et al., 2016b)
A1DD33 Aminotransferase,
Class IV, Puta-
tive
Aspergillus fischeri (Mathew et al., 2016b)
F2XBU9 Pyruvate
transaminase
Vibrio fluvialis (Genz et al., 2016)
A0A1B4YGI6 Beta-Alanine
Pyruvate Trans-
aminase
Mesorhizobium loti (Shin et al., 2003)
P28269 Omega Amino
Acid: Pyruvate
Aminotransfer-
ase
Pseudomonas putida (Yonaha et al., 1983)
D5VI64 Aspartate
Aminotrans-
ferase Family
Protein
Caulobacter segnis (Sayer et al., 2013)
Q9I700 Aspartate
Aminotrans-
ferase Family
Protein
Pseudomonas aeruginosa (Ho¨hne et al., 2010)
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Table A.12: Reference structures for the standard numbering schemes of ω-transaminase su-
perfamilies Fold Type I and Fold Type IV.
Fold Type I PDB entry Fold Type I Source
1DTY Escherichia coli
1SZS Escherichia coli
2OAT Homo sapiens
2YKU Mesorhizobium sp. LUK
2ZSL Aeropyrum pernix
3A8U Pseudomonas putida
3DOD Bacillus subtilis
3FCR Ruegeria sp. TM1040
3I5T Rhodobacter sphaeroides
4AOA Variovorax paradoxus
4E3R Homo sapiens
4JEW Salmonella enterica
4UOX Escherichia coli
4YSN Lactobacillus buchneri
Fold Type IV PDB entry Fold Type IV Source
3WWH Arthrobacter sp. KNK168
4CE5 Aspergillus terreus
4CHI Aspergillus fumigatus
4CMD Nectria haematococca
5E25 Geoglobus acetivorans
5K3W Curtobacterium pusillum
Table A.13: Relevant fingerprints of oTAED Fold Type IV standard positions as reported
previously (Ho¨hne et al., 2010) for 4-amino-4-deoxychorismate lyase (ADCL), d-amino acid
aminotransferases (DATA), l-branched chain amino acid aminotransferases (l-BCAT) and (R)-
amine transaminases (ATA). In addition, the catalytic lysine at Fold Type IV standard position
180 is conserved in the four subfamilies.
Standard
position
55 60 62 64 115- 128-130
ADCL F/Y F T/S - (V/I/L)x(K/R) RGY
DATA F Y/E/D V K/R x(V/I/L)Y(V/I/L)Q RxH
L-BCAT Y F/E/D G R/K Y(V/I/L)R (V/I/L)G(V/I/L)
ATA H/R Y V/T S/T/A/H/P (F/Y)V(E/A/S/N/Q) -
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A.4 BioCatNet: a database system for the integration of enzyme
sequences and biocatalytic experiments
P. C. F. Buchholz, C. Vogel, W. Reusch, M. Pohl, D. Rother, A. C. Spieß, and J. Pleiss. BioCat-
Net: a database system for the integration of enzyme sequences and biocatalytic experiments.
ChemBioChem, 17(21):2093–2098, 2016
Own contributions
I refined the relational data model of BioCatNet (see chapter 2.2.1) and curated the data
provided by experimental collaborators. Based on the previous work by Reusch (2014) and
Vogel (2015) I conceptualized BioCatNet with a focus on time-course data for kinetic modeling
in upcoming projects. I contributed to the writing of the original manuscript.
A.4.1 Abstract
The development of novel enzymes for biocatalytic processes requires knowledge on substrate
profile and selectivity which can be derived from separate databases and publications. Often,
these data sources lack the time courses of substrate or product, and an unambiguous link
between experiment and enzyme sequence. The lack of integrated, original data hampers the
comprehensive analysis of enzyme kinetics and the evaluation of sequence-function relation-
ships. To accelerate enzyme engineering, BioCatNet integrates protein sequence, structure,
and original experimental data for a given enzyme family. BioCatNet explicitly assigns the
enzyme sequence to an experiment, which consists of information on reaction conditions and
time course data. BioCatNet facilitates the consistent documentation of reaction conditions,
the archiving of measured time course data, and the efficient exchange of original experimental
data among collaborators. Data integration is demonstrated for three case studies using the
Thiamine diphosphate-dependent Enzymes Engineering Database15.
A.4.2 Introduction
Enzymes are widely used as biocatalysts with desirable activity and selectivity for an increasing
range of interesting synthetic applications (Adrio and Demain, 2014). Since the availability of
known, natural enzymes that perform in a given process is still limited, there is an urgent need
for efficient methods to identify new enzyme candidates and to improve enzymes by enzyme
engineering, especially for non-natural reactions. The development of new enzymes aims at
desired properties such as optimized catalytic activity, solvent stability, chemo-, regio- or stere-
oselectivity (Bornscheuer et al., 2012). The efficient development of new enzymes by computa-
15 https://teed.biocatnet.de, accessed on April 30, 2018.
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tional methods such as data mining and molecular modeling is based on a profound knowledge
of sequence-structure-function relationships (Bornscheuer, 2016). Consequently, data on pro-
tein sequences, structures, and the effects of mutations on biochemical properties have become
precious raw materials for successful protein design (Pleiss, 2014). Comprehensive online repos-
itories such as the National Center for Biotechnology Information (NCBI) Protein Database
(Benson et al., 2011), UniProt (Apweiler et al., 2014), DNA Data Bank of Japan (DDBJ)
(Kaminuma et al., 2011), and Protein Data Bank (PDB) (Berman et al., 2000) enable system-
atic analyses of sequences and structures of biocatalysts, while the experimental results from
mutational studies are reported in scientific papers and are accessible by repositories such as
NCBI PubMed16, Web of Science17, Google Scholar18 or SciFinder19.
Systematic analysis of available protein sequence and structure data allows for identifica-
tion of functionally relevant amino acids and the prediction of promising mutation sites by
determining conserved (Lehmann et al., 2002; Anbar et al., 2012), family-specific (Mazin et al.,
2010; Suplatov et al., 2012, 2014), or correlated positions (Kuipers et al., 2009; Kowarsch et al.,
2010). To enable the analysis of a rapidly increasing number of protein sequences and struc-
tures, enzyme family databases have been established for cytochrome P450 monooxygenases
(Fischer et al., 2007), β-lactamases (Widmann et al., 2012), triterpene-cyclases (Racolta et al.,
2012), imine reductases (Scheller et al., 2014), lipases and other α/β-hydrolases (Fischer and
Pleiss, 2003; Hotelier et al., 2004), carbohydrate-active enzymes (Lombard et al., 2013), and
thiamine diphosphate-dependent enzymes (Widmann et al., 2010). The commercially available
3DM databases follow a similar approach by using multiple structure alignments of reference
enzymes to describe an enzyme family (Kuipers et al., 2010b). Among others, the applica-
tion of 3DM databases includes the automated assignment of mutations from literature sources
(Kuipers et al., 2010a). Apart from enzyme family databases, the UniProt database contains
information on natural variants of proteins (Apweiler et al., 2014).
Although family databases make the rapidly increasing number of protein sequences and
structures accessible to systematic analysis, they lack biocatalytic experimental data. Providing
consistently linked data on sequence, structure, and experimentally determined biochemical
properties of enzyme variants will result in an invaluable information resource for directly
deriving sequence-function relationships.
Experimental characterization of enzymes and designed variants results in a large quantity
of highly heterogeneous data, which is usually reported as plain text, tables or figures in pub-
lications or laboratory notebooks. It would be desirable if the information on the enzyme, the
reaction conditions, and the biochemical properties were integrated and accessible to an auto-
16 http://www.ncbi.nlm.nih.gov/pubmed, accessed on April 30, 2018.
17 http://ipscience.thomsonreuters.com/product/web-of-science/, accessed on April 30, 2018.
18 https://scholar.google.de/, accessed on April 30, 2018.
19 http://www.cas.org/products/scifinder, accessed on April 30, 2018.
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mated analysis. In most studies systematic experiments have been performed by varying the
sequence of the biocatalyst, the substrate scope, or the reaction conditions, and by measuring
the respective catalytic activity, chemo-, regio- or stereoselectivity, but only a subset of most
relevant data was selected for publication, which results in a substantial loss of information.
Since scientific publications are the only available source of experimental data on sequence-
function relationships, a scientist has to invest considerable time in finding, collecting, and
combining this fragmented and sparse data. To support this data collection process, databases
such as the Braunschweig Enzyme Database (BRENDA) (Schomburg et al., 2012), ExplorEnz
(McDonald et al., 2007), Kyoto Encyclopedia of Genes and Genomes (KEGG) REACTION
(Kanehisa et al., 2006), and SABIO-RK (Wittig et al., 2012) incorporate biochemical informa-
tion obtained by literature mining and provide comprehensive repositories of enzyme function.
However, these databases lack unambiguous information on the complete protein sequence of
an enzyme as well as information on the reaction conditions and the kinetic models which were
used to derive the reported kinetic parameters.
To fill this gap, community-wide standards on reporting enzymatic data (Tipton et al.,
2014; Gardossi et al., 2010) and comprehensive databases on biocatalytic experiments have been
proposed (Apweiler et al., 2010). Minimal requirements for reporting biocatalytic results were
suggested by the Standards for Reporting Enzyme Data (STRENDA) Consortium20 (Tipton
et al., 2014). These recommendations include an unambiguous identification of the applied
enzyme, the reaction conditions and the experimental outcome.
However, all currently available databases report only kinetic parameters such as Km and
kcat rather than the underlying time course data monitoring the conversion of substrate(s) to
product(s). While the kinetic parameters are a consequence of the assumed kinetic model,
reporting the underlying time course data would allow for the comparison of different kinetic
models to characterize biochemical function (Zavrel et al., 2008; Schnell, 2014). For a model-
independent documentation of biochemical function, it would be crucial to report original data
on substrate conversion or product formation rather than kinetic parameters only. The combi-
nation of time course data, a documentation of reaction conditions, and an unambiguous link to
the respective protein sequence would considerably improve the reproducibility of published ex-
periments and allow for systematic computational analyses of sequence-function relationships.
Therefore, we established the BioCatNet system which integrates sequence and structure of en-
zymes with biocatalytic data such as reaction conditions and time-dependent biochemical data
(Figure A.27). Besides substrate or product concentration, BioCatNet can store conversion,
yield or enantiomeric excess, since these types of data are usually generated upon screening
potential enzyme candidates for activity or selectivity towards various substrates.
Application of BioCatNet is demonstrated on reactions catalyzed by thiamine diphosphate
20 http://www.beilstein-institut.de/en/projects/strenda, accessed on April 30, 2018.
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(ThDP)-dependent enzymes. Therefore, sequence and structure data from the TEED, the
ThDP-dependent Enzymes Engineering Database (Widmann et al., 2010), have been migrated
to the BioCatNet system, updated, and enriched by experimentally and computationally de-
rived information. The BioCatNet system can be used as a comprehensive platform to store and
exchange biochemical data on any protein family and to make this data accessible to selected
users for later systematic analyses.
A.4.3 Results and Discussion
The BioCatNet Concept The BioCatNet database system was established as a repository
to analyze the sequence-function relationships of a complete enzyme family. Original data
is parsed from data repositories or experiments, such as sequences, structures or biocatalytic
measurements (Figure A.28). Data analysis is based on mathematical models and therefore
produces ”model-derived information”. Examples are sequence alignments, which are derived
from original sequence data by applying a distance metric and alignment parameters, and
kinetic parameters, which are derived from original time course data by applying a kinetic
model.
Original sequence data is parsed from the NCBI protein database by BLAST (Basic Local
Alignment Search Tool) searches starting from a set of seed sequences (Fischer et al., 2006).
Model-derived information for sequence data comprises hierarchical sorting of individual se-
quences to proteins and homologous families by the USEARCH clustering algorithm (Edgar,
2010), sequence alignments generated by Clustal Omega (Sievers et al., 2011), generation of
family-specific sequence profiles by profile hidden Markov models (Eddy, 1998), assignment of
standard position numbers (Vogel et al., 2012), links to literature entries (Gricman et al., 2015),
and the annotation of structurally or functionally relevant positions. Additionally, structure
data can be used for homology modeling.
Experimental data is provided by experimenters rather than parsed automatically from lit-
erature sources. Each experimental data set refers unambiguously to the protein sequence of
the respective enzyme. BioCatNet has been designed as a tool for experimenters to store, or-
ganize, retrieve, and analyze their own experimental data or data from collaborative projects.
Experimental data include the reaction conditions as suggested by the STRENDA Consortium
(Tipton et al., 2014), as well as time-dependent data of substrate and product concentra-
tions or of derived properties such as enantiomeric excess (ee values), conversions, or yields
(Table A.14).
As an initial example of an enzyme family database, the TEED (Widmann et al., 2010) was
migrated to BioCatNet21 (Vogel, 2015).
21 See footnote 15 on page 174.
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Reporting of Experimental Data The minimal requirements for submission of experi-
mental measurement data to BioCatNet constitute a compromise between completeness and
usability Table A.14). Therefore, BioCatNet distinguishes between mandatory and optional
attributes for data submission. Since the description of the reaction under investigation was
considered as indispensable to map sequence-function relationships, the involved substrates and
products as well as the reaction stoichiometry are mandatory inputs. To describe the reaction
conditions, the specification of the reaction buffer is mandatory, while additional information
such as pH and temperature are optional but recommended inputs. All additional information
on preparation of enzymes, analytical methods and other laboratory routines are considered
not to be mandatory, but are usually documented in laboratory journals or by a laboratory
information management system (LIMS).
Before experimental measurement data can be uploaded, BioCatNet requires the distinct
protein sequence of the respective enzyme, which guarantees an unambiguous distinction be-
tween the biocatalytic properties of enzyme variants or homologues. We recommend the men-
tioning of source organism and expression host for a given enzyme. The usage of the SMILES
code (simplified molecular-input line-entry system) (Weininger, 1988) is recommended as un-
ambiguous identifier of a substrate or product, which facilitates the search for experimental data
by compounds. In order to ease usage of the SMILES code, the BioCatNet documentation22
links to the SMILES generator NCBI PubChem Sketcher (Ihlenfeldt et al., 2009). Substrates,
enzymes, and additive compounds can be quantified either by a combination of amount of
substance and volume or by concentration.
To facilitate submission of biocatalytic data to BioCatNet, a Microsoft Excel template
is provided within the documentation page23. The following examples describe case studies
for experiments combining a substrate with different enzyme variants, measurement of time
courses for substrate and product concentrations, and conversion of substrates under varying
conditions.
Example 1: Experiments with Different Substrates and Enzyme Variants As a
first example, biocatalytic experiments using C-terminally His-tagged pyruvate decarboxylase
from Acetobacter pasteurianus (ApPDC) and the variant E469G (Rother nee´ Gocke et al.,
2011; Rother et al., 2014; Sehl et al., 2017) were uploaded to the TEED. The sequence of
the ApPDC variant was uploaded, and annotations of mutated residues, domain boundaries
of the catalytically relevant pyrophosphate- and pyrimidine-interacting domains, and the stan-
dard position numbers for ThDP-dependent decarboxylases (Vogel et al., 2012) were generated,
thus facilitating the communication of mutation sites and the analysis of conserved positions
22 http://wiki.biocatnet.de/, accessed on April 30, 2018.
23 See footnote 8 on page 51.
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(Figure A.29).
In the biocatalytic experiments, the ApPDC-catalyzed coupling reactions of benzaldehyde
with pyruvate was monitored by measuring conversion of benzaldehyde and enantiomeric ex-
cess (ee) of phenylacetylcarbinol after a reaction time of 16 hours. Each experiment describes
the measurement using one enzyme. For each experiment, the enzymatic reaction, the reac-
tion conditions including a description of the reaction buffer and the enzyme preparation, the
substrate, and the enzyme sequence are specified. The two experiments were grouped into a
single ”experiment set”. Reaction conditions and experimental results are visualized as tables
in the web interface (Figure A.30). A summary of the experimental setup can be displayed
as full-text for a comprehensive documentation of the biocatalytic experiments. Excel files for
the two experiments were created by filling in the Excel template (Supporting Information 24
and 25) and can be downloaded from the documentation page26.
Example 2: Experiments with Measured Time Courses of Substrate and Prod-
uct Concentration Time-dependent substrate and product concentrations upon self-ligation
of benzaldehyde to benzoin catalyzed by benzaldehyde lyase from Pseudomonas fluorescens
(Pf BAL) were measured for varying initial concentrations of substrate and product (Ohs et al.,
2018). The C-terminally His-tagged sequence, reaction conditions, and the time course data of
one experiment were uploaded to the TEED. The time course data are visualized on the web in-
terface (Figure A.31). An Excel file of the experiment is available as supporting information27
and can be downloaded from the documentation page28.
Example 3: Experiments under Varying Conditions The conversion of benzaldehyde
and acetaldehyde to (S )-2-hydroxy-1-phenylpropan-1-one was catalyzed by C-terminally His-
tagged benzoylformate decarboxylase under varying pH to find the optimum pH for the recently
described ”µMORE” microfluidics reactor (Jussen et al., 2016). The time courses of benzalde-
hyde and (S )-2-hydroxy-1-phenylpropan-1-one were monitored in an ”experiment set” for the
pH values of 6.5 and 8.0. Two independent experiments were conducted for each pH value.
While a publication usually contains only mean values and standard deviations, BioCatNet
keeps all original time courses in a readable format for future analyses. The storage of original
time course data allows for a model-based analysis of multiple data sets to study the effect of
reaction conditions (pH, temperature) on the reaction kinetics, which might later serve as a
basis for reaction optimization process design. Excel files of the experiment set are available as
24 wiki.biocatnet.de/wiki/examples/example1a.xlsx, accessed on April 30, 2018.
25 wiki.biocatnet.de/wiki/examples/example1b.xlsx, accessed on April 30, 2018.
26 See footnote 22 on page 178.
27 wiki.biocatnet.de/wiki/examples/example2.xlsx, accessed on April 30, 2018.
28 See footnote 22 on page 178.
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supporting information29, 30, 31, 32, and can be downloaded from the documentation page33.
The Benefit of Unambiguously Linking Sequence and Biochemical Function The
protein sequence uniquely identifies an enzyme. Nevertheless, in many publications the re-
spective enzyme is specified ambiguously by naming its enzymatic function and its source
organism, e.g. ”pyruvate decarboxylase from Acetobacter pasteurianus”. A search for this
term in the NCBI protein database matches 30 protein entries, which differ not only in length
but also in positions distributed over the entire protein sequence (Supporting Information
Figure A.33).
While highly similar sequences commonly fold into similar three-dimensional structures
(Browne et al., 1969) and usually resemble each other in their catalytic function (Chattopadhyay
et al., 2009) , single mutations might affect the activity and specificity, even if the mutated
positions are outside the active site (Drawz et al., 2009). Specifically, the effect of protein fusion
tags for affinity chromatography on activity, stability, and selectivity of an enzyme is often
neglected in scientific publications (Majorek et al., 2014). Thus, protein sequence, structure,
and experimental results have to be assigned consistently in order to enable a comprehensive
investigation of the sequence-function relationships of a biocatalyst.
Representation of Biochemical Data It has been widely recognized that detailed results
from biocatalytic experiments are an invaluable source of data for many fields of research, in-
cluding protein design (Adrio and Demain, 2014; Bornscheuer et al., 2012; Bornscheuer, 2016;
Pleiss, 2014), synthetic biochemical pathway construction (Bhan et al., 2013), reaction opti-
mization and process design. Therefore, guidelines for reporting enzymatic (Tipton et al., 2014)
and biocatalytic data (Gardossi et al., 2010) have been proposed. Guidelines have also been
proposed in other fields of research such as systems biology (Schilling et al., 2008)and crystal-
lization (Raccuglia et al., 2016). Storing data in the BioCatNet system or in the Excel files
facilitates the collaboration of different research groups ranging from biocatalysis to modeling.
In BioCatNet, biocatalytic data is represented either as time courses of substrate or prod-
uct concentrations or as time-dependent ratios such as conversion, yield or enantiomeric excess,
depending on the desired type of experiment. The availability of original data circumvents the
limitation of data retrieved manually from scientific papers and facilitates documentation of
results. For many published kinetic parameters, the underlying original data or the detailed
reaction conditions are not available, hindering in-depth analysis of kinetic properties by dif-
29 wiki.biocatnet.de/wiki/examples/example3a.xlsx, accessed on April 30, 2018.
30 wiki.biocatnet.de/wiki/examples/example3b.xlsx, accessed on April 30, 2018.
31 wiki.biocatnet.de/wiki/examples/example3c.xlsx, accessed on April 30, 2018.
32 wiki.biocatnet.de/wiki/examples/example3d.xlsx, accessed on April 30, 2018.
33 See footnote 22 on page 178.
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ferent kinetic models. The widely used Michaelis-Menten equation is only valid under specific
conditions (Apweiler et al., 2010) and excludes enzyme inhibition or inactivation by substrate or
product. The lack of time course data results from difficulties in data generation, especially in
former studies when methods like high performance liquid chromatography (HPLC) or fluorime-
ters where yet unavailable. We suggest to make time-resolved data accessible, whenever they
have been determined. Besides time course data, ratios like conversion, yield and enantiomeric
excess allow for computational comparison of potential enzyme candidates, as previously shown
for data on activity and selectivity for cyclododecanone monooxygenase (Fink et al., 2012).
A.4.4 Conclusion
The availability of original time course data enables researchers to determine kinetic parameters
and to explore different enzymatic mechanisms (Zavrel et al., 2008). Kinetic modeling provides
a link between individual biochemical experiments, and bioprocess design facilitates the search
for productive reaction conditions to improve the performance of a biocatalyst and the overall
process in a bioreactor (Vasic´-Racˇki et al., 2003). In this context, the BioCatNet system
supports both the design of enzymes and the optimization of reaction parameters by linking
sequence, structure and biochemical data of an enzyme family within collaborative projects.
While the current version of BioCatNet describes reactions catalyzed by a single enzyme, the
data model will be extended in the future to describe more complex reaction schemes such as
pre-incubation or cascade reactions.
A.4.5 Computational Methods
The BioCatNet Data Model The BioCatNet data model integrates original data such as
protein sequence, protein structure, reactions conditions, and time course data (concentrations
or derived properties as a function of time). BioCatNet uses the relational database manage-
ment system Firebird 34. The data model of the DWARF system (Fischer et al., 2006) was
extended by tables for taxonomic relations, experimental data, and tables for user management.
The DWARF model organizes sequences in four hierarchical levels of sequences, proteins,
homologous families, and superfamilies. In BioCatNet, groups of homologous families and
groups of superfamilies were added to the hierarchy to allow for additional sorting by biological
knowledge like similarities in domain arrangement and annotation. For each sequence, indi-
vidual positions can be annotated in BioCatNet by standard positions (Vogel et al., 2012) or
function. The data model of the DWARF system was amended in BioCatNet for taxonomic
information about the biological source, including taxonomic synonyms, represented by links
to NCBI taxonomy.
34 See footnote 9 on page 51
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Additional tables were added for data on the reaction under investigation, reaction con-
ditions, compounds, and time course data. The link between the respective sequence entry
of the experimentally applied enzyme and the experimental time course data was established
by a dedicated table (Figure A.32). In addition, the data model was enabled to cope with
compounds that are neither substrates nor products, such as inhibitors or detergents. To al-
low for cascade reactions, a single experiment can include multiple enzymes. For fed-batch
experiments, the time points of enzyme or substrate addition can be specified.
The BioCatNet Web Interface The web-accessible user interface for BioCatNet was de-
veloped in PHP 535 (backend) and HTML5/JavaScript (frontend) and is hosted on an Apache
webserver36. While sequence and structure data usually is accessible to all users, access to
individual biocatalytic data sets is limited to registered users or user groups. Users can navi-
gate between the hierarchical levels of sequence information and taxonomic lineage. Sequences
are available as FASTA files and as alignments of homologous families or superfamilies. Ex-
perimentally determined structural data and homology models are presented using PV protein
viewer37. Biocatalytic data is grouped in ”experiments” and ”experiment sets”. Currently, the
upload of the sequences and of experimental data will be done by the BioCatNet administrator
in the framework of collaborative projects. In the future, we plan to allow direct upload via
a web form to registered users. Furthermore, we would also encourage the use of our Excel
template for documentation and communication of biocatalytic data outside BioCatNet. A
documentation of the interface and the data model is available online38.
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Figure A.27: Workflow between bioinformatics and experiment using the BioCatNet database
system. Arrows pointing from left to right represent data analysis or modeling, arrows pointing
from right to left represent submission of biocatalytic data via file upload. Dashed arrows mark
initial procedures and modeling steps beyond the scope of the database.
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Figure A.28: Concept of the established BioCatNet database system. Original data are stored in
the individual enzyme family database on the levels of protein sequence, structure and exper-
imental data. Analysis of data leads to new knowledge which helps to amend the database
(model-derived information). Sequences and structures are parsed from other repositories
whereas experimenters contribute experimental data and sequences of their applied enzymes.
Expansions of the workflow are currently under development to include metagenomic sequences
and establish a framework for estimation of kinetic parameters (∗).
Figure A.29: Screenshot detail from the BioCatNet web interface depicting a C-terminally His-
tagged variant of pyruvate decarboxylase from Acetobacter pasteurianus. The Mutated residue
(G469), domain boundaries (PYR: pyrimidine interaction, PP: pyrophosphate interaction) and
the His-tag are annotated. ”DC” indicates the respective standard position number (Vogel
et al., 2012).
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Figure A.30: Exemplary screenshot detail from the BioCatNet web interface, showing the
possibility to display a plain text summarizing the reaction conditions from the individual
tables.
Figure A.31: Screenshot detail from the BioCatNet web interface for a measurement of substrate
and product concentrations over time (here: self-ligation from benzaldehyde to benzoin).
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Table A.14: Overview of mandatory and optional input for submitting experimental data to
BioCatNet. Experimental data can be experimenter-defined or measured concentrations as well
as derived properties like conversion, yield or enantiomeric excess.
topic mandatory input optional input
reaction reaction name, involved sub-
strates and products, stoichiom-
etry
SMILES code for compounds
(Weininger, 1988)
reaction condition initial reaction volumea, pH, tem-
perature, pressure, shaking fre-
quency, further description
reaction buffer unique name, description
enzyme exact protein sequence, sequence
name, expression host, time of ad-
dition
preparation/ purification/ im-
mobilization/ crude cell extract/
whole cell transformation,
source organism (recommended),
concentration or amount and
volumea
substrate compound name, time of addition
or measurement
preparation, measurement
method, concentration or amount
and volumea, measurement repli-
cation number
product compound name, time of mea-
surement
preparation, measurement
method, concentration or amount
and volumea, measurement repli-
cation number
additive compound name, time of addition preparation, concentration or
amount and volumea
parameter compound of reference, time of
measurement, parameter, value
and unit
parameter abbreviation, wild-
type/reference sequenceb, mea-
surement method, additional in-
formation
a Enzymes, substrates and additive compounds (e. g. enzyme inhibitors) are quantified by
chemical amount and volume (if the initial reaction volume is specified) or by concentra-
tion.
b Some measured parameters might refer to a wild-type or reference sequence.
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Net: a database system for the integration of enzyme sequences and biocatalytic experiments.
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Figure A.32: Simplified scheme of the relational data model for the BioCatNet database system for experimental data. The
PARAMETER MEASUREMENTS and ENZYME FEEDS tables link to SEQUENCES, which was inherited from the previously described DWARF
system (Fischer et al., 2006).
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Figure A.33: Alignment of 30 entries in the NCBI protein database for ”pyruvate decarboxylase
from Acetobacter pasteurianus” showing multiple sequences varying both at the N- and C-
termini and within the sequences (beginning on page 190). The alignment was generated using
Clustal omega (Sievers et al., 2011).
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CLUSTAL O(1.2.1) multiple sequence alignment
gi|20385191|gb|AAM21208.1|AF368435_1 MTYTVGMYLAERLVQIGLKHHFAVGGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|899754028|gb|AKR47906.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGRILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|529247081|ref|WP_020944449.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|915485271|ref|WP_050818574.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGRILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|737384544|ref|WP_035366029.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|517917915|ref|WP_019088123.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|504270371|ref|WP_014457473.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|1039400602|ref|WP_064776314.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|528528981|emb|CCT59281.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256652749|dbj|BAI18683.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256655805|dbj|BAI21732.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256649761|dbj|BAI15702.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256646708|dbj|BAI12656.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256643653|dbj|BAI09608.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256640596|dbj|BAI06558.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256637544|dbj|BAI03513.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|256634486|dbj|BAI00462.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLVNKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|371478271|dbj|GAB31399.1| ------MYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|985556514|dbj|BAU39462.1| MTYTVGMYLAERLSQIGLKHHFAVAGDFNLVLLDQLLANKEMEQVYCCNELNCGFSAEGYARAHGAAAAVVTFSVGAISAMNAIAGAYAENLPVILISGSPNSNDYGTGHILHHTLGTNDYTYQLEMMRHVTCAAESITDAASAPAKIDHVIRTALRE-RKPAYVEIACN
gi|178847311|pdb|2VBI|H MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847310|pdb|2VBI|G MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847309|pdb|2VBI|F MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847308|pdb|2VBI|E MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847307|pdb|2VBI|D MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847306|pdb|2VBI|C MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847305|pdb|2VBI|B MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|178847304|pdb|2VBI|A MTYTVGMYLAERLVQIGLKHHFAVAGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|20385192|gb|AAM21209.1|AF368435_2 ----------------------------------------------------------------MDVRAAVAFEAGRPLEIE-----------RVQLEGP------RAGEVL------------VEVKATGLCHTDKYTLSGADPEGLFPA---ILGHEGAGVVVEVG--
gi|296524250|emb|CBM36781.1| MTYTVGMYLAERLVQIGLKHHFAVGGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
gi|57998209|emb|CAI45839.1| MTYTVGMYLAERLVQIGLKHHFAVGGDYNLVLLDQLLLNKDMKQIYCCNELNCGFSAEGYARSNGAAAAVVTFSVGAISAMNALGGAYAENLPVILISGAPNSNDQGTGHILHHTIGKTDYSYQLEMARQVTCAAESITDAHSAPAKIDHVIRTALRE-RKPAYLDIACN
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gi|20385191|gb|AAM21208.1|AF368435_1 IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLKNRPAPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSGMPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|899754028|gb|AKR47906.1| VSDAECVRPGPVSSLLAELRVDDVSLKAAVEASLNLLEKSQRVTIIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|529247081|ref|WP_020944449.1| ISDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|915485271|ref|WP_050818574.1| VSDAECVRPGPVSSLLAELRVDDVSLKAAVEASLNLLEKSQRVTIIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|737384544|ref|WP_035366029.1| VSDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTVIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|517917915|ref|WP_019088123.1| ISDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|504270371|ref|WP_014457473.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|1039400602|ref|WP_064776314.1| VSDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTVIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|528528981|emb|CCT59281.1| ISDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256652749|dbj|BAI18683.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256655805|dbj|BAI21732.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256649761|dbj|BAI15702.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256646708|dbj|BAI12656.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256643653|dbj|BAI09608.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256640596|dbj|BAI06558.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256637544|dbj|BAI03513.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|256634486|dbj|BAI00462.1| VSDAECVRPGPVSSLLAELRADDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|371478271|dbj|GAB31399.1| VSDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTVIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|985556514|dbj|BAU39462.1| ISDAECVRPGPVSSLLAELRVDDVSLKAAVEASLALLEKSQRVTMIVGSKVRAAHAQTQTEHLAD-KLGCAVTIMAAAKSFFPEDHKGFR--GL----YWGDVSSPGAQELVEKSDALICVAPVFNDYSTVGWTAWPKGDNVLL---AEPNR-VTVGGKTYEGFTLREFL
gi|178847311|pdb|2VBI|H IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847310|pdb|2VBI|G IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847309|pdb|2VBI|F IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847308|pdb|2VBI|E IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847307|pdb|2VBI|D IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847306|pdb|2VBI|C IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847305|pdb|2VBI|B IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|178847304|pdb|2VBI|A IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLEKSASPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSAWPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|20385192|gb|AAM21209.1|AF368435_2 -AGVQHLRPGDHVIPLYTPEC------------------------------RECK-----SCLSRKTNLCTAIRATQGKGLMPDGTSRFSFKGQPIHHYMGCSTFANYTVLPEIALAKIRPDAPFDKVCYIGCGVTTGIGAVLFTAKVEPGSTVVVFG--LGGIGLNVIQ
gi|296524250|emb|CBM36781.1| IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLKNRPAPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSGMPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
gi|57998209|emb|CAI45839.1| IASEPCVRPGPVSSLLSEPEIDHTSLKAAVDATVALLKNRPAPVMLLGSKLRAANALAATETLAD-KLQCAVTIMAAAKGFFPEDHAGFR--GL----YWGEVSNPGVQELVETSDALLCIAPVFNDYSTVGWSGMPKGPNVIL---AEPDR-VTVDGRAYDGFTLRAFL
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gi|20385191|gb|AAM21208.1|AF368435_1 QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLA-GARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|899754028|gb|AKR47906.1| EE---------LAKKAPSRPLTAQESQKHTPVIEPAKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|529247081|ref|WP_020944449.1| EE---------LAKKAPSRPLTAQESKKHTPVIEAYKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|915485271|ref|WP_050818574.1| EE---------LAKKAPSRPLTAQESQKHTPVIEPAKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|737384544|ref|WP_035366029.1| EE---------LAKKAPSRPLTAQESKKHTPVIEVSKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|517917915|ref|WP_019088123.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|504270371|ref|WP_014457473.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|1039400602|ref|WP_064776314.1| EE---------LAKKAPSRPLTAQESKKHTPVIEVSKADARLTNDEMTRQINAMLTSDTTLVAETGDSWLNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|528528981|emb|CCT59281.1| EE---------LAKKAPSRPLTAQESKKHTPVIEAYKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256652749|dbj|BAI18683.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256655805|dbj|BAI21732.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256649761|dbj|BAI15702.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256646708|dbj|BAI12656.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256643653|dbj|BAI09608.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256640596|dbj|BAI06558.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256637544|dbj|BAI03513.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|256634486|dbj|BAI00462.1| EE---------LAKKAPSRPLTAQESKKHTPVIEASKGDARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|371478271|dbj|GAB31399.1| EE---------LAKKAPSRPLTAQESKKHTPVIEVSKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|985556514|dbj|BAU39462.1| EE---------LAKKAPSRPLTAQESKKHTPVIEAYKADARLTNDEMTRQINAMLTSDTTLVAETGDSWFNATRMDLPRGARVELEMQWGHIGWSVPSAFGNAMGSQERQHILMVGDGSFQLTAQE-------MAQMVRYKLPVI-IFLVNNRGYVIEIAIHDGPYNYIK
gi|178847311|pdb|2VBI|H QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847310|pdb|2VBI|G QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847309|pdb|2VBI|F QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847308|pdb|2VBI|E QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847307|pdb|2VBI|D QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847306|pdb|2VBI|C QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847305|pdb|2VBI|B QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|178847304|pdb|2VBI|A QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLPRGARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|20385192|gb|AAM21209.1|AF368435_2 GAKMVGADRIIGVDINPAREAMARQFGMTDF-VN--PRDLG-PNGDVVGHLVELT-------GGGADYTFEC--VGNP--TLMRQALECAHRGWGVSTIIGVAAAGQEIST------RPFQLVTGRRWIGSAFGGARGRTDVPKIVDWYMENRINIDDLITHKLPLERIN
gi|296524250|emb|CBM36781.1| QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLA-GARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
gi|57998209|emb|CAI45839.1| QA---------LAEKAPARPASAQKSSVPTCSLTATSDEAGLTNDEIVRHINALLTSNTTLVAETGDSWFNAMRMTLA-GARVELEMQWGHIGWSVPSAFGNAMGSQDRQHVVMVGDGSFQLTAQE-------VAQMVRYELPVI-IFLINNRGYVIEIAIHDGPYNYIK
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gi|20385191|gb|AAM21208.1|AF368435_1 NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLA--------
gi|899754028|gb|AKR47906.1| NWDYAGLMEVFNAEDEHGLGMKATTAGELAEAIKKAKANREGPTIIECQIERSDCTKTLVKWGKKVAAANARKPQVS--------
gi|529247081|ref|WP_020944449.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|915485271|ref|WP_050818574.1| NWDYAGLMEVFNAEDEHGLGMKATTAGELAEAIKKAKANREGPTIIECQIERSDCTKTLVKWGKKVAAANARKPQVS--------
gi|737384544|ref|WP_035366029.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|517917915|ref|WP_019088123.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|504270371|ref|WP_014457473.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|1039400602|ref|WP_064776314.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|528528981|emb|CCT59281.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256652749|dbj|BAI18683.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256655805|dbj|BAI21732.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256649761|dbj|BAI15702.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256646708|dbj|BAI12656.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256643653|dbj|BAI09608.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256640596|dbj|BAI06558.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256637544|dbj|BAI03513.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|256634486|dbj|BAI00462.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKTNREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|371478271|dbj|GAB31399.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|985556514|dbj|BAU39462.1| NWDYAGLMEVFNAEDGHGLGLKATTAGELEEAIKKAKANREGPTIIECQIERSDCTKTLVEWGKKVAAANSRKPQVS--------
gi|178847311|pdb|2VBI|H NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847310|pdb|2VBI|G NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847309|pdb|2VBI|F NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847308|pdb|2VBI|E NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847307|pdb|2VBI|D NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847306|pdb|2VBI|C NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847305|pdb|2VBI|B NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|178847304|pdb|2VBI|A NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLALEHHHHHH
gi|20385192|gb|AAM21209.1|AF368435_2 E--------GFD--------M----------------------------MERGESIRTVVEF-----------------------
gi|296524250|emb|CBM36781.1| NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLA--------
gi|57998209|emb|CAI45839.1| NWDYAGLMEVFNAGEGHGLGLKATTPKELTEAIARAKANTRGPTLIECQIDRTDCTDMLVQWGRKVASTNARKTTLA--------
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Own contributions
I curated the data provided by Zavrel et al. (2008) and Ohs et al. (2018) within the previously
established BioCatNet database system. I applied the workflow for parameter estimation from
Ohs et al. (2018) on both datasets for different kinetic models (see chapter 2.2.2). I contributed
to the writing of the original manuscript.
A.5.1 Abstract
The estimation of kinetic parameters provides valuable insights into the function of biocatalysts
and is indispensable in optimizing process conditions. Frequently, kinetic analysis relies on the
Michaelis-Menten model derived from initial reaction rates at different initial substrate concen-
trations. However, by analysis of complete progress curves, more complex kinetic models can
be identified. This case study compares two previously published experiments on benzaldehyde
lyase-catalyzed self-ligation for the substrates benzaldehyde and 3,5-dimethoxybenzaldehyde to
investigate (1) the effect of using different kinetic model equations on the kinetic parameter
values, and (2) the effect of using models with and without enzyme inactivation on the kinetic
parameter values. These analyses first highlight possible pitfalls in the interpretation of kinetic
parameter estimates and second suggest a consistent strategy for data management and vali-
dation of kinetic models: First, Michaelis-Menten parameters need to be interpreted with care,
complete progress curves are necessary to describe the reaction dynamics, and all experimental
conditions have to be taken into consideration when interpreting parameter estimates. Second,
complete progress curves should be stored together with the respective reaction conditions,
to consistently annotate experimental data and avoid misinterpretation of kinetic parameters.
Such data management strategy is provided by the BioCatNet database system.
A.5.2 Introduction
Modeling is a versatile tool in industrial biotechnology (Vasic´-Racˇki et al., 2003, 2011; Almquist
et al., 2014; Glynn et al., 2014). With cells as biocatalysts, mathematical models are used to
understand, predict, and optimize the properties and behavior of cell factories (Tyo et al., 2010).
Moreover, models are applied to suggest targets for metabolic engineering leading to increases
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in productivity, to optimize and control biotransformation as well as fermentation processes,
and to guide in the choice of cell factory when introducing a novel product (Almquist et al.,
2014). With isolated enzymes as biocatalysts, enzyme kinetic models significantly increase the
knowledge about the reaction systems (Vasic´-Racˇki et al., 2003; Glynn et al., 2014), which is
especially helpful if the enzyme has only recently been discovered (Bas¸ et al., 2007). Thereby,
models help to find an optimal microenvironment for the biocatalyst and optimal operating
conditions to increase productivity (Vasic´-Racˇki et al., 2003), which allows for an effective
scale-up of pharmaceutical processes (Pollard and Woodley, 2007) as well as an efficient design
of continuously operated enzyme reactors (Vasic´-Racˇki et al., 2003). The main potential of
enzyme kinetic models lies in identifying new process improvement strategies in silico and then
using simulations to evaluate these strategies time- and resource-efficiently.
To fully exploit this potential, the enzyme kinetic models must be valid over a wide range of
reaction conditions, or at least under the conditions that apply to a potential large-scale process
in question (Vasic´-Racˇki et al., 2003, 2011; Almquist et al., 2014; Wandrey, 1993; Bommarius
and Riebel, 2008; Schmidt et al., 2009). More specifically, the effect of all compounds in
the reaction medium on the reaction rate should be taken into account, for example, high
concentrations of substrate and product as they might have a strong influence on the rate,
as well as the enzyme stability under operating conditions (Vasic´-Racˇki et al., 2011). To also
detect enzyme inhibition by reaction products, kinetic analysis should favor using the complete
progress curve of the reaction over only using initial velocities (Gutie´rrez and Danielson, 2006).
Moreover, these progress curve data can be used for detecting long-time phenomena, such as
enzyme deactivation (Straathof, 2001) and for discriminating competing models (Michalik et al.,
2007; Bates and Frieden, 1973).
The corresponding enzymatic experiments yield heterogeneous data sets, containing not
only the observed progress curves, that is, the time course of substrate depletion or product
formation, but also a description of the reaction conditions. Keeping track of the method-
ological details of an enzyme-catalyzed reaction is indispensable to enable the comparison of
measurements. Since full-text descriptions of experimental literature cannot be read efficiently
in an automated manner, databases and representative data formats comprising both exper-
imental conditions and experimental data have been proposed to facilitate the exchange of
scientific knowledge on enzymatic reactions (Gardossi et al., 2010; Buchholz et al., 2016; Tip-
ton et al., 2014). The STRENDA consortium has suggested a comprehensive set of attributes
as a benchmark for documentation of enzymatic data39.
However, databases on literature mining of enzymatic reactions like BRENDA (Placzek
et al., 2017; Schomburg et al., 2002) and SABIO-RK (Wittig et al., 2012) lack detailed infor-
mation on the complete sequence of the enzyme or the description of the underlying kinetic
39 See footnote 20 on page 176.
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models, which hinders comparing and reproducing the experiments. Many kinetic analyses rely
on simplified Michaelis-Menten models that are only valid under certain conditions (Dette et al.,
2010; Schnell, 2014). A Michaelis-Menten model might fit the initial phase of the progress curve
sufficiently well while neglecting long-term effects in the dynamics of the enzymatic reaction,
such as reaction equilibrium or enzyme inactivation. Using inappropriate kinetic models hin-
ders the mechanistic interpretation of previously published measurements, for example, in the
case of regulatory interactions or enzyme inhibition (Walsh, 2014). In most cases, databases
and literature rather summarize enzyme properties by listing kinetic parameters, sometimes
referring to the steady-state of a reaction, instead of showing the underlying progress curve
data on the dynamics of an enzymatic reaction. Thereby, it becomes impossible to analyze and
compare previously published parameter estimates.
To exploit the full potential of experimental data, this study presents a workflow to measure,
archive, and analyze experimental data efficiently, supported by a database system for storage
and annotation of experimental data and a Matlab routine for applying different kinetic models.
The results obtained from different kinetic models are compared, emphasizing the importance
of a consistent data management.
A.5.3 Experimental section
Experimental data Two published datasets (Table A.15) were used to establish the work-
flow from measured data to kinetic model analysis. Dataset 1 covers the symmetric carboliga-
tion of 3,5-dimethoxybenzaldehyde (DMBA) molecules yielding (R)-3,3’,5,5’-tetramethoxybenzoin
using benzaldehyde lyase (EC 4.1.2.38) from Pseudomonas fluorescens (Pf BAL) as biocata-
lyst (Zavrel et al., 2008). The assay contained 50 mM potassium phosphate (KPi) buffer as
well as 0.25 mM MgCl2 and 0.25 mM thiamine diphosphate (ThDP) as cofactors. 30 (v/v) %
of the co-solvent dimethylsulfoxide (DMSO) was added to increase the solubility of aromatic
compounds. The pH value was set to 8.5 and the ionic strength to 150 mM. The fluorescent
substrate DMBA enabled the measurement of highly resolved progress curves using a fluorime-
ter (PerkinElmer, LS55, Waltham, MA) conducted in cuvettes at 25 ◦C. The dataset comprises
nine progress curve experiments of substrate depletion with in total 2786 data points.
Dataset 2 covers the symmetric carboligation of benzaldehyde (BA) to (R)-benzoin using
the same enzyme, Pf BAL (Ohs et al., 2018), and also consists of progress curve experiments.
In this case, a reaction mixture containing the enzyme Pf BAL, buffer (50 mM triethanolamine
(TEA) pH 8.5), cofactors (2.5 mM MgSO4, 0.5 mM ThDP), co-solvent (30 (v/v) % DMSO) and
substrate was distributed to 1800µL HPLC vials after mixing. The vials were immediately
closed to prevent evaporation of benzaldehyde, then located into a heat shaker (preheated to
30 ◦C) and shaken at 300 rpm. At specific times, 600µL samples were taken from one vial,
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and the reaction was stopped by adding 300µL trichloroacetic acid. Subsequently, the sample
was diluted and analyzed using high performance liquid chromatography (HPLC). The dataset
comprises 13 progress curve experiments of substrate depletion and product formation with
in total 374 data points. As a test for data quality, the mass balance was checked for each
experiment.
The progress curve data from datasets 1 and 2 are available as supplementary files (40 and
41, respectively).
Workflow for kinetic parameter estimation The workflow of data management and data
analysis combines the consistent data model of the BioCatNet database system with advanced
routines for kinetic parameter estimation.
Two datasets of enzyme-catalyzed self-ligation with either 3,5-dimethoxybenzaldehyde (DMBA)
or benzaldehyde (BA) as substrate were analyzed by four different kinetic models, and the pa-
rameter estimation was performed in three subsequent steps of Monte-Carlo, algebraic, and
dynamic parameter estimation to gradually increase the accuracy of the estimation while sav-
ing computation time (Figure A.34).
(1) Data management
The BioCatNet database system stores data on protein sequences, protein structures and bio-
catalytic experimental data, preferably progress curves of substrate depletion and/or product
formation, providing a starting point for the comparative analysis of experimental data and a
link to sequences and structural data for the applied enzymes. Experimental data are described
by several attributes, including information on the initial concentrations, the reaction buffer,
and additives, for example, co-solvents. In addition, the full protein sequence of the applied
enzyme is linked to the experiment. The two datasets for self-ligation of BA and DMBA were
uploaded as experiment sets into the Thiamine diphosphate-dependent Enzymes Engineering
Database42.
(2) Matlab tool for kinetic analysis of enzyme reactions
The kinetic analysis of the two datasets is conducted using a Matlab-based tool for kinetic
analysis of carboligation reactions (Ohs et al., 2018). This tool can be expanded by additional
kinetic models to allow for analysis of further enzyme-catalyzed reactions, see below. Here,
the kinetic analysis starts with choosing a reaction model from a pool of implemented models
according to the reaction mechanism. In a second step, boundaries for the kinetic parameters
are specified. Afterwards, the experimental data sets containing the progress curve data are read
in. The tool then interpolates the reaction rates from these data. The subsequent parameter
40 SuppTab-S3.xlsx, accessed on June 14, 2018.
41 SuppTab-S2.xlsx, accessed on June 14, 2018.
42 See footnote 15 on page 174.
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estimation comprises three steps, first, a parameter estimation based on reaction rates by
Monte-Carlo simulation with a user-defined sample size of random parameter values, second, an
algebraic parameter estimation also based on the reaction rates, and third, a dynamic parameter
estimation based on the original progress curve data. The overall parameter estimation routine
comprising all three steps was repeated five times. Finally, the quality of the model fit is
returned, together with the relative standard deviations of the parameter estimates, derived
from the covariance matrix. Details on the parameter estimation routine are given in the
supplementary material. The parameter set resulting in the lowest residual sum of squares
(RSS) is reported as result of the parameter estimation. Thereby, the tool can easily be used
to compare different models. The Matlab code is available for download at43.
Model equation for enzyme kinetics In the following, the term model refers to a math-
ematical model, described by an equation system. One underlying reaction mechanism may
be represented by several mathematical models, that is different model equations, based on
different assumptions each. Model 1 is the irreversible macrokinetic Michaelis-Menten model,
with adapted stoichiometry for the symmetric carboligation (Figure A.35) and which does
not consider enzyme inactivation:
dcA
dt
= −2dcP
dt
=
kcatfcEtcA
KmA + cA
(A.1)
where t is time, cA is the substrate concentration, cP is the product concentration, cEt
is the total enzyme concentration, and the two model parameters kcatf are the rate constant
for the forward reaction and KmA the Michaelis-Menten constant, respectively. The macroki-
netic Michaelis-Menten parameter lumps several elementary rate parameters into one effective
parameter, which describes the substrate binding affinity.
Model 2 uses macrokinetic rate expressions, including reversibility of the reaction (Zavrel
et al., 2008) and does not consider enzyme inactivation. It takes all elementary reaction steps
of the ordered bi-uni mechanism (Figure A.35) (Zavrel et al., 2008; Ohs et al., 2018) into
account:
dcP
dt
= −1
2
dcA
dt
=
N1
D1
(A.2)
N1 =
kcatf
KiAKmB
(
c2A −
cP
Keq
)
cEt (A.3)
D1 = 1 +
cA
KiA
+
KmAcA
KiAKmB
+
c2A
KiAKmB
+
cP
KmP
+
cAcP
KmPKiB
(A.4)
43 http://ibvt.de/DE/Publikationen/, accessed on June 14, 2018.
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with the Haldane relations
KiB =
KmBKiA
KmA
(
1−
(
KmA
KiA
− 1
)
KmP
KeqKmBKiA
) (A.5)
KmP =
KmB (KmB −KmA)2Keq
2KmA
(A.6)
KiA = KmB −KmA (A.7)
Keq =
cP
c2A
(A.8)
(A.9)
with the four model parameters kcatf as the rate constant for the forward reaction, Keq as the
equilibrium constant, and KmA as well as KmB as the Michaelis-Menten constants for the first
binding (donor) and the second binding substrate (acceptor), respectively. The parameters
KmP , KiA, and KiB are the Michaelis-Menten constants for the product (reverse reaction), the
inhibition constants of the first binding substrate and the second binding substrate respectively,
which are derived from the model parameters by the Haldane equations (Zavrel et al., 2008).
Here, the model assumes that the kinetic parameters for substrate binding and release are
identical (k2 = k1, k−2 = k−1). The last two Haldane relations (Equation A.7 and A.8) result
from this assumption. In this study, model 2 is called simplified macrokinetic self-ligation
model.
Model 3 is a microkinetic model, again without considering enzyme inactivation. It is a
different mathematical formulation of the same reaction mechanism underlying also model 2,
namely in elementary rate parameters instead of effective macroscopic rate parameters (Zavrel
et al., 2008). The model equations for model 3 read as:
dcP
dt
= −1
2
dcA
dt
=
N2
D2
(A.10)
N2 =
(
k21 k3 c
2
A − k2−1 k−3 cP
)
cEt (A.11)
D2 = k
2
−1 + k−1 k3 + k
2
1 c
2
A + k1 k−3 cA cP + (2 k1 k3 + k1 k−1) cA + 2 k−1 k−3 cP (A.12)
where ki are the rate parameters for the corresponding elementary reactions, in the following
named microkinetic parameters. Model 3 is called simplified microkinetic self-ligation model
(Zavrel et al., 2008; Ohs et al., 2018), as it also assumes that the two kinetic parameters for
substrate binding and release are identical (k2 = k1, k−2 = k−1), leading to four independent
model parameters k1, k−1, k3, and k−3. The macro- and microkinetic models are equivalent,
since both models represent the same first principles of the bi-uni reaction mechanism. There-
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fore, the kinetic parameters can be converted into each other. The relations to calculate the
microkinetic parameters from the macrokinetic parameters are:
k1 = k2 =
kcatf
KmA
(A.13)
k−1 = k−2 =
kcatf (KmB −KmA)
KmA
(A.14)
k3 = kcatf (A.15)
k−3 =
kcatf
Keq (KmB −KmA) (A.16)
and the ones to calculate the macrokinetic parameters from the microkinetic ones:
kcatf = k3 (A.17)
KmA =
k3
k1
(A.18)
KmB =
k−1 + k3
k1
(A.19)
Keq =
k21 k3
k2−1 k−3
(A.20)
While kcatf , KmA and KmB are enzyme-specific constants, Keq is enzyme-independent and only
depends on the chemical equilibrium of substrate and product. This fact implies that k1, k3,
k−1 and k−3 are linked by an external thermodynamic constraint.
Model 4 is a microkinetic model which considers substrate-dependent enzyme inactivation
(Ohs et al., 2018) by adding an inactivation term to model 3. The equation for the inactivation
reads as:
dcE
dt
= −kinS · cA · cE (A.21)
where kinS is the inactivation parameter.
A.5.4 Results
Michaelis-Menten model 1 is only applicable for the initial part of the progress
curve The Michaelis-Menten model 1 is the standard choice for evaluating enzyme kinet-
ics from initial rate data. Indeed, since the carboligation reactions are reversible, the irre-
versible Michaelis-Menten model 1 cannot sufficiently fit the complete progress curve data
(Figures A.36 and A.37). As a result, the estimated macroscopic kinetic parameters KmA
and kcatf show high uncertainty and cannot be identified reliably (Table A.18). Therefore,
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the Michaelis-Menten model 1 was applied to the first six minutes of the progress curve, cor-
responding to typical initial rate measurements with presumably low product concentrations.
For both substrates, the shortened progress curve subset resulted in an improved model fit
(Figures A.38 and A.39) and in macroscopic kinetic parameters KmA and kcatf with remark-
ably reduced uncertainty in comparison to the full progress curves (Tables A.16 and A.17).
The evaluation of the first six minutes of the reaction progress covers a suitable range of sub-
strate concentrations between 1.5 and 3 mM for DMBA and between 30 and 75 mM for BA
(Table A.15), below and above the respective KmA-values of 2.6 mM and 55 mM of model 1
(Tables A.16 and A.17). While the KmA values differ by an order of magnitude, the kcatf
values are very similar for both substrates.
Michaelis-Menten model 1 provides better parameter quality than the macroki-
netic model 2 for the initial reaction phase The resulting kinetic parameters of the
Michaelis-Menten model 1 covering the shortened progress curves were compared to the pre-
viously published macrokinetic bi-uni model 2 covering the full progress curves (Tables A.16
and A.17). Model 2 for the bi-uni reaction mechanism has been applied previously to the
symmetric carboligation of DMBA (Zavrel et al., 2008). While for both substrates the kcatf
values were similar to model 1, the Km values were consistent with model 1 for BA, but differed
by up to three orders of magnitude for DMBA. The Km-values of the bi-uni model 2 showed
significantly larger relative standard deviations of more than 100 %, meaning that both Km pa-
rameters were unidentifiable, in contrast to the Km returned by model 1 for the initial progress
curves.
Microkinetic model 3 results in more certain parameter estimates than macroki-
netic model 2 As expected, the macrokinetic and the microkinetic model for the reversible
bi-uni reaction without inactivation had similar RSS/n for both substrates, indicating a similar
overall fit quality (Figures A.40 to A.43). For DMBA, the kcatf (equivalent to k3), and Keq
values were found identical, but the KmA and KmB as well as the other microkinetic parameters
differed by an order of magnitude for models 2 and 3 (Table A.16). Noteworthy, most relative
standard deviations for the parameter estimates were remarkably smaller for the microkinetic
model 3 than for the previously published macrokinetic model 2, although both models describe
the same reaction mechanism. For BA, all kinetic parameters differed by less than a factor of
two. The low Km values for DMBA and the high Keq for BA give first hints that kinetic mod-
els 2 and 3 are unsuitable, in contrast to the previously published kinetic analysis for DMBA
(Zavrel et al., 2008).
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Microkinetic model 3 is outperformed by microkinetic model 4 with substrate-
dependent inactivation Since the symmetric carboligation of BA has been studied with
respect to substrate-dependent enzyme inactivation (Ohs et al., 2018), it seemed promising to
test model 4 on the DMBA dataset, too. For both substrates, the RSS/n and the relative stan-
dard deviations of the kinetic parameters were remarkably lower for microkinetic model 4 with
substrate-dependent inactivation, indicating a better model quality and improved identifiability
of the parameter estimates (Figures A.44 and A.45). Unexpectedly, the equilibrium constant
differed by a factor of twenty between both substrates. The catalytic activity of Pf BAL towards
both substrates differed by less than a factor of two, whereas KmA towards DMBA was more
than two orders of magnitude lower than KmA towards BA (Tables A.16 and A.17). The
differences in KmA and KmB between the substrates correlate to the two orders of magnitude
difference in k1 and k−3 between the substrates, whereas k−1 and k3 for the two substrates were
similar. The inactivation constant kinS for BA was one order of magnitude smaller than the
one of DMBA.
A.5.5 Discussion
Model and parameter quality hint at substrate-dependent inactivation mechanism
The model fit and the parameter quality of the microkinetic model 4 with substrate-dependent
inactivation clearly support the mechanism of substrate-dependent inactivation for both sub-
strates as observed previously (Leksawasdi et al., 2004). Michaelis-Menten model 1, which has
a similar fit quality and similar kcatf values, cannot capture inactivation since it neglects the
later parts of the progress curves. It is interesting, that the kinetic models 2 and 3 without
inactivation term misinterpret the effect of inactivation on the reaction rate in two different
ways: for BA as a shift in reaction equilibrium (Keq), but for DMBA as a shift in substrate
affinity (KmA). This can be explained by differences in the experimental data (Figures A.42 to
A.45): While the DMBA progress curves reached reaction equilibrium, and thus led to reliable
estimates of Keq, the BA progress curves do not fully reach the equilibrium, and leave more
freedom to the estimation of Keq. The 10-fold higher rate constant for substrate-dependent
enzyme inactivation for DMBA correlates with its higher binding affinity, which suggests that
inactivation might be caused by substrate binding near to the active site. However, at respective
substrate concentrations of 3 mM DMBA and 50 mM BA, half times τ1/2 of Pf BAL inactivation
(τ1/2 = (kinS · cA)−1 ) are 40 and 30 min, respectively, which precludes mere binding effects.
Interpretation of the Michaelis-Menten parameters In the microkinetic model 4 with
substrate-dependent inactivation, KmA is smaller than KmB by a factor 1.5 to 3 since the
probability of substrate binding is higher upon the first binding step as reflected by Equa-
tions A.18 and A.19. For BA, the KmA value of the Michaelis-Menten model 1 (55 mM)
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is consistent with the KmA and KmB values (20 and 32 mM, respectively) of the microkinetic
model 4 with inactivation, because model 4 describes the substrate depletion as a subsequent
two-step-mechanism, each with separate binding affinities KmA and KmB, whereas model 1
combines both binding events into a single substrate affinity, which is accordingly higher than
the individual binding affinities. For DMBA, the trend is similar. The differences between
the KmA and KmB values between model 1 and model 4, however, is not caused by prod-
uct inhibition at low conversion (Pleiss, 2017), because the Michaelis-Menten parameters KmP
(0.12 mM for 3,3’,5,5’-tetramethoxybenzoin and 23 mM for benzoin) as derived from model 4
(Equation A.6) were similar to the respective KmB values (0.2 mM and 32 mM, respectively).
Solvent effects and substrate solubility The KmA and KmB values for BA of 20 and
32 mM at 30 % DMSO are in agreement with previously published data showing that KmA
and KmB increase with increasing DMSO co-solvent content from 0.28 and 0.39 mM without
DMSO to 1.96 and 6.13 mM at 10 % DMSO, respectively (Kokova et al., 2009). The decrease
of the apparent affinity to the hydrophobic active site by two orders of magnitude at 30 %
DMSO is a consequence of two factors, one being the decrease of the activity coefficients of
the substrates and products (Pleiss, 2017) and the other being the competitive inhibition of
Pf BAL by DMSO (Gerhards et al., 2012). Although BA is considered to be the ”natural”
substrate of Pf BAL, its kcatf value was similar to the ”unnatural” DMBA, but its KmB was
two orders of magnitude higher than KmB of DMBA. Because the KmB value results from two
main phenomena, the enzyme-substrate interaction and the substrate-solvent interaction, the
lower KmB value of DMBA can be partially explained by its sixfold lower estimated aqueous
solubility resulting in sixfold higher activity coefficient of DMBA. A corresponding separation
of the substrate-solvent effects from the substrate-enzyme effects has been accomplished by
expressing the kinetic parameters in terms of thermodynamic activities (Grosch et al., 2017).
In general, it is advisable to annotate reaction conditions consistently, including the composition
of the reaction buffer and co-solvents, since this information is a prerequisite to capture solvent
effects.
Lessons learned Although the reaction system of this case study is not overly complex,
researchers unfamiliar with the concepts of kinetic modeling might encounter pitfalls when
trying to reliably estimate kinetic parameters. To avoid misinterpretations and to enhance
reproducibility of results, several points have to be noted:
1. Be careful with the interpretation of Michaelis-Menten parameters. The basic phenomena
of the substrates’ affinity can be interpreted using the Michaelis-Menten model 1, but only
the mechanistic microkinetic model 4 including substrate-dependent inactivation can be
interpreted in detail by calculating the corresponding microkinetic parameters for KmA
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and KmB. Only then, the elementary reaction rates allow for identifying rate-limiting
steps.
2. Use progress curves for kinetic analysis of the reaction dynamics. Our findings show that
only the initial portion, but not the full progress curves are well fit by the Michaelis-
Menten model 1, and confirm Hill et al. (1977) analysis that literature does not widely
support the Michaelis-Menten model. As experienced kinetic modelers know, only com-
plete progress curves reveal phenomena like reversibility, inhibition or inactivation, which
are not yet observable during the initial phase of the reaction when product formation
is still low. The better model fit of the Michaelis-Menten model 1 to the initial fraction
in comparison to the full progress curves does not guarantee that this model sufficiently
describes the underlying mechanism (Stroberg and Schnell, 2016). When using progress
curves for estimating kinetic parameters, the biochemist avoids the information loss of
the rate regression from the concentration over time data and is rewarded by more precise
information about the full enzymatic reaction, in contrast to investigations of the initial
reaction phase or steady-state kinetics (Schnell and Maini, 2003).
3. Consider all relevant phenomena in mechanistic modelling. Only when substrate-dependent
inactivation was considered, the mechanistic modelling led to significantly better results
than the Michaelis-Menten model and to correct interpretation of the occurring phenom-
ena. In other words, mechanistic modelling needs to be sufficiently detailed and describe
not only the reaction mechanism and the accompanying reaction equilibria, but also re-
flect enzyme inactivation (Rachinskiy et al., 2009) and for example, substrate instability
by suitable expressions. If additional influence factors such as co-solvent concentration,
temperature, and/or pH-value are varied, thermodynamic activities may replace the con-
centrations, and additional terms may complement the microkinetic models. The model
might be further refined by dropping the assumptions k1 = k2 and k−1 = k−2 (Zavrel
et al., 2008) The selection of a suitable kinetic model did not only influence the mecha-
nistic interpretation of reactions in biochemistry and in pharmaceutical studies (Walsh,
2014), but has also been pivotal for determining meaningful cytochrome P450 enzyme
kinetics (Tracy, 2006; Kramer and Tracy, 2008).
4. Manage your experimental data well. Two prerequisites have to be fulfilled to re-analyze
progress curve data from different data sources with new models: First, efficient, stepwise
parameter estimation reduces the effort for progress curve integration (Ohs et al., 2018).
The Monte Carlo methods used therein have also stood the test in more complex kinetic
models (Srinivasan et al., 2015). Second, only the storage of progress curve raw data on
a publicly available platform like the BioCatNet database system allows for evaluating
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alternative kinetic models. In structural biology, the problem of misinterpretation of
protein structures has been recognized many years ago, and nowadays, deposited original
data enable alternative approaches to structure refinement (Jones et al., 1996; Kleywegt
and Jones, 1998). Similarly, the BioCatNet concept of providing original data will be
helpful in the management of higher amounts of data, such as combinations of enzyme
variants with progress curve data measured under various initial conditions.
5. Annotate experimental conditions consistently. Likewise, biocatalytic data should be con-
sistently stored together with the respective reaction conditions as an essential prerequisite
for a reproducible kinetic analysis (Gardossi et al., 2010). Similar critical requirements
for managing enzymatic data were formulated by the STRENDA consortium (Tipton
et al., 2014) and database projects such as SABIO-RK (Wittig et al., 2012) and BioCat-
Net, with the latter also comprising the original progress curve data of a biocatalytic
experiment (Buchholz et al., 2016). Finally, kinetic analyses need to be linked not only
to the experimental conditions, but also to the corresponding kinetic models and to the
protein sequence or structure data. The integration of experimental biocatalytic data
with information on the respective enzyme sequence will support the systematic study
of sequence-structure-function relationships and, based on the knowledge obtained, the
design of improved enzyme variants and bioprocesses.
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Figure A.34: Simplified scheme of the workflow that combines experimental data retrieved from
the BioCatNet database with routines for the estimation of kinetic parameters. In each repe-
tition of the kinetic parameter estimation, three subsequent steps of parameter estimation are
performed as a trade-off between accuracy and performance (Ohs et al., 2018), using previously
interpolated reaction rates (Monte-Carlo and algebraic parameter estimation) and finally using
progress curves of concentrations over time (dynamic parameter estimation). Quality indica-
tors comprise standard deviations of kinetic parameters and the residual sum of squares (RSS)
with respect to the full data set.
Figure A.35: Microkinetic representation of the Michaelis-Menten model for symmetric
carboligation (model 1) with substrate (A), product (P), free enzyme (E), and enzyme-
substrate/product-complexes (EA, EAA, EP). For the microkinetic model of the ordered bi-uni
mechanism (models 2 to 4), it is assumed that for the first and second binding substrate (A
and B) k1 = k2 and k−1 = k−2 (Zavrel et al., 2008; Ohs et al., 2018).
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Table A.15: Initial experimental conditions.
Dataset 1 (DMBA) 1 cA(0) [mM]
3 cP (0) [mM]
3 cEt [mM]
4 duration [min]
A 3 0 8.33 · 10−5 25
B 2.75 0 8.33 · 10−5 25
C 2.5 0 8.33 · 10−5 25
D 2.25 0 9.20 · 10−5 25
E 2 0 1.00 · 10−4 12
F 1.5 0 8.33 · 10−5 17
G 3 0 4.17 · 10−5 50
H 2.75 0 4.17 · 10−5 50
I 2.5 0 4.17 · 10−5 50
Dataset 2 (BA) 2 cA(0) [mM]
3 cP (0) [mM]
3 cEt [mM]
4 duration [min]
A 72.5 0 4.75 · 10−4 40
B 36.25 0 9.33 · 10−4 30
C 36.25 1.25 4.75 · 10−4 40
D 72.5 0 2.04 · 10−4 180
E 72.5 0.2 4.41 · 10−4 60
F 30 0 3.39 · 10−5 180
G 75 0 6.79 · 10−5 120
H 0 1.25 6.79 · 10−5 20
I 35 0 3.22 · 10−4 55
J 75 1 3.34 · 10−4 15
K 30 0.5 8.36 · 10−5 65
L 72.5 1.25 4.75 · 10−4 60
M 75 0 1.25 · 10−4 105
1 Dataset 1 (Zavrel et al., 2008) comprises 9 progress curves (A-I).
2 Dataset 2 (Ohs et al., 2018) comprises 13 progress curves (A-M).
3 Initial concentrations of substrate A and product P .
4 Enzyme concentration.
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Table A.16: Estimated kinetic parameters and the residual sum of squares (RSS)
over sample size n for the benzaldehyde lyase-catalyzed self-ligation of 3,5-dimethoxy-
benzaldehyde and four kinetic models 1,2. Estimated parameter values are given in bold,
whereas parameter values obtained from Equations A.10 to A.20 are set in regular
font. The relative standard deviations (in %) are given in parentheses. Relative stan-
dard deviation values < 100 % are marked with ∗ to indicate the higher reliability of
the respective kinetic parameter values.
Unit Model 1 3 Model 2 4 Model 3 5 Model 4 5
k1
mM−1 min−1
-
1.6 · 107 9.3 · 105 4.5 · 104
(501) (108) (14)∗
k−1
min−1 - 6.4 · 104 1.6 · 104 4.3 · 103
(590) (53)∗ (6)∗
k3
min−1 - 2.7 · 103 2.7 · 103 2.8 · 103
(1)∗ (1)∗ (1)∗
k−3
mM−1 min−1
-
4.2 · 107 2.4 · 106 7.7 · 104
(547) (110) (16)∗
kinS
mM−1 min−1
- - -
8.0 · 10−3
(4)∗
kcatf
min−1 4.4 · 103 2.7 · 103 2.7 · 103 2.8 · 103
(5)∗ (1)∗ (1)∗ (1)∗
KmA
mM 2.6 1.7 · 10−4 2.9 · 10−3 6.2 · 10−2
(9)∗ (501) (108) (14)∗
KmB
mM
-
4.2 · 10−3 2.0 · 10−2 0.2
(262) (117) (15)∗
Keq
mM−1
-
3.9 3.9 4.1
(1)∗ (364) (35)∗
RSS
n
mM2 6.7 · 10−3 1.4 · 10−3 1.4 · 10−3 1.1 · 10−3
1 Estimated parameters, their relative standard deviation (%), and the residual sum
of squares (RSS) over sample size n were applied to nine experiments containing
n = 2786 samples. Relative standard deviations of independent parameters were
determined using the covariance matrix. Error propagation was used to determine
relative standard deviations of derived parameter values. Compare supplementary
material for details.
2 Model 1: Michaelis-Menten, model 2: macrokinetic model without inactivation,
model 3: microkinetic model without inactivation, model 4: microkinetic model
including substrate-dependent inactivation
3 Model 1 was applied for a maximum reaction time of 6 min, resulting in 549 samples.
Parameters of model 1 for the full progress curves are listed in Table A.18.
4 Values for k1, k−1, k3 and k−3 were calculated from the macrokinetic parameters
according to Equations A.13 to A.16 including propagation of uncertainty.
5 Values for kcatf , KmA, KmB andKeq were calculated from the microkinetic parameters
according to Equations A.17 to A.20 including propagation of uncertainty.
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Table A.17: Estimated kinetic parameters and the residual sum of squares (RSS) over
sample size n for the benzaldehyde lyase-catalyzed self-ligation of benzaldehyde and four
kinetic models 6. Footnotes and descriptions are equivalent to Table A.16.
Unit Model 1 7 Model 2 4 Model 3 5 Model 4 5
k1
mM−1 min−1
-
135 134 245
(142) (77)∗ (22)∗
k−1
min−1 - 3.6 2.2 3.1 · 103
(1.4 · 105) (3 · 104) (37)∗
k3
min−1 - 3.0 · 103 3.1 · 103 4.9 · 103
(55)∗ (54)∗ (12)∗
k−3
mM−1 min−1
-
1.4 · 103 1.4 · 103 158
(2.9 · 105) (39)∗ (36)∗
kinS
mM−1 min−1
- - -
7.4 · 10−4
(4)∗
kcatf
min−1 5.0 · 103 3.0 · 103 3.1 · 103 4.9 · 103
(15)∗ (55)∗ (54)∗ (12)∗
KmA
mM 55 22 23 20
(28)∗ (131) (94)∗ (25)∗
KmB
mM
-
22 23 32
(113) (97)∗ (27)∗
Keq
mM−1
-
3.0 · 103 8.6 · 103 0.2
(3.6 · 104) (6.0 · 104) (94)∗
RSS
n
mM2 1.4 15 15 2.7
6 Estimated parameters, their relative standard deviation (%), and the residual sum
of squares (RSS) over sample size n were applied to thirteen experiments containing
n = 374 samples.
7 Model 1 was applied for a maximum reaction time of 6 min, resulting in 110 samples.
Parameters of model 1 for the full progress curves are listed in Table A.18.
c©2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 209
A.5 Progress curve analysis within BioCatNet: comparing kinetic models for
enzyme-catalyzed self-ligation
A.5.6 Supporting Information
P. C. F. Buchholz, R. Ohs, A. C. Spieß, and J. Pleiss. Progress curve analysis within BioCatNet:
comparing kinetic models for enzyme-catalyzed self-ligation. Biotechnology Journal, 2018a. in
press
Parameter estimation procedure
Each iteration of the parameter estimation routine comprised three steps:
1. Monte-Carlo-based parameter estimation,
2. algebraic and
3. dynamic parameter estimation:
• The Monte-Carlo simulation in step (1) generates a user-defined number (here, 100,000)
of random parameter sets that serve to calculate reaction rates using the kinetic models.
The lowest RSS between these calculated rates and the rates interpolated from the ex-
perimental data defines the best parameter set, which is used as starting point for the
subsequent step (2).
• The algebraic parameter estimation in step (2) uses the lsqnonlin solver from Matlab and
the interpolated reaction rates. Lsqnonlin is a solver suitable to optimize least-squares
curve fitting problems and uses the residuals as objective function, i. e. it minimizes
the distances between input data and fitted data. A maximum of 2000 iterations and
the specific ”Jacobian” option for better convergence were set as solver options. The
parameter estimates from step (2) were used as input for dynamic parameter estimation
routine in step (3)
• In the dynamic parameter estimation in step (3), the ordinary differential equation of the
respective kinetic model was solved to finally fit the model against the actual progress
curve data, i.e. concentrations over time. Step (3) used the lsqnonlin solver with the
same settings as for the previous step (2)
The parameter estimation routine was repeated five times. Subsequently, the independent
estimates were compared, and the parameters of the model fit with the lowest residual sum of
squares were chosen as the final parameter estimates.
All parameter estimations were performed in Matlab (The Mathworks, Natick, MA, USA,
version R2016a) with upper and lower bounds for the parameter estimates set to 10−3 and 103,
respectively.
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Errors of the parameter estimates
The errors of the parameter estimates were determined by analyzing the covariance matrix of
the estimates. The covariance matrix V was approximated as follows:
V (θˆ) =
(
QTQ
)−1
s2 =
(
QTQ
)−1 RSS(θˆ)
n− p , (A.22)
where θˆ is the best available parameters estimate, Q is the (Jacobian) sensitivity matrix,
s2 is the estimate of the unknown measurement variance (assuming uncorrelated and constant
measurement errors), RSS(θˆ) is the residual sum of squares, n the total number of measure-
ments, and p the number of parameters (Ohs et al., 2018). The standard deviation sd(θˆ) and
the relative standard deviation RSD(θˆ) were calculated as
sd(θˆ) = (vii)
1
2 (A.23)
RSD(θˆ) =
sd(θˆi)
θˆi
(A.24)
where the variance vii is the ith diagonal entry of the covariance matrix V .
The relative standard deviations of the corresponding macrokinetic parameters of the mi-
crokinetic model, or vice versa, were calculated using the error propagation equation (Zavrel
et al., 2008)
σK =
√√√√ n∑
i=1
(
∂K
∂pi
· σi
)2
(A.25)
where σK is the standard deviation of the dependent parameter K and n is the number of
independent parameters pi with respective standard deviations σi.
211
A.5 Progress curve analysis within BioCatNet: comparing kinetic models for
enzyme-catalyzed self-ligation
Figure A.36: Fits of the two-substrate Michaelis-Menten model (model 1, dotted lines) to the
full progress curve of dimethoxy-benzaldehyde self-ligation reactions (red points (Zavrel et al.,
2008)). The reaction was performed in 50 mM KPi buffer with 0.25 mm MgCl2 , 0.25 mM ThDP
and 30 % DMSO at pH 8.5 and 25 ◦C. The initial concentrations of substrate and enzyme are
given in Table A.15. The respective parameter estimates are given in Table A.18.
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Figure A.37: Fits for the benzaldehyde self-ligation (Ohs et al., 2018) and the two-substrate
Michaelis-Menten model (model 1). Fitted data are indicated as lines, experimental measure-
ment data as points with straight lines and full circles for the substrate benzaldehyde and
dotted lines and open circles for the product benzoin. The respective parameter estimates are
given in Table A.18. The reaction was performed in 50 mM TEA buffer with 2.5 mM MgSO4,
0.5 mM ThDP and 30 % DMSO at pH 8.5 and 30 ◦C. The initial concentrations of substrate
and enzyme are given in Table A.15.
213
A.5 Progress curve analysis within BioCatNet: comparing kinetic models for
enzyme-catalyzed self-ligation
Figure A.38: Fits for the first six minutes of the dimethoxy-benzaldehyde self-ligation (points)
and the two-substrate Michaelis-Menten model (model 1, dotted lines). The respective param-
eter estimates are given in Table A.16 with reaction conditions according to Figure A.36
and Table A.15.
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Figure A.39: Fits for the first six minutes of the benzaldehyde self-ligation and the two-substrate
Michaelis-Menten model (model 1). Symbols as described in Figure A.37. The respective pa-
rameter estimates are given in Table A.17 with reaction conditions according to Figure A.37
and Table A.15.
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Figure A.40: Fits for the first six minutes of the dimethoxy-benzaldehyde self-ligation (points)
and the macrokinetic model (model 2, dotted line). The respective parameter estimates are
given in Table A.16 with reaction conditions according to Figure A.36 and Table A.15.
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Figure A.41: Fits for the benzaldehyde self-ligation and the macrokinetic model (model 2).
Symbols as described in Figure A.37. The respective parameter estimates are given in Ta-
ble A.17 with reaction conditions according to Figure A.37 and Table A.15.
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Figure A.42: Fits for the dimethoxy-benzaldehyde self-ligation (points) and the microkinetic
model (model 3, dotted line). The respective parameter estimates are given in Table A.16
with reaction conditions according to Figure A.36 and Table A.15.
218
A.5 Progress curve analysis within BioCatNet: comparing kinetic models for
enzyme-catalyzed self-ligation
Figure A.43: Fits for the benzaldehyde self-ligation and the microkinetic model (model 3).
Symbols as described in Figure A.37. The respective parameter estimates are given in Ta-
ble A.17 with reaction conditions according to Figure A.37 and Table A.15.
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Figure A.44: Fits for the dimethoxy-benzaldehyde self-ligation (points) and the microkinetic
model with substrate-dependent enzyme inactivation (model 4, dotted lines). The respective pa-
rameter estimates are given in Table A.16 with reaction conditions according to Figure A.36
and Table A.15.
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Figure A.45: Fits for the benzaldehyde self-ligation and the microkinetic model with substrate-
dependent inactivation (model 4). Symbols as described in Figure A.37. The respective pa-
rameter estimates are given in Table A.17 with reaction conditions according to Figure A.37
and Table A.15.
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Table A.18: Estimated kinetic parameters for two substrates and the Michaelis-Menten model.
Relative standard deviations (%) are given in italics. The residual sum of squares (RSS) over
sample size n is indicated for nine experiments containing n = 2786 samples for 3,5-dimethoxy-
benzaldehyde self-ligation (Zavrel et al., 2008) and thirteen experiments containing n = 374
samples for benzaldehyde self-ligation (Ohs et al., 2018).
Data source kcatf [min
−1] KmA [mM] RSSn [mM
2]
3,5-dimethoxybenzaldehyde self-ligation
9.6 · 106 1.4 · 104
0.05
1 .8 · 10 4 1 .8 · 10 4
benzaldehyde self-ligation
5.7 · 105 3.4 · 104
0.4
9 .0 · 10 3 9 .0 · 10 3
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